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Amyotrophic lateral sclerosis (ALS) is a devastating disease which affects both motor 
neurons and skeletal muscle.  Skeletal muscle atrophy and weakness are two of the main 
features of ALS disease progression.  We hypothesized that disruptions in the 
sarcoplasmic reticulum and endoplasmic reticulum (SR/ER) play an important role in 
skeletal muscle pathology in ALS.  This dissertation is comprised of three studies 
investigating ER stress in skeletal muscle and its relationship to oxidative stress and SR 
Ca2+ regulation.  Study#1 established that the ER stress markers PERK, IRE1α and 
Grp78/BiP as well as the ER-stress specific apoptotic marker CHOP are upregulated in 
skeletal muscle of ALS transgenic (ALS-Tg) mice and that these changes were greater in 
fast white vs. slow red muscles.  Study #2 showed that skeletal muscle-specific 
overexpression of the SR Ca2+ ATPase SERCA1 improved motor function, delayed 
disease onset and attenuated the muscle atrophy in ALS-Tg mice but did not attenuate the 
ER stress markers.  Study #3 investigated the potential molecular mechanisms of ER 
 
 
stress in skeletal muscle pathology in ALS. This final dissertation study showed that the 
Grp78/BiP protein interacts with SERCA1 and various mitochondrial proteins including 
ATP synthase subunits in skeletal muscle of ALS-Tg but not wild-type mice. Disruption 
of the Grp78/BiP-SERCA1 protein-protein interaction by antibody sequestration of 
Grp78/BiP decreased SERCA ATPase activity, suggesting that Grp78/BiP preserves 
SERCA function.  In C2C12 myocytes, oxidative stress induced by H2O2 dramatically 
decreased SERCA ATPase activity and catalase, which removes H2O2, could recover 
SERCA ATPase activity.  Inhibition of ER stress by 4-PBA partially rescued H2O2-
induced decreases in SERCA ATPase activity suggesting that this mechanisms can 
mitigate oxidative stress-induced SERCA impairment.  Collectively, these studies 
provided insight into the cellular mechanisms underlying skeletal muscle dysfunction in 
ALS and suggest a role for ER stress chaperone proteins in minimizing Ca2+ overload 
damage in skeletal muscle. These data further suggest that the ER stress pathway could 
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Chapter 1: Introduction and Specific Aims 
 
Background 
Amyotrophic lateral sclerosis (ALS) is a devastating disease which affects both 
motor neurons and skeletal muscle (1).  It affects approximately 30,000 people in the 
USA and the prevalence is 3-5 people/100,000 each year (1).  Therefore, ALS is defined 
as a rare disease. Most ALS cases are sporadic with no known family history. However, 
the familial type of ALS, which contributes to ~10% of all ALS cases, has led to the 
identification of genetic causes of ALS (1). Mutations in the superoxide dismutase 1 
(SOD1) gene were first identified in 1993 as a genetic cause of ALS (2; 3). Shortly 
thereafter, a mouse model of the Glycine to Alanine at codon 93 (G93A*SOD1) SOD1 
mutation was generated and found to reproduce the ALS phenotypes (4) and this has been 
used as a valuable tool to understand the pathobiology of ALS.     
ALS was traditionally viewed as a neurodegenerative disease, in which neuron 
degeneration causes muscle weakness (1).  However, accumulating evidence indicated 
that skeletal muscle atrophy was temporally independent of motor neuron death, 
suggesting that muscle-specific pathological events could induce cell death in skeletal 
muscle of ALS (5).  Indeed, skeletal muscle-specific overexpression of mutant SOD1 
proteins was shown to induce skeletal muscle atrophy and ALS-like phenotype in mice 
(6). Moreover, when mutant SOD1 proteins were overexpressed in skeletal muscle, motor 
neuron cell death was observed, suggesting the important role of skeletal muscle in 
inducing ALS pathophysiology (6).  Therefore, a better understanding of pathological 
mechanisms in skeletal muscle could be valuable and may lead to novel therapeutic 
methods to treat ALS. 
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Our previous study using the G93A*SOD1 mutant ALS mouse model showed 
that elevated resting intracellular calcium level was evident in the early pre-symptomatic 
stage, when the mice do not show any symptoms (7).  Intracellular calcium level is 
tightly regulated and disruptions of calcium level are linked to the activation of various 
cellular stress signals, including endoplasmic reticulum stress (ER stress) (8).  Activation 
of ER stress involves several ER stress markers including ER stress sensors protein 
kinase RNA-activated-like ER kinase (PERK), inositol-requiring kinase 1-alpha (IRE1α), 
activating transcription factor 6 (ATF6), ER chaperones chaperone immunoglobulin 
binding protein (Grp78/BiP), protein disulfide isomerase (PDI), and ER stress-specific 
cell death signals including C/EBP homologous protein (CHOP) and caspase-12 (9).  In 
Study #1 we have shown that ER stress is induced in skeletal muscle of the G93A*SOD1 
mouse model of ALS (10).  Based on these findings, we hypothesized that ER stress 
activation contributes to muscle atrophy in ALS mice based on several lines of evidence: 
1) ER stress-specific cell death signal CHOP was upregulated at early pre-symptomatic 
stage and was increased further when mice were in the late symptomatic stage, 
suggesting  that CHOP expression is related to disease progression; 2) activation of ER 
stress is a skeletal muscle-specific event; and 3) ER stress activation was induced more in 
fast white than in slow red muscle fiber type, consistent with the preferential decline in 
fast motor units  in this ALS mouse model (11).   
SERCA1 is an ATP-dependent calcium pump located on the ER membrane and 
responsible for taking up intracellular calcium into SR/ER lumen during skeletal muscle 
contraction (12). As the most abundant protein in the SR/ER, SERCA1 is essential to 
preserve calcium homeostasis and decreased SERCA1 function has been linked to 
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various muscle pathological conditions such as in muscular dystrophy and muscle 
atrophy (12; 13). 
Based on our findings that elevations in skeletal muscle intracellular Ca2+ was 
associated with ER stress during symptom progression in the G93A*SOD1 mice, we 
tested the hypothesis that increasing intracellular Ca2+ clearance with increased 
overexpression of the SR Ca2+ ATPase pump (SERCA1) would attenuate the muscle 
atrophy and ER stress.  In Study #2 (Chapter 4) muscle-specific SERCA1 overexpressing 
mice were crossed with the G93A*SOD1 mice to generate G93A*SOOD1/+SERCA1 
mice.  This mice had a reduction in muscle atrophy, improved grip function and a delay 
in disease progression in G93A*SOD1/+SERCA1 mice (Chen et al.. manuscript in 
review; Chapter 4).  While this suggested a recovery of the pathophysiology of skeletal 
muscle with increased SERCA1 expression and increased intracellular Ca2+ clearance, 
there was not a decrease in Grp78/BiP or the ER stress apoptotic marker CHOP.  Our 
results indicated that the rescue effects of SERCA1 overexpression on ALS mice could 
be independent of inhibition of the ER stress pathway.  These data also indicate that 
skeletal muscle pathology involves various pathological mechanisms and that other 
mechanisms such as oxidative stress and mitochondrial dysfunction contribute to the 
disease pathology (14).  Therefore, it is not surprising that SERCA1 overexpression 
improved skeletal muscle function via modulating some other pathological factors.  
However, considering that SERCA1 proteins are the most abundant proteins in skeletal 
muscle, we cannot rule out the possibility that overexpression of SERCA1 proteins leads 
to ER protein overload and thus induced the activation of ER stress.  Indeed, in our study, 
SERCA1 overexpression was shown to induce upregulate ER stress markers even in 
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skeletal muscle of wild type mice (Chapter 4). Nevertheless, our SERCA1 
overexpression in ALS mice study clearly showed that SERCA1 protein is critical to 
preserve skeletal muscle function in ALS mice.  Moreover, improved skeletal muscle 
function is consistent with a delayed disease progression, suggesting that skeletal muscle 
pathology plays a very important role in inducing whole body pathogenesis in ALS.  
A separate in vivo drug treatment study also supports our notion that SERCA1 
function is critical to preserve skeletal muscle function and an improved phenotype in 
ALS-Tg mice. When G93A*SOD1 mice were treated in vivo with 6-gingerol, a 
compound previously shown to increase SERCA1 activity in vitro, there were 
improvements in muscle grip function and an attenuation of ER stress markers Grp78/BiP 
and CHOP ((15); manuscript in preparation).  Since 6-gingerol has also been shown to 
have anti-oxidant properties (16), we hypothesized that the efficacy of this compound in 
reducing ER stress may be due, at least in part, to the anti-oxidant properties of 6-
gingerol.  This would also explain why SERCA1 overexpression in itself had different 
effects from 6-gingerol.  
Mutant SOD1 proteins are thought to induce the ALS phenotype via a “gain-of-
function” effect (17).  SOD1 proteins are responsible for catalyzing superoxide free 
radicals to hydrogen peroxide (H2O2), which is then degraded to O2 and H2O by catalase. 
However, hyper-activity of mutant SOD1 proteins induces oxidative stress by over 
producing H2O2.  Therefore, oxidative stress, particularly excess H2O2 is suggested to be 
the main contributor to inducing skeletal muscle pathology in ALS.   Collectively, our 
results revealed that: i) intracellular Ca2+ regulation is altered and ER stress activated in 
skeletal muscle of ALS mice; and ii) ER stress was not rescued by SERCA1 
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overexpression but was attenuated by a compound with anti-oxidant properties.  Thus, we 
further hypothesized that the oxidative stress along with altered Ca2+ regulation could be 
causally linked to the skeletal muscle ALS pathobiology in the G93A*SOD1 mice.       
The purpose of Study #3 (Chapter 5) was to investigate the role of oxidative stress 
and ER stress in the skeletal muscle pathobiology in ALS. Based on our previous studies 
showing that Grp78/BiP was dramatically upregulated in skeletal muscle of G93A*SOD1 
mice (10) and was attenuated by the in vivo treatment of these mice with 6-gingerol (15), 
this project specifically focused on oxidative stress and Grp78/BiP protein.  Grp78/BiP is 
a member of 70 kDa heat shock proteins (hsp70) family and has been shown to be 
upregulated under ER stress conditions and thus used widely as a classical marker for ER 
stress activation (18).  Moreover, Grp78/BiP is an ER chaperone and required to maintain 
ER function.  Previous studies established the role of protein-protein interactions of 
Grp78/BiP with other proteins in preserving ER function and cellular homeostasis by 
binding to unfolded/misfolded proteins and directing their intracellular folding and 
translocation (18). The biological significance of Grp78/BiP is demonstrated by studies 
showing that Grp78/BiP is important in protein quality control pathways such as ER-
associated protein degradation (ERAD) and ER stress-induced autophagy (9).  In light of 
these facts, a better understanding of Grp78/BiP protein interacting patterns in skeletal 
muscle is essential to elucidating the mechanisms of the protective role of Grp78/BiP in 
preserving ER function and cellular homeostasis.  Preliminary data revealed that one of 
the Grp78/BiP binding partners was SERCA1, further prompting investigation into the 
protein-protein interaction and functional relationship between Grp78/BiP and SERCA1 




Specific Aim 1: To investigate Grp78/BiP protein-protein interactions in skeletal 
muscle of wild type and ALS mice using Grp78/BiP co-immunoprecipitation (Co-IP) 
and MS/MS-based proteomics techniques.   
Hypothesis: analysis of Grp78/BiP Co-IP products using MS/MS will identify 
novel binding proteins in skeletal muscle and these will differ between skeletal muscle of 
wild type and ALS animals, both in proteins identified and protein abundance.   
As previous mentioned, Grp78/BiP conducts its protective role in maintaining ER 
function via binding to unfolded/misfolded proteins (19).  Studies also indicated that the 
interaction of Hsp70s and their targeting proteins is a beneficial event under several 
cellular stress events via enhancing SERCA1 function (20).  Our preliminary data 
showed that SERCA1, a key calcium pump located in ER membrane in skeletal muscle, 
was identified in the Grp78/BiP co-IP products.    
Specific Aim 2: To investigate the effects of Grp78/BiP and SERCA1 interaction on 
SERCA function.  
Hypothesis: SR Ca2+ ATPase activity in SR vesicles isolated from skeletal muscle 
of mice will decrease when incubated with Grp78/BiP antibody compared with no 
antibody or control IgG antibody incubation. 
Oxidative stress has been associated with disease pathology including skeletal 
muscle pathology in ALS and its role in initiating cell death has been documented (21).  
Moreover, other studies report that oxidative stress could activate ER stress and its 
biological consequences need to be further evaluated (22; 23).  In the light of these facts, 
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we hypothesized that oxidative stress contributes to decreased SERCA1 ATPase activity 
and elevated intracellular calcium level (7).     
Specific Aim 3: To investigate the role of oxidative stress in inducing ER stress 
response and regulating SERCA function in a C2C12 cell culture model.   
Hypothesis #1: In C2C12 myotubes, hydrogen peroxide (H2O2) treatment will 
activate ER stress and decrease SR Ca2+ ATPase activity. 
Hypothesis 2:  Catalase and the chemical chaperone 4-phenyl butyric acid (4-PBA) 




Chapter 2: Review of Literature 
 
Amyotrophic lateral sclerosis 
 
Amyotrophic lateral sclerosis (ALS), also termed Lou Gehrig’s disease in the 
United States, was first reported in 1869 by Jean Martin Charcot, a French neurologist 
and anatomical pathology professor (1). Based on his observations, the characterization 
of ALS was described as “a progressive death of upper and lower motor neurons”.  
Subsequent research confirmed that degeneration of upper motor neurons was found in 
the motor cortex of the brain, which contributed to ALS syndrome by causing excessive 
muscle contraction from neuron hyper-excitability (1). The degeneration of lower motor 
neurons was found in the brain stem, which, it suggested, contributed to muscle atrophy 
and muscle weakness (1).   
ALS is a devastating neurodegenerative disease without expeditious diagnosis and 
effective treatment (24). It affects three out of 100,000 people a year in the United States 
(1; 25; 26).  Most people are diagnosed with ALS between 45-55 years of age, and 
disease cases decrease dramatically after 80 years of age (27-29). ALS has been 
characterized as two types: familial and sporadic.  Familial ALS, which occurs in a 
family lineage and accounts for ~5 to 10% of all ALS cases, has been shown to be 
associated with several gene mutations such as superoxide dismutase 1 (copper/zinc, 
SOD1), Tat DNA binding protein (TDP-43), and chromosome 9 open reading frame 72 
(C9ORF72) (29-31).  Mutations in SOD1 protein contribute to around 20% of total 
familial ALS cases (Figure 2.1) (29).  This finding prompted the development of the 
SOD1 G93A transgenic mouse model by Gurney et al. (4; 32). SOD1 G93A transgenic 
mice replicate many of the ALS hallmarks seen in ALS patients, including loss of motor 
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neurons and development of progressive muscle paralysis.  Therefore, this mouse model 
has been widely used to study pathophysiological mechanisms of this disease (4; 32).  
Most ALS cases (~90%) are sporadic with unknown causative factors (1). Several 
environmental conditions have been proposed to be linked with sporadic ALS 
pathogenesis, including Guamanian ALS, and a higher incidence of disease in US Air 
Force and professional leagues soccer players (1).  However, epidemiological studies 
failed to distinguish any specific factors contributing to development of those ALS 
phenotypes.  Although the causes of sporadic ALS are still uncertain, it is suggested that 
those two forms of ALS share similar pathophysiological mechanisms (33; 34).  
ALS has long been recognized as a typical neurodegenerative disease, in which 
motor neuron degeneration is mediated by the excessive activation of various 
postsynaptic receptors (35).  According to this hypothesis, ALS pathology originates 
from motor neuron disorder, and skeletal muscle dysfunction is recognized as a 
secondary event resulting from degeneration of the motor system (36).  Glutamate-
induced cellular toxicity has been suggested to initiate the “dying-forward” process in the 
Figure 2.1. Superoxide dismutase (Cu-Zn) SOD1 
protein. SOD1 binds to copper and zinc ions and is 
responsible for removal of free superoxide radicals 
in cells by the chemical reaction converting 
superoxide to oxygen and hydrogen peroxide, which 
is then neutralized by catalase enzymes.   
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neurodegeneration in ALS.  Glutamate is a neurotransmitter in the nervous system. 
Immoderate releasing of glutamate, which is termed as glutamate-induced excitotoxicity, 
was suggested to trigger neurodegeneration via a calcium-dependent cell death signal 
pathway (37-39).  Several lines of evidence collected by Baker et al. support the “dying-
forward” model as clinical studies showed that over-excitability of the cortical area 
occurred early in sporadic ALS patients and came before onset of the disease in familial 
ALS patients (5).  The “dying-forward” hypothesis is further supported by the fact that a 
clinical drug, Riluzole, which is an inhibitor of glutamate releasing, has been shown to 
improve the survival of ALS patients by repressing cortical hyper-excitability (37; 38). 
Besides glutamate-induced pathogenesis of ALS, other mechanisms proposed to explain 
ALS include mitochondrial dysfunction, increased oxidative stress, and protein 
aggregates-induced ER stress (Figure 2.2) (24).     
11 
 
Mitochondrial dysfunction - Mitochondria damage and dysfunction is involved in 
a range of human diseases because of its primary role in cell energetics, preserving 
cellular homeostasis, buffering intracellular calcium levels, and initiating mitochondrion-
dependent cell death signals (40).  Consequently, mitochondrial dysfunction has been 
emerging as a main contributor to the pathogenesis of various neurodegenerative diseases 
including Alzheimer’s disease, Parkinson’s disease, and ALS (Figure 2.3) (41).   
In ALS, mitochondrial dysfunction is suggested as an important factor inducing 
ALS pathogenesis. Autopsy analysis of sporadic ALS cases conducted by Wong et al. 
showed that aberrant mitochondria were present in various pathological tissues including 
Figure 2.2. Mutant SOD1 induced cellular toxicity in motor neurons of ALS. 
Motor neuron degeneration in ALS has been shown to involve in various pathological 
events such as glutamate excitotoxicity, mitochondrial dysfunction, oxidative stress, 
and protein aggregates.  Adapted from figure 2 from Kiernan, et al, 2011.    
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proximal axons, anterior horns, and skeletal muscle (41).  Moreover, previous studies 
suggested that the morphological and ultrastructural alterations in mitochondria were 
linked to the decrease in their function (42; 43). Indeed, it has been shown that 
mitochondrial function in ALS patients was consistently impaired, as indicated by 
decreased mitochondrial electron transfer chain activity, mitochondrial DNA damage, 
resulting decreased respiratory function, over-production of free radicals, and 
dysregulation of calcium signals in motor neurons (35; 44; 45).  Despite the presence of 
mitochondrial dysfunction in ALS, questions remain over whether mitochondrial disorder 
is a primary cause of ALS pathogenesis or simply a pathological consequence of motor 
neuron degeneration.   
 
The use of animal models of ALS has provided a better understanding of the role 
of mitochondrial dysfunction in ALS pathogenesis.  Histological examinations of motor 
neurons in ALS mice showed the presence of abnormal membrane-bound organelles, 
which were suspected to be the product of mitochondrial degradation (4).  Furthermore, 
Figure 2.3. Mutant SOD1 induced mitochondrial dysfunction in ALS. Mutant 
SOD1 has been reported to translocate to mitochondria and interact with mitochondrial 
proteins such as Bcl-2 and translocation machinery proteins, resulting in release of 
cytochrome C and induce mitochondria-dependent apoptosis pathway.  
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those abnormal membrane-bound organelles were suggested as a primary factor inducing 
cellular pathological change. A systematic study conducted by Palomo et al. (46) using 
SOD1*G93A mice showed that the excessive emerging of those organelles in spinal 
cords were related with the onset of ALS disease, which is defined by a sudden decreased 
muscle strength and function without massive motor neuron death.  This indicated that 
mitochondrial disorder might be a cellular event triggering early onset of the disease, not 
merely a consequence of motor neuron degeneration.   
Mutant SOD1 proteins-induced cell toxicity was indicated to cause pathological 
changes of mitochondria and decreased mitochondrial function in ALS, as one study 
conducted by Nguyen et al. (47) showed mitochondrial depolarization, a biomarker 
indicating respiratory chain dysfunction, when neuroblastoma cells were transfected with 
mutant SOD1.  Besides the decrease in mitochondrial function, a higher intracellular 
calcium level was also seen in this study, indicating impaired mitochondrial calcium 
buffering capacity (47).  The use of SOD1*G93A ALS mice study further supported this 
notion. Yi et al. (48) showed dysregulation of mitochondrial respiratory chain enzymes 
and increased cytoplasmic calcium level were observed in isolated primary motor 
neurons of ALS mice.   
Decreased mitochondrial function and impaired calcium buffering capacity 
induced by mutant SOD1 proteins could also contribute to the motor neuron degeneration 
seen in ALS (12; 23; 49).  Decreased mitochondrial calcium buffering capacity is 
speculated to be involved in glutamate-induced excitotoxicity in motor neurons.  This 
notion is supported by finding that moto neuron overexpression of GLUR2, which is a 
calcium-permeable AMPA receptor, attenuated disease progression in SOD1 G93A ALS 
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mice (50; 51). Second, an increase in intracellular calcium level is associated with the 
elevated production of free radicals from mitochondria, which is suggested to induce cell 
death (35; 52; 53).  This notion is partly supported by the studies conducted by An et al. 
(54) showed that treatment of antioxidant chemicals had beneficial effects on mutant 
SOD1 ALS mice.  Upon the existence of mitochondrial dysfunction, cells could initiate 
mitochondria-dependent apoptotic cell death pathways via releasing pro-apoptotic factors 
such as cytochrome c, Bad, Bid, and Bim (55-57).  Mitochondria-dependent apoptotic 
cell death pathway are involved in motor neuron degeneration in ALS and cytochrome c 
has been shown to be released and lead to activation of caspase-9 in the motor neurons of 
SOD1*G93A ALS mice (58).  Therefore, inhibition of mitochondria-dependent apoptotic 
cell death pathway is considered a therapeutic strategy to treating ALS.  It has been 
shown that overexpression of Bcl-2, which is an anti-apoptotic factor, attenuated motor 
neurons loss and disease progression in mutant SOD1 ALS mice (59).  Besides the use of 
transgenetic methods, pharmacological intervention suppressing the releasing of pro-
apoptotic factors was shown to have beneficial effects.  Minocycline treatment, a 
chemical inhibiting cytochrome c release, was shown to delayed disease progression in 
transgenic ALS mice (60-62).   
Oxidative stress - It is still debatable that whether oxidative damage in ALS is a 
secondary event as a consequence of disease or a predominant factor causing ALS 
pathogenesis (14; 63; 64).  Genetic SOD1 mutations, which play an important role in 
regulating cellular oxidative/redox status, contribute to around 15% of all familial ALS 
cases (65).  Based on these observations, mutant SOD1 proteins were speculated as a 
primary factor inducing ALS pathology. Several hypotheses were proposed to interpret 
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mutant SOD1 induced toxicity: 1) “loss of function” of mutant SOD1 proteins leads to 
generation of high level of superoxide and peroxynitrite; 2) “dominant-negative” 
mechanism is induced by mutant SOD1, in which mutant SOD1 proteins are proposed to 
lose the activity as well as repress normal SOD1 proteins; 3) “gain-of-function” of 
mutant SOD1 results in over-production of reactive oxygen radicals (4; 17).  “Loss-of-
function” and “dominant-negative” mechanisms of mutant SOD1 have now been 
dismissed since SOD1 knockout mice do not show ALS phenotypes, suggesting that 
mutant SOD1 proteins acquire toxicity in a “gain-of-function” manner (4; 66; 67).  
The oxidative stress-induced cellular toxicity in ALS was proposed based on the 
“gain-of-function” principle of mutant SOD1 proteins (4). SOD1 proteins are involved in 
catalyzing super oxygen into hydrogen peroxide (Figure 2.1).  Mutant SOD1 proteins 
prompt the over-production of reactive hydroxyl radicals such as hydrogen peroxide, 
resulting in a succession of reactions that trigger oxidative damage.  Animal studies 
further confirmed this notion. Previous studies conducted by Cookson et al. showed that 
the disease progression in SOD1 G93A mice was consistent with the oxidized products 
(17; 68).  Besides reactive hydroxyl radicals, peroxynitrite was suggested to be another 
candidate contributing to oxidative damages mediated by mutant SOD1 proteins (14).  
This notion was based on the fact that elevated levels of 3-nitrotyrosine, which is used as 
a marker to evaluate oxidative damage induced by peroxynitrite, were seen in both 
mutant SOD1 transgenic ALS mice and ALS patients (69).    
Considering its important role in inducing ALS pathology, oxidative stress has 
long been recognized as an attractive mechanism for developing therapeutic treatment for 
ALS (70-72).  Many clinical trials have been carried out evaluating anti-oxidant 
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treatments but efficacy was surprisingly disappointing (73; 74). For example, Vitamin E, 
which is a fat-soluble antioxidant stopping production of reactive oxygen species, has 
been tested in several well controlled double-blind studies (73).  In one study, 289 
patients diagnosed with ALS less than five years before being enrolled were treated with 
a 500mg Vitamin E twice a day for 12 months.  Although it was stated that ALS patients 
in the vitamin E treatment group had less chance to develop into a more aggressive state 
of ALS, the treatment had no significant effect on some other key outcome measures as 
well as no effects on the survival rate (74).  To rule out the possibility of using a sub-
optimal dose, another study (83) used a higher dose of Vitamin E (5000 mg) treatment in 
160 ALS patients for 18 months.  Consistent with the previous study, no significant 
treatment effect was seen in this study and there was no evidence showing improvement 
in disease endpoint tests such as assisted ventilation and time to death rate (73; 74).  
Based on these observations, doubts were raised about whether oxidative stress plays a 
primary role in modulating ALS disease progression. Consequently, to better understand 
the lack of efficacy of the Vitamin E treatment, other factors, such as drug 
pharmacokinetics, needed to be considered.  Vitamin E would need to be delivered into 
the right tissues and cells (i.e. to motoneurons) to perform its anti-oxidation effect.  A 
dose-response study investigating vitamin E levels in fluids of different parts of the body 
indicated that vitamin E was not delivered readily to the central neuron system, which 
partly explained why both moderate and high amount dosage of vitamin E had no 
significant effect on ALS disease progression (73; 74). In light of this finding, other anti-
oxidants with improved SNS penetrance would need to be developed and tested.     
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Mitochondria are considered as the main site producing reactive oxygen species 
and a great quantity of evidence showing that mitochondrial dysfunction is a major 
contributor to ALS pathology (64; 75).  As mentioned previously, mitochondria 
morphological alterations and dysfunction have been observed in motor neurons and 
skeletal muscle of both ALS patients and ALS animal models (66; 76; 77).  In light of 
those facts, therapeutic strategies targeting both oxidative damage and mitochondrial 
dysfunction would be more favorable (Figure 2.4).   
 
Protein Aggregates - Neurodegenerative diseases are commonly characterized by 
intracellular aberrant protein aggregates but it is still questionable whether protein 
aggregates are involved in disease pathogenesis or are simply an inoffensive cellular 
defense event eliminating harmful mutant proteins (78-81).  The early formation of 
Figure 2.4. Mutant SOD1-mediated activation of oxidative stress.   Oxidative 
stress is induced in pathological tissues of ALS via “gain-of-function” mechanism 
and associated with various cellular toxicity events including DNA damage, 




SOD1-enrich protein aggregates was found in pathological tissues of both ALS patients 
and animal models, as well as in cells with expression of mutant SOD1, indicating it as a 
typical pathological event in ALS (82; 83).  The formation of mutant SOD1-enriched 
protein aggregates was thought to be due to defects in mutant SOD1 protein metal 
binding region. In the normal condition, the SOD1 protein structure is maintained by the 
metal ions; however, mutant SOD1 proteins, such as in G85R form, are more likely to 
form protein aggregates due to the weaker metal ion binding capacity, resulting in 
decreased thermal stability and high susceptibility of forming aggregates (84).  Studies 
conducted by several groups showed that SOD1-enriched protein aggregates existed prior 
to the manifestation of ALS symptoms and were concomitant with disease progression, 
suggesting that it is likely an early event involved in ALS pathogenesis (82; 85-87).  
Several mechanisms have been proposed to interpret mutant SOD1-induced toxic 
properties including mutant SOD1-mediated coaggregation of essential components, low 
efficiency of ubiquitin-mediated removal of mutant SOD1 proteins, and impaired 
chaperone capacity to properly fold proteins in the ER lumen (86; 88; 89).   
Previous studies indicated that there was a tight link between mutant SOD1-
enriched protein aggregates, mitochondrial dysfunction, and oxidative stress (33).  
Normal SOD1 proteins are mainly located in cytoplasm. However, mutant SOD1 proteins 
were found to be ectopically translocated to other organelles such as within mitochondria 
and the intermembrane spaces, indicating their pathological role in initiating 
mitochondrial pathological changes such as impaired respiratory activity, overproduction 
of reactive oxygen species, and activation of mitochondrial-dependent cell death signals 
(4; 26; 40; 90).  Removal of mutant SOD1-enriched protein aggregates has also been 
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shown to be an effective therapeutic method to slow down ALS disease progression (91-
93). For example, selective degradation of protein aggregates by overexpressing Dorfin, 
which is a RING finger-type E3 ubiquitin ligase, was found to alleviate mutant SOD1-
induced toxicity and protect neuron cells from different lines of SOD1 mutations (93).  
Furthermore, transgenic overexpression of 70 kDa heat shock protein in a mouse model 
of ALS was shown to reduce the formation of protein aggregates, preserve motor neuron 
survival, and increase the viability rate (94).   
Unfolded Protein Response & ER Stress 
 
In Eukaryotic cells, the endoplasmic reticulum (ER) is a highly developed 
organelle which is essential to conduct various cellular processes such as preserving 
intracellular calcium homeostasis and protein synthesis (9; 18; 21; 95; 96).  The newly 
synthesized polypeptides are translated into the ER lumen, where proteins are 
continuously translated with the assistance of ER chaperones and get properly folded.  
Before being transported to the Golgi compartment, newly synthesized proteins 
experience a cellular “quality control” event, in which misfolded or unfolded proteins are 
either conserved in the ER lumen for further modifications or guided to a protein 
degradation pathway called ER-associated degradation (ERAD) (9; 18).   
Numerous pathological events such as calcium depletion and changes of 
oxidative/redox status in the ER lumen, could result in accumulation of a large quantity 
of misfolded and unfolded proteins in the ER, which is known to activate a cellular stress 
response named unfolded protein response (UPR) or ER stress (Figure 2.5) (8; 97).  Short 
term ER stress activation is manageable with the primary goal to preserve normal ER 
function and cellular homeostasis by upregulating proteins involved in ER folding 
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capacity and protein degradation. However, prolonged or severe ER stress is harmful and 
has been showed to induce apoptosis via activation of the ER stress-specific cell death 
pathway (9).   
 
Figure 2.5. Unfolded Protein Response (UPR) and ER stress pathway.   Under normal 
condition, ER stress sensors PERK, IRE1, and ATF6 bind to Grp78/BiP (BiP) and are 
inhibited.  Upon accumulation of misfolded and unfolded proteins, BiP is preferable to 
bind to those proteins and then ER stress are activated.  The consequence of activation of 
ER stress is to upregulate ER chaperones, which are essential for proper protein folding; if 
fails to handle the stress, ER stress-specific cell death pathway will be induced via 
upregulation of CHOP and cleavage of caspase-12. 
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Under normal conditions, three specific ER stress sensors, inositol-requiring 
kinase 1 (IRE1α), protein kinase RNA-like endoplasmic reticulum kinase (PERK), and 
activating transcription factor 6 (ATF6), are retained and inhibited by an ER membrane 
protein Grp78/BiP (78 kDa - glucose regulated protein) (9; 98).  Upon the accumulation 
of misfolded and unfolded proteins in the ER lumen, Grp78/BiP binds to those abnormal 
proteins and moves away from ER stress sensors IRE1α, PERK, and ATF6 (9; 99).  
Consequently, ER stress sensors are aggregated and activated, resulting in a succession of 
events that attenuate the production of misfolded and unfolded proteins in the ER lumen 
by upregulating ER chaperones, repressing mRNA translation, and directing misfolded 
and unfolded proteins to proteasome for protein degradation (9).  If the ER stress 
response is not able to reduce the accumulation of misfolded and unfolded proteins, the 
ER stress-specific cell death pathway is induced, including upregulation of the pro-
apoptotic transcription factor C/EBP homologous protein (CHOP) and caspase-12 
(Figure 2.5) (9; 100; 101).  
IRE1α – IRE1α belongs to the type I transmembrane protein that is located on the 
ER membrane with two functional sequences: a serine/threonine protein kinase domain 
and a ribonuclease endonuclease domain (102).  Under normal conditions, IRE1α 
interacts with Grp78/BiP and thus retains its nonfunctioning form.  Accumulation of 
misfolded and unfolded proteins results in departure of Grp78/BiP and the formation of 
IRE1α homodimers, and initiation its endonuclease activity by autophosphorylation (103).  
The comprehensive effect of IRE1α phosphorylation is to regulate gene expression and to 
induce posttranslational modifications of mRNAs encoding secreted proteins 
participating in ER stress and ERAD pathways. Consequently, activation of IRE1α 
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results in repression of protein synthesis and release of protein overload in the ER lumen 
(104; 105).  Specifically, one primary target of IRE1α endonuclease activity is X-box 
binding protein (Xbp-1). Activation of IRE1α yields a spliced and active form of Xbp-1, 
which is known as a transcriptional factor and regulates various gene expressions 
involved in ER stress and ERAD pathways (96; 102).  Cells with either IRE1α or Xbp-1 
knockout fail to initiate ER-induced protein degradation, indicating their importance in 
protein homeostasis (9).   
The IRE1α – Xbp-1 pathway has also been shown to play an essential role in a 
mammalian survival and tissue development (96; 106; 107).  Knockout of either IRE1α 
or Xbp-1 results in embryonic lethality in mice (96; 102).  Furthermore, although 
heterozygous Xbp-1 knockout mice show a normal phenotype, these mice develop insulin 
resistance under a high-fat diet challenge (108).  In addition, the ER stress signaling 
pathway-mediated IRE1α activation and Xbp-1 splicing has been shown to play an 
essential role in mediating beta cell differentiation as one study showed that cells with 
IRE1α deficiency had the ability to product pro-beta cells but not mature beta cells (109; 
110).  IRE1α – Xbp-1 was required to produce beta cell receptors and to allow the 
translocation of mature beta cells into antibody-secreting plasma cells, indicating the 
importance of IRE1α – Xbp-1 in each stage of beta lymphopoiesis (109; 110).  IRE1α 
also has been reported to be involved in cell death mechanisms as it has been shown to 
interact with various pro-apoptotic and anti-apoptotic cell death factors including B-cell 
leukemia/lymphoma 2 (Bcl-2) family protiens, Bcl-2 killer (BAK), and Bcl-2 associated 
X protein (Bax) (111).  The IRE1α-mediated activation of apoptosis signal-regulating 
kinase (ASK1) and Jun N-terminal kinase (JNK) has been reported to prompt cell death 
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mechanism via activation pro-apoptotic factor BIM, which belongs to the Bcl-2 family 
(112; 113).  Besides modulating various cell death pathways, IRE1α was also known to 
activate a list of cysteine proteases such as caspase-12 (mouse) and caspase-4 (human) 
proteins (100; 114).  Caspase-4 has been recognized as an ER stress-specific cell death 
factor as previous studies showed that cells with caspase-4 deficiency were resistant to 
ER stress-induced cell death but not to mitochondrial dysfunction-induced cell death 
signals induced such as in UV exposure and DNA toxins conditions (115-117).   
PERK – upon activation of ER stress, the cellular response is expected to reduce 
protein synthesis and secretion through the ER lumen, thus ER homeostasis can be 
preserved.  The ER stress-mediated activation of PERK phosphorylation has been shown 
to contribute to this process by activating various downstream signaling factors, such as 
phosphorylation of eukaryotic translation initiation factor 2 alpha (eIF2α) (118).  PERK 
is a transmembrane protein kinase located on the ER membrane and interacts with 
Grp78/BiP in its inactive form (104).  Upon activation of ER stress, Grp78/BiP 
preferentially interacts with misfolded and unfolded proteins in the ER lumen, resulting 
in oligomerization and autophosphorylation of PERK.  PERK-mediated phosphorylation 
of its downstream signal eIF2α has been shown to slow down mRNA translation events 
and thus relief ER protein overload.   On the other hand, phospho-PERK activates  
selective mRNA translation such as activating transcription factor 4 (ATF4), which 
modulates various gene promoters encoding several genes involved in ER stress, ER 
chaperones, and protein metabolism (18; 104; 119). The essential role of the PERK 
pathway was confirmed by cell knockout studies, in which they showed that PERK 
deficienct cells could not activate eIF2α phosphorylation and were more sensitive to cell 
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death signals induced by ER stress, suggesting this pathway is important to preserve 
cellular homeostasis and ER function (9; 18).   
Besides phosphorylating eIF2α, PERK has also been shown to mediate other 
transcription factors such as nuclear respiratory factor 2 (NRF2), which is suggested to 
regulate protein expression involved in the oxidative stress response (120).  This notion is 
supported by the fact that PERK phosphorylation caused the translocation of NRF2 from 
cytoplasm to nucleus and that cells lacking NRF2 were more resistant to ER stress-
induced cell death signals, indicating that the PERK phosphorylation-mediated pathway 
protected cells from ER stress (121).  Although PERK autophosphorylation has a 
protective role during activation of ER stress, it has also been suggested to contribute to 
cell death.  Based on the observation that eIF2α phosphorylation can activate the pro-
inflammatory signaling protein nuclear factor kappa B (NFκB), which is a transcriptional 
factor linked to various pathological conditions such as in cancer, tissue atrophy, and 
autoimmune diseases, PERK activation of eIF2α may also be pro-apoptotic (9; 122-124).  
For example, our previous study (Chapter 3) showed that PERK was phosphorylated in 
skeletal muscle of a mouse model of ALS and one of its downstream signals 
CAAT/enhance binding protein (C/EBP) homolgous protein (CHOP) was upregulated 
accordingly, suggesting that ER stress-mediated activation of PERK may contribute to 
cell death in skeletal muscle (10; 125).  
ATF6 – Activating transcriptional factors (ATF6) alpha and beta have been 
identified as additional important ER stress sensors besides PERK and IRE1α (104).  
Instead of experiencing autophosphorylation after separating from Grp78/BiP, ATF6 is 
shown to translocate from ER membrane to the Golgi, where ATF6 is cleaved by certain 
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protease (104).  Consequently, as a transcriptional factor, the spiced form of ATF6 is 
released into the cytoplasm and then relocates to the nucleus to modulate gene expression 
(106).  Genes regulated by ATF6 include a list of targets that contribute to cell survival 
mechanisms including those that have chaperone activity and those that remove 
misfolded and unfolded proteins in the ER lumen, such as Xbp-1, Grp78/BiP, and ER 
degradation enhancing alpha-mannosidase like protein 1 (EDEM) (106).   
Grp78/BiP – The ER is considered to be one of the most dynamic cell organelles 
based on its interaction with other cellular components such as mitochondria and nuclei 
(18; 104; 119).  The ER is the main site for protein synthesis and calcium storage, and 
has been shown to play an important role in conducting cell signaling processes, 
modulating cellular stress, and maintaining cellular homeostasis (18; 119).   This notion 
is further supported by that fact that in eukaryotic cells the ER encompasses nearly 50% 
of its cellular membrane system.  As one of the most important ER chaperones, 
Grp78/BiP has been recognized as the predominant factor regulating ER function.  A 
large number of studies show that Grp78/BiP participated in various cellular processes 
including maintaining ER membrane integrity, managing protein folding, regulating ER-
associated misfolded protein degradation, preserving ER calcium homeostasis and 
modulating ER stress pathway (Figure 2.6) (18; 104; 119).   
Grp78/BiP is one of the Hsp70 family members with ATP binding sequences 
interacting with unfolded proteins (18).  Newly synthesis polypeptides are translocated 
into the ER lumen, where they experience further folding following post-translational 
modification with the assistance of a list of ER chaperones such as Grp78/BiP and PDI 
(18).  In most cases, the newly synthesized proteins are folded correctly; however, some 
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proteins or regions of a protein are not correctly modified and folded (18).  In this case, 
Grp78/BiP, with the assistance of its cofactors, recruit and bind to the unfolded regions of 
the proteins in an ATP-dependent manner (18).  After a cycle of protein folding events, 
the proteins are released from the ER to their home-components if folded properly, or 
experience another cycle of ATP-dependent folding and ultimately, directed to protein 
degradation process if the unfolded protein events are irreversible (18).   
 
Free intracellular calcium is recognized as a secondary messenger modulating 
various key cell processes (126).  The ER plays an essential role in controlling 
intracellular calcium level through regulation of several calcium transporters, channels, 
pumps, and buffering-proteins located on the ER membrane such as ryanodine receptor 
(RyR), inositol trisphosphate receptor, SERCAs, and Grp78/BiP (127).  The role of 
Grp78/BiP in handling intracellular calcium concentration has been established in studies. 
Cells with Grp78/BiP overexpression had a significant better capacity to bind 
intracellular calcium (128; 129).   
Figure 2.6. The primary role of Grp78/BiP in determining cell destiny under 
various cellular stress conditions.   Various cellular stress processes are known to 
activate ER stress pathway such as intracellular calcium disruption.  Grp78/BiP is 
suggested to play a central role in modulating different ER stress components to 
determine the cell destiny.  
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Recent evidence indicated that activation of autophagy is associated with the ER 
stress signaling pathway and that Grp78/BiP is essential for ER stress-induced autophagy 
activation (19).  This notion is based on the observation that cells with Grp78/BiP 
knockdown showed nutrition restriction-induced ER stress activation and LC3 
conversion, a hallmark of autophagy, but were deficient in forming double-membrane 
autophagosomes (19).  Furthermore, disruptions in ER integrity such as increased 
numbers of ER structures and ER lumen expansion were observed in cells with 
Grp78/BiP knockdown, suggesting that activation of autophagy was tightly associated 
with ER homeostasis and that Grp78/BiP played an essential role in initiating these cell 
processes (18; 119).   
Grp78/BiP protein has long been established as an ER-located chaperone as it 
contains an ER-residence sequence KDEL on the C-terminus (18).  However, the large-
scale study of cancer cell membrane proteins showed that Grp78/BiP was located on the 
cell surface, suggesting that activation of ER stress could lead to Grp78/BiP translocation 
from ER lumen to cell surface (129).  Grp78/BiP has also been reported to be present 
unusually in mitochondria and nuclei. The role of ER stress and uncommon expression of 
Grp78/BiP in deteriorating mitochondrial function was investigated (130; 131).  In those 
studies, it was reported that activation of ER stress could induce translocation of 
Grp78/BiP from the ER lumen to the plasma membrane, where Grp78/BiP was acting as 
a component of a receptor to initiate the translocation of a cell death signal protein ISM-1 
(130; 131).  After translocation to the cytoplasm, ISM-1 was shown to interact with a 
mitochondrial inner membrane protein ATP/ADP carrier.  This protein-protein 
interaction would impair the function of ATP/ADP carrier and thus disrupt its ability to 
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transport ATP and ADP, ultimately resulting in depletion of cytoplasmic ATP levels (130; 
131).  Although this study did not test the biological consequence of the depleted 
cytoplasmic ATP level directly, it is largely known that ATP depletion is one of the 
causes of mitochondrial-dependent cell death (130; 131). 
ER stress-induced cell death - Early activation of ER stress is an essential cellular 
event that aims to respond to various physiological/pathological challenges via 
upregulation of ER chaperones, repression of protein synthesis, and removal of 
unfolded/misfolded proteins (9).  However, chronic and persistent activation of ER stress 
can be irreversible and eventually leads to cell death (9).  ER stress-induced cell death 
has been linked to several deleterious conditions such as beta cell dysfunction in diabetes, 
development of neurodegenerative diseases, and cardiac muscle cell death (114; 116; 
132).  Having a better understanding of ER stress-induced cell death mechanisms and its 
related signals is essential to future development of therapeutic inventions to treat these 
diseases.  On the one hand, ER stress is a necessary cell biological event contributing to 
the preservation of normal cellular function; on the other hand, as mentioned previously, 
severe and prolonged ER stress can trigger cell death via activation of several 
downstream signals.  Therefore, it is biologically more beneficial and reasonable to 
prevent ER stress-induced cell death at the level of the cell death-related signals.  Indeed, 
several studies have shown deletion of specific ER stress-induced cell death signals is an 
attractive strategy to prevent cellular dysfunction induced by ER stress (Figure 2.7).   
Several cellular disturbances have been shown to trigger ER stress and cell death 
such as massive accumulation of unfolded proteins, cytoplasmic calcium dysfunction, 
redox/oxidative stress, and viral infection (9).  Cellular pathways triggering cell death 
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under ER stress conditions have been investigated extensively and several mechanisms 
have been proposed, including apoptosis and aggressive autophagy (9).  Caspase-12 and 
CHOP are two cell death signals specifically induced by ER stress (9).  Caspase-12 has 
been shown to be located in the ER lumen and activated by ER stress induced signals but 
not by other signals such as mitochondrial-dependent apoptosis (9).  The role of capase-
12 in modulating cell death due to ER stress has been elucidated in both caspase-12 
deficient and overexpression models as deficiency in caspase-12 resulted in cell death 
resistance in response to ER stress and caspase-12 overexpression sensitized cells to ER 
stress induced cell death (9; 114).  Caspase-12 deletion has been used as a therapeutic 
approach to treat ER stress related cellular function as one study showed that knockout of 
caspase-12 attenuated ER stress-induced muscle pathology a mouse model of Duchenne 




CHOP is one of the C/EBP family members and can be induced by several ER 
stress signals such as IRE1α and ATF6 (9).  The role of CHOP in contributing to ER 
stress-induced cell death has been studied extensively and it appears likely that CHOP is 
a more attractive target to development therapeutic inventions for diseases in which 
severe ER stress is an underlying cause.  A previous study showed that CHOP deficiency 
contributed to an attenuation of an oxidative stress response, improvement of beta cell 
Figure 2.7. CHOP is a specific ER stress-induced cell death signal.   Long term 
activation of ER stress pathway is known to trigger cell death signals and CHOP is 
found to be one of the specific cell death signals induced by fatal activation of ER stress.  
Several pathways are suggested to contribute to the upregulation of CHOP such as 
ASK1- p38/MAPK and JNK.  As a transcriptional factor, CHOP is indicated to regulate 
gene expression involved in cell death such as Bcl-2 family proteins. 
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function, and beta cell survival in various animal models of diabetes (133).  Besides 
being an important factor in modulating beta cell function in diabetes, CHOP has also has 
been shown to play an important role in other ER stress involved diseases such as kidney 
disease and brain damage (134).  CHOP expression is induced in the early stage of ER 
stress activation and thus can be used as a specific marker to demonstrate activation of 
ER stress.  However, extensive upregulation of CHOP requires cross-talk between 
different branches of the ER stress pathway and requires increased CHOP expression at 
the transcriptional level.  CHOP protein post-translational modification has also been 
observed  in previous studies, with phosphorylation of CHOP being induced by IRE1α – 
ASK1- p38 MAPK signals (135).  The apoptotic role of CHOP was investigated and it 
has been shown that upregulation of CHOP could increase expression of Bim protein, 
which is a pro-apoptotic factor in the Bcl-2 family, and thus induces apoptosis under 
activation of ER stress (133; 136). 
Besides introduction of protease- mitochondria-dependent cell death pathways, 
aggressive autophagy has been shown recently to be another way of inducing cell death 
under activation of ER stress (137).  Autophagy is a necessary cell survival response 
devoted to protein degradation and removal of damaged cellular organelles under certain 
conditions such as starvation or accumulation of protein aggregates (138).  A functional 
autophagy is initiated by the formation of a double layer membrane structure called an 
autophagosome, where targeted proteins or cell organelles are included and digested by 
certain lysosomal enzymes (19; 139).  As mentioned previously, autophagy is an essential 
cellular process modulating cellular homeostasis; however, abnormal or aggressive 
autophagy could cause loss of cellular components under certain pathological conditions 
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such as neurodegenerative diseases and metabolic diseases.  Autophagy-induced cell 
death is not necessarily involved in activation of apoptotic elements and is distinguished 
morphologically from traditional cell death pathways such as apoptosis and necrosis.  
Thus, autophagy is defined as a new pathway inducing cell death and may decide the cell 
destiny by interacting coordinately with these two traditional pathways.  The rationale  
linking ER stress with autophagy is that accumulated unfolded/misfolded proteins need to 
be eliminated thus autophagy is one of the best candidates besides ERAD to conduct this 
task (138).  Indeed, several studies showed that ER stress could trigger the formation of 
the autophagosome and inhibition/deletion of key ER stress elements could impair the 
effects of autophagy (19; 140).  For example, two ER stress chemical inducers, DTT and 
tunicamycin, were shown to upregulate Atg8, which is a conserved marker for the 
formation of autophagosomes (19; 137; 140).  Moreover, deletion of key ER stress 
elements IRE1α and Hac1 proteins resulted in an inhibition of autophagy, indicating that 
ER stress is upstream of autophagy (141).  The important role of ER stress in inducing 
autophagy was investigated with a dominant-negative PERK,  the dnPERK could inhibit 
the formation of the autophagosome, thus indicating that the PERK/eIF2α branch of ER 
stress is involved in activation of autophagy (141).  ER stress has been shown to be a new 
pathway to induce autophagy in several studies but the delicate correlation between those 
two pathways still needs to be further investigated.  Nevertheless, a better understanding 
of those pathways could prompt the development of therapeutic inventions treating 





ER stress & skeletal muscle 
The role of the Sarcoplasmic/Endoplasmic Reticulum (SR/ER) in ER stress and 
ER-stress induced apoptosis in striated muscle is not well understood.  This is an 
important new area of research within the fields of cardiac and neuromuscular diseases 
(142).  Since, SR/ER is one of the largest organelles in muscle with the SR/ER covering 
as much as 50% of the volume of a muscle fiber, it could play a critical role in cellular 
pathology as well as in contraction-relation cycling.  Double layers of SR/ER membrane 
are highly presentative and, similar to other cell organelles or structures, it has been 
shown that these membranes can be the donor of mitochondria during turnover and the 
formation of some key components such as the autophagosome (138).  This notion has 
been further confirmed by the fact that abnormal changes in SR/ER morphology could be 
linked to skeletal muscle tissue pathology such as in DM1 (122-124). 
SR/ER is the main site for preserving skeletal muscle intracellular calcium levels 
via the precise function of various calcium binding/buffer proteins in the ER lumen such 
as parvalbumin and calreticulin (97).  ER membranes are not permeable to free calcium 
and the transportation of this ion is highly regulated by several ion channels and specific 
ATP-dependent calcium pumps located in the ER membrane such as SERCA1 and 
SERCA2 (8).  Distribution of the intracellular calcium level due to disruption of those 
calcium buffering proteins, calcium channels, and calcium pumps could lead to severe 
cell dysfunction and eventually result in cell death (8).  Simultaneously, a higher calcium 
level in the ER lumen and a lower calcium level in cytoplasm are essential to maintaining 
cellular redox/oxidative status as the ER lumen is the main site for protein synthesis and 
protein posttranslational modifications.  The oxidative status in the ER lumen must be 
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maintained to enable formation of disulfide bonds.  in addition, it has been shown that 
there is a tight dynamic interaction between ER and mitochondria as specific channels are 
involved in this interaction (23).  The link between ER and mitochondria is critical as ER 
is buffering calcium levels in mitochondria, which is beneficial to keep mitochondrial 
homeostasis (143).  Preliminary data from our proteomics study indicated that there could 
be more protein-protein interactions (PPIs) between proteins in ER and those in 
mitochondria (Chapter 5).  Although the biological meaning of those PPIs has not been 
investigated in this dissertation, this finding is very interesting and is worthy of further 
evaluation based on the dynamic communication between and significance of ER-
mitochondrial interactions.   
ER stress has been linked to metabolic diseases as ER stress has been shown to be 
activated in the skeletal muscle under high fat diet treatment (144).  ER stress has also 
been shown to be a beneficial event for muscle development as it is responsible for 
removal of vulnerable myoblasts via inducing apoptosis in those cells (145; 146).  
Inhibition of ER stress resulted in impaired muscle fiber function, indicating that 
moderate ER stress activation is essential to maintaining cellular quality control by 
eliminating underdeveloped cell types (145; 146).  Another study showed that one branch 
of the ER stress pathway, via ATF6, was involved in the exercise-induced metabolic 
adaptation of skeletal muscle physiology by interacting with PGC1α (147).  In this study, 
exercise challenge activated ER stress and knockout of ATF6 resulted in impaired 
recovery of skeletal muscle damage after exercise (147).  Moreover, this study showed 
that in a mouse model of CHOP deletion, there was a similar phenotype to the PGC1α 
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knockout mouse model with an exercise intolerance phenotype, indicating the important 
role of ER stress in regulating skeletal muscle metabolic flexibility (147).   
ER stress is also associated with skeletal muscle pathology as several studies 
detected the activation of ER stress under various pathological conditions such as in 
muscle dystrophy, muscle wasting, neurodegenerative diseases, and myotonic dystrophy 
1 disease (22; 122-125; 148).  A study using an animal model of DMD has further 
confirmed this notion. ER stress was activated in skeletal muscle of muscular dystrophy 
such as upregulation of CHOP and cleavage of caspase-12 (149). (149).  Moreover, 
deletion of caspase-12 in one mouse model of DMD was shown to attenuate disease 
phenotypes including impaired muscle function and muscle fiber degeneration (149).  
This study suggested that ER stress activation plays a critical role in the muscle 
pathology in DMD and that deletion of key ER stress elements could be a novel way to 
improve muscle function in DMD.  In another study, muscle biopsies from myotonic 
dystrophy 1 disease (DM1) patients were analyzed and ER stress was shown to be 
induced in skeletal muscle represented by upregulation of Grp78/BiP on both 
transcriptional and translational levels (124).  ER stress has been a hot topic in the field 
of skeletal muscle related to metabolism and pathology since it plays an important role in 
regulating key cellular events such as protein quality control, mitochondrial turnover, 
intracellular calcium homeostasis, and cell death.   
ER stress & ALS 
 
Investigations into ER stress in ALS is possible due to the generation of a 
transgenic mouse model of ALS: the mutant G93A SOD1 mouse model (4).  As 
mentioned previously, mutant SOD1 has normal dismutase enzymatic activity and the 
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“gain-of-function” is proposed as a working model for studying pathogenesis in ALS.  
SOD1 protein is located mostly in the cytoplasm but mutant SOD1 aggregates were 
shown to accumulate in other sites of the cells.  Therefore, it was expected that protein 
aggregates could induce several cellular stress response pathways.   
ER stress was investigated in both ALS patients and animal models of ALS (10; 
21; 23; 95; 100; 140; 150-156).  As expected, several lines of evidence suggest that ER 
stress was induced in motor neurons of human sporadic ALS, human familial ALS, and 
in animal models of ALS (151; 154).  In a recent study, protein expression profiles were 
analyzed in spinal cords of human ALS patients and three ER stress sensors PERK, 
IRE1α, and ATF6 were shown to be significantly upregulated (153).  Also, several ER 
stress-induced chaperones Grp78/BiP, PDI, and Erp57 were shown to be increased in 
spinal cords of ALS patients (153).  The ER stress-induced cell death signals were also 
evaluated in the same study and the results showed the introduction of ER stress-induced 
cell death, including upregulation of CHOP, caspase-4, and p38 (Figure 2.7) (150).   
The comprehensive analysis of the ER stress pathway, including ER stress sensors, 
ER chaperones, and apoptotic factors, fully supported the notion that ER stress was 
activated in spinal cords of ALS patients and upregulation of caspase-4 in ALS patients 
indicated that activation of ER stress may contribute, not only an early survival stage, but 
also late in disease to tissue pathology (140; 150; 152; 153).  To further investigate this 
notion, animal models of ALS were used and it was shown that activation of ER stress 
and upregulation of CHOP occurred prior to disease onset (10).  The evidence for ER 
stress participating in ALS pathology was also evaluated using both gain-of-function and 
loss-of-function transgenic animal models.  Nervous system-specific deletion of Xbp-1, 
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which is a key ER stress induced protein and transcriptional factor, significantly extended 
the life span of ALS mice (140).  Also, deletion of another ER stress element PUMA, 
which is a BH-3 only protein and induced by ER stress, was shown to increase motor 
neuron survival, delay disease progression, and preserve motor-neuron function (152).  
Collectively, those studies suggest that ER stress is induced in the nervous system of 
ALS and may contribute to motor neuron dysfunction and cell death.   
ER stress activation in skeletal muscle of ALS has never been evaluated 
systematically and recent mass spectrometry-dependent high-through mapping of skeletal 
muscle in ALS indicated elevation of heat shock protein families including Grp78/BiP, 
suggesting ER stress could be present in skeletal muscle of ALS (10).  Our lab 
determined the ER stress pathway in skeletal muscle of ALS mice and preliminary data 
showed that ER stress was present in skeletal muscle of ALS and may be linked to 
skeletal muscle pathology (10; 125).  To rule out the possibilities of ubiquitous tissue 
activation of ER stress due to whole body mutant SOD1 overexpression, , we also 
assessed the  ER stress pathway in tissues other than skeletal muscle and nerve.  These 
other tissue (liver and cardiac muscle) did not show activation of ER stress, thus our 
results clearly showed that activation of ER stress is a specific event in skeletal muscle 
(10; 125).  
Skeletal muscle & ALS 
 
ALS has long been recognized as a motor neuron disease which firstly impairs 
upper and lower motor neurons and, as a consequence, causes progressive muscle atrophy 
(1).  However, this point of view has been recently questioned by the observation that 
other cell types such as astrocytes and myocytes are involved in the ALS disease 
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phenotype.  Thus,  ALS is a disease affecting multiple cell types in which these cell types 
(i.e. muscle and nerve) interact coordinately to induce the ALS pathophysiology (5).   
Skeletal muscle is one of the primary tissues affected in the muscle weakness 
phenotype of ALS.  Mutant SOD1 proteins, linked to familial ALS, have been shown in 
skeletal muscle of both ALS patients and animal models of ALS, raising the question 
whether skeletal muscle contributes to ALS pathogenesis or not.  In addition, a previous 
study using transgenic mice with skeletal muscle-specific expression of mutant SOD1 
showed transgenic mice developed an ALS phenotype including progressive skeletal 
muscle atrophy, decreased muscle function, and other muscle pathology (157).  
Furthermore, another study employing the same strategy showed that mice with skeletal 
muscle restricted expression of mutant SOD1 developed muscle weakness and some 
neuronal deficits.  More interestingly, besides presenting muscle abnormities, those 
transgenic mice developed impaired neuromuscular junction and loss of spinal motor 
neurons, suggesting that skeletal muscle  vulnerability induced by mutant SOD1 toxicity 
is enough to prompt motor neuron degeneration in ALS (6).  
Mitochondrial dysfunction in skeletal muscle of ALS – Mitochondrial dysfunction 
has been considered as the final pathological pathway involved in motor neuron 
degeneration in ALS due to its primary role in modulating key cellular processes such as 
ATP synthesis, calcium buffering, and cell death (66; 76; 77).  It is suggested that 
mitochondrial dysfunction is a typical pathology in skeletal muscle of ALS as alterations 
in mitochondrial ultra-structure such as aggregates and giant size were reported in 
skeletal muscle of ALS patients and animal models of ALS (66; 76).  Besides showing 
pathological changes of structure, mitochondrial function has also been determined and it 
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was shown that there was a decrease in mitochondrial function in skeletal muscle of ALS 
patients, including downregulation of NADH/CoQ oxidoreductase and complex IV (40; 
158).  Moreover, decreased ATP level and increased uncoupling protein 3 (UCP-3) have 
been reported in skeletal muscle of ALS mice and patients and it is suggested that 
upregulation of UCP-3 in skeletal muscle contributed to mitochondrial damage and 
muscle pathology in ALS (Figure 2.8) (158).  
 
Figure 2.8. SR/ER system in skeletal muscle and proposed mechanisms contributing 
to skeletal muscle atrophy in ALS.   SR/ER is the main site for calcium storage and 
intracellular calcium level is tightly regulated by ER-located proteins such as SERCAs 
and ryanodine receptors (RyR).  Increased intramuscular calcium level has been reported 
and suspected to contribute to muscle atrophy in ALS via various cellular processes such 
as mitochondrial dysfunction and ROS generation. 
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Mutant SOD1 protein aggregates in skeletal muscle of ALS – Accumulation of 
unexpected protein aggregates in tissues including skeletal muscle is a hallmark feature 
of ALS pathology, although it is still debated whether these protein aggregates contribute 
to disease pathogenesis or are simply an adaptive protective mechanism (1).  Previous 
studies showed two forms of protein aggregates were present in skeletal muscle of ALS 
mice: mutant SOD1-containing aggregates and non-SOD1 protein aggregates (82).  
However, their pathological role in inducing skeletal muscle dysfunction in ALS is still 
not clear.  Mutant SOD1 protein aggregates are not suggested to be linked with disease 
progression based on the fact that higher protease activity was also observed, indicating 
an increased ability to remove mutant SOD1 in skeletal muscle (159).  There is 
increasing evidence that non-SOD1 protein aggregates are involved in ALS disease 
progress and one study showed that there is a close correlation between non-SOD1 
protein aggregates and over-production of reactive oxygen species in mitochondria of 
skeletal muscle (160). However, the role of different forms of protein aggregates in 
skeletal muscle needs further investigation.    
Proteasome activity in skeletal muscle of ALS – As mentioned previously, the 
formation of protein aggregates in pathological tissues such as in motor neurons and 
skeletal muscle has been recognized as a hallmark of ALS (1).  However, the clearance 
rate of protein aggregates conducted by the proteasome pathway between different tissues 
is divergent and it is suggested that skeletal muscle has better efficiency in removing 
mutant SOD1 proteins than motor neurons (161).  The higher rate of removing mutant 
SOD1 proteins in skeletal muscle is thought to be due to of a higher concentration of the 
ubiquitin proteasome system and greater activation of autophagy in muscle cells (161; 
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162).  Indeed, previous studies showed that the dysregulation of proteasome activity 
induced by mutant SOD1 was less impaired in C2C12 muscle cells as those cells 
demonstrated a higher chymotryptic proteasome activity, which is the main process of 
degradation misfolded and unfolded proteins (161).  Moreover, autophagy has been 
shown extensively in muscle cells but not motor neuron cells, suggesting muscle cells 
have a better system to prevent the accumulation of protein aggregates (161).  (161).  
Besides proteasome pathway and activation of autophagy, several muscle atrophy factors 
such as transcriptional factor forkhead box o3 (FOXO3) and NF-κB have been shown to 
be upregulated and contribute to the production of reactive oxygen species in skeletal 
muscle (157). It has been suggested that FOXO3 links oxidative stress to the autophagy 
pathway and it is suggested that moderate activation of autophagy could be an attractive 
therapeutic method to treat skeletal muscle dysfunction in ALS (157).    
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Chapter 3: Activation of the endoplasmic reticulum stress response in skeletal 
muscle of G93A*SOD1 Amyotrophic Lateral Sclerosis mice 
 
 
The following article was published in the journal of Frontiers in Cellular Neuronscience 
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Mutations in Cu/Zn superoxide dismutase (SOD1) are one of the genetic causes of 
Amyotrophic Lateral Sclerosis (ALS).  Although the primary symptom of ALS is muscle 
weakness, the link between SOD1 mutations, cellular dysfunction and muscle atrophy 
and weakness is not well understood.  The purpose of this study was to characterize 
cellular markers of ER stress in skeletal muscle across the lifespan of G93A*SOD1 
(ALS-Tg) mice.  Muscles were obtained from ALS-Tg and age-matched wild type (WT) 
mice at 70d (pre-symptomatic), 90d and 120-140d (symptomatic) and analyzed for ER 
stress markers.  In white gastrocnemius (WG) muscle, ER stress sensors PERK and 
IRE1α were upregulated ~2-fold at 70d and remained (PERK) or increased further 
(IRE1α) at 120-140d.  Phospho-eIF2α, a downstream target of PERK and an inhibitor of 
protein translation, was increased by 70d and increased further to 12.9 –fold at 120-140d.  
IRE1α upregulation leads to increased splicing of X-box binding protein 1 (XBP-1) to the 
XBP-1s isoform.  XBP-1s transcript was increased at 90d and 120-140d indicating 
activation of IRE1α signaling.  The ER chaperone/heat shock protein Grp78/BiP was 
upregulated 2-fold at 70d and 90d and increased to 6.1-fold by 120-140d.  The ER-stress-
specific apoptotic signaling protein CHOP was upregulated 2-fold at 70d and 90d and 
increased to 13.3-fold at 120-140d indicating progressive activation of an apoptotic signal 
in muscle.  There was a greater increase in Grp78/BiP and CHOP in WG vs. the more 
oxidative red gastrocnemius ALS-Tg at 120-140d indicating greater ER stress and 
apoptosis in fast glycolytic muscle.  These data show that the ER stress response is 
activated in skeletal muscle of ALS-Tg mice by an early pre-symptomatic age and 
increases with disease progression.  These data suggest a mechanism by which 
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myocellular ER stress leads to reduced protein translation and contributes to muscle 
atrophy and weakness in ALS.  
Background 
 
Amyotrophic Lateral Sclerosis (ALS) is a fatal motor neuron disease 
characterized by degeneration of motor neurons and progressive paralysis of skeletal 
muscle (1).  ALS is inevitably fatal, with patients generally dying due to respiratory 
failure within 2-5 years of diagnosis (1).  Although the majority of ALS cases are 
sporadic without family history, 5-10% of the total cases of ALS have a known genetic 
basis (1).  Mutations in human Cu/Zn superoxide dismutase 1 (SOD1) account for ~20% 
of familial ALS (fALS) cases (1).  Mice generated to express a human Cu/Zn SOD1 
mutation found in fALS patients (Gly93 to Ala; G93A) develop a rapidly progressive and 
fatal motor neuron disease similar to the clinical phenotype of ALS (32).  There is 
evidence that the SOD1 mutations exert their deleterious effects through a “gain-of-
function” mechanism rather than through a loss of superoxide dismutase activity (4).  The 
nature of this toxic “gain-of-function” is not known, although a number of putative 
mechanisms have been proposed, including oxidative stress, glutamate-mediated 
excitotoxicity, mitochondrial dysfunction, protein aggregation and endoplasmic reticulum 
(ER) stress (163). 
Neurodegenerative diseases, including ALS, that result from unfolded/misfolded 
proteins have been linked to ER stress (164).  Most newly synthesized proteins are folded 
properly in the ER, but unfolded and misfolded proteins accumulate in the ER lumen, 
causing cellular stress, activation of unfolded protein response (UPR) and an ER stress 
response (9).  The ER stress response involves activation of three ER-resident stress 
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sensors: protein kinase RNA-activated-like ER kinase (PERK), inositol-requiring kinase 
1-alpha (IRE1α), and activating transcription factor 6 (ATF6) (9).  Normally, these ER 
stress sensors physically interact with the ER chaperone immunoglobulin binding protein 
(Grp78/BiP) which suppresses their activation (9).  However, when unfolded/misfolded 
proteins accumulate, Grp78/BiP preferentially binds to unfolded/misfolded proteins, 
resulting in activation of the ER stress response, including an upregulation of genes 
encoding Grp78/BiP, protein disulfide isomerase (PDI) and down regulation of protein 
synthesis (104; 164).  PERK activation induces the eukaryotic initiation factor 2 alpha 
subunit (eIF2α) kinase and phosphorylation of eIF2α resulting in inhibition of protein 
translation (9).  Activation of IRE1α leads to the alternative splicing of the transcription 
factor X-box binding protein 1 (XBP1) to the spliced XBP1 form to induce genes that 
regulate protein quality control in the ER (9).  Although ER stress is usually a short term 
homeostatic event essential for cell survival, prolonged and severe ER stress can trigger 
apoptosis by ER stress-specific cell death signals, including C/EBP homologous protein 
(CHOP) and caspase-12 (114; 165).  
It has previously been shown that mutant SOD1 accumulates inside the ER, where 
it forms insoluble high molecular weight aggregates and interacts with Grp78/BiP in 
spinal cord microsomal fractions (151).  Markers of ER stress activation have been 
shown in spinal cord sections of ALS patients and in mouse models of ALS (151; 153).  
Pathology studies show that ER stress is evident in spinal cords of ALS patients 
suggesting that ER stress-induced apoptosis may contribute to motor neuron death (21; 
153).  The ER stress response is also activated in mouse models of ALS, although the 
time course is controversial (21; 95; 150; 151; 153-155).   
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The targets of mutant SOD1-induced toxicity in ALS pathology are the motor 
neurons and the skeletal muscle that it innervates (166). While the primary focus has 
been on selective defects in the motor neuron causing muscle weakness and atrophy, it 
has been shown that muscle-restricted SOD1 mutations also recapitulate the hallmark 
signs of ALS, albeit at a slower rate of progression (6; 157).  Thus, it has been proposed 
that defects in skeletal muscle, leading to muscle cell dysfunction, also contribute to the 
motor neuron pathology via a “dying-back” phenomenon.  It has previously been shown 
that early markers of muscle adaptation in the G93A*SOD1 mouse (i.e. by 49d, prior to 
atrophy) include metabolic enzymes, particularly down regulation of enzymes of 
oxidative metabolism and upregulation of enzymes of glycolytic metabolism and 
increases in proteins involved in protein synthesis. (167).  Putative markers of disease 
progression, which were altered at 98d when atrophy was evident, include glycolytic 
enzymes which decrease and cell stress markers (i.e. heat shock proteins) and transport 
proteins (i.e. albumin), which increase. 
The intracellular mechanisms leading to altered gene/protein expression in 
skeletal muscle with disease-induced plasticity are not fully understood.  However, there 
are reports of mitochondrial depolarization leading to reduced mitochondrial Ca2+ 
buffering and increased cytosolic Ca2+ which may trigger events in the muscle atrophy 
process (48; 168).  Recently we reported impaired intracellular Ca2+ regulation in the 
sarcoplasmic reticulum (SR) in muscle fibres from G93A*SOD1 mice (7).  The changes 
intracellular Ca2+ occurred prior to the decline in motor function (by 90d) and were 
associated with decreases in myocellular Ca2+ buffering proteins SERCA1, SERCA2 and 
parvalbumin.  Based on the known association between SR/ER Ca2+ regulation and 
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protein folding (49; 142), and the putative contribution of skeletal muscle defects to the 
progression of ALS, we hypothesized that ER stress would be induced in skeletal muscle.  
Thus, the primary aim of this study was to investigate the ER stress signaling pathway in 
skeletal muscle at three different ages across the lifespan of the G93A*SOD1 mouse 
model of ALS.  A secondary aim was to compare key markers of ER stress in skeletal 
muscles of varying fiber type composition and metabolic capacities as well as to non-
muscle tissue.  Our findings indicate that ER stress is activated in skeletal muscle of 
G93A*SOD1 mice as early as 70d, with ER stress pathways leading to inhibition of 
protein translation.  Our data further suggest that defects in myocellular protein handling 
and activation of apoptosis may contribute to the muscle atrophy and weakness observed 




All procedures were conducted under a protocol approved by the Institutional 
Animal Care and Use Committee (IACUC) of the University of Maryland, College Park.   
Animals 
Control C57BL/6 SJL hybrid female and transgenic ALS B6SJL-Tg (SOD1-
G93A) Gur/J (G93A*SOD1) male mice were obtained from The Jackson Laboratory.  
Wild-type control (WT) and transgenic G93A*SOD1 heterozygote (ALS-Tg) mice were 
bred to establish a colony at our animal care facility at the University of Maryland.  Mice 
were weaned at postnatal day 21 and genotyped. Male and female ALS-Tg mice along 
with their wild-type littermates were investigated at a range of ages from the pre-
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symptomatic to the symptomatic stages of the disease: i) early pre-symptomatic at 
postnatal day 70 (70d); ii) late pre-symptomatic at postnatal day 90 (90d); and iii) end 
stage at postnatal day 120-140 (120-140d) (see Table 1).  Early signs of disease such as 
muscle tremors can be detected between 65 and 90d but overt muscle weakness and 
limitations in mobility do not occur until 100-120d (2).  We chose the 70d and 90d time 
points based on differences observed in single muscle fiber resting intracellular Ca2+ 
concentration that we now have reported (7).  The final time point (120-140d) was based 
on symptom progression, with the date of use determined by the inability of the mouse to 
right itself after 30s of being placed on its side as previously described by others (169). 
At time of use, animals were euthanized by CO2 inhalation followed by cervical 
dislocation.  Skeletal muscles, cardiac muscle, and liver were harvested, quickly frozen in 
liquid nitrogen and stored at -80°C for subsequent analysis.  Various skeletal muscles 
were harvested in order to assess differences in ER stress between muscles of varying 
fiber type and of different oxidative and glycolytic capacities.  White gastrocnemius 
(WG) has primarily fast glycolytic fibers (97% type IIB, 1.5% IIX/B and 1.5% IIX), red 
gastrocnemius (RG) primarily fast oxidative glycolytic fibers (22% type IIB, 3% IIX/B, 
20% IIX, 42% IIA and 8% and type I) (170) and diaphragm (DIA) has a mixed fiber type 
including both slow oxidative, fast oxidative and fast glycolytic fibres (39% type IIX, 
23% type IIX/B, 23% IIA/X and 10% type I (171).  Tibialis anterior (TA) has primarily 
fast glycolytic fibers (50% type IIB, 40% type IIX and 10% IIA), with reports of a fiber 
type shift to more oxidative (20% IIB, 10% IIX and 70% IIA) at 115d in the 
G93A*SOD1 mouse (169).  In WT mouse muscle, glycolytic capacity is greatest in type 
IIB > IIB/X >IIX = type I > IIA/X > IIA (170) and thus expected to be highest in 
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WG>TA>DIA>RG.  Conversely, in WT, oxidative capacity is greatest in type IIA > type 
I = type IIX > IIB and thus would be highest in RG>DIA>TA>WG.  
Protein Extraction 
The superficial (white) and deep (red) gastrocnemius, diaphragm, cardiac muscle, 
and liver tissues were used for assessment of protein levels using western blot technique.  
Tissue samples were homogenized on ice using a polytron at 50% maximal power for 
three 10 sec bursts, separated by 30 sec in ice cold lysis buffer (20 mM Hepes, pH= 7.5, 
150 mM NaCl, 1.5 mM MgCl2, 0.1% Triton X-100, 20% Glycerol) containing 1 mM 
DTT and protease inhibitor cocktail (cOmplete mini EDTA-free Protease Inhibitor 
Cocktail, Roche). After 20 min of incubation at 4oC followed by centrifugation for 5 min 
at 20,000 × g, the supernatant was collected, quick frozen in liquid nitrogen and stored at 
-80oC until required.  
Western Blot Analyses 
Total protein concentration in the samples was determined using a BCA protein 
assay kit (Thermo Scientific).  Samples were then prepared with loading buffer and 
denatured by incubating samples at 100oC for 5 min.  For western blot analyses, 30 µg 
total protein was loaded on bis-acrylamide gels and separated using polyacrylamide gel 
electrophoresis (PAGE).  Samples were then transferred to PVDF membrane (Millipore) 
and blocked with 5% (w/v) non-fat dry milk in Tris-buffered saline (pH 8.0) for 1 hr.  
The appropriate primary antibodies were added (PERK, phospho-PERK (Thr 980), 
IRE1α, eIF2α, phospho-eIF2α (Ser51), Grp78/BiP, PDI, and CHOP; 1:1000, Cell 
Signaling Technology) and membranes were incubated at 4oC overnight, washed and 
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then and subsequently probed with HRP-linked anti-rabbit IgG or anti-mouse IgG 
antibodies (1:1000, Cell Signaling Technology) 1 hr at room temperature.  Secondary 
antibodies were detected using HRP-linked chemiluminescence with SuperSignal West 
Dura Chemiluminescence Substrate (Thermo Scientific) and imaged using the 
chemiluminescence imaging system (GeneGnome, Syngene).  The signal for the target 
protein of each sample was quantified using densitometry (Image J Software) and 
expressed in arbitrary unit (AU).  GAPDH (1:2000, Thermo Scientific) or β-actin 
(1:1000, Cell Signaling Technology) was used to confirm equal protein loading across 
samples. 
Mass Spectrometry based protein relative quantification  
To confirm differential expression of ER stress proteins using a non-antibody 
based method, we completed in-gel digestion of proteins in the molecular weight range of 
the Grp78/BiP protein.  We focused on the Grp78/BiP protein based on preliminary work 
with an antibody that gave us a divergent response (125) to the one we report here.  
Skeletal muscle total protein samples were prepared as described previously.  For the 
purpose of protein separation, 30 μg of total protein was loaded onto 8% one-dimensional 
SDS-PAGE gel.  After gel electrophoresis, protein bands were stained using a protein 
blue stain kit (Thermo Scientific).  The targeted bands (~80 kDa) were carefully excised 
and in-gel tryptic digestion carried out following standard procedure.  Briefly, proteins 
were reduced with 5 mM DTT, alkylated with 55 mM iodoacetamide, and digested with 
20 ng/µL trypsin (Life TechnologiesTM) at 37°C overnight.  All reagents were dissolved 
in 50 mM ammonium bicarbonate (pH 8.5). 
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After trypsin digestion, peptide products were collected and analyzed by nano 
LC-MS/MS analysis using LTQ Orbitrap mass spectrometer coupled to a Shimadzu 2D 
Nano HPLC system.  Peptides were loaded with an autosampler into an Zorbax SB-C18 
trap column (0.3×5.0 mm) (Agilent Technologies, Palo Alto, CA) at 10 µL/min with 
solvent A (97.5% water, 2.5% ACN, 0.1% formic acid) for 10 min, then eluted and 
separated at 300 nL/min with a gradient of 0-35% solvent B (2.5% water, 97.5% ACN, 
0.1% formic acid) in 30 min using a Zorbax SB-C18 nano column (0.075×150 mm).  The 
mass spectrometer was set to acquire a full scan at resolution 60,000 (m/z 400) followed 
by data dependent MSMS analysis of top 10 peaks with more than 1 charge in the linear 
ion trap at unit mass resolution.  The resulting LC-MS/MS data were searched against a 
mouse protein database generated from uniprot and a common contaminant database 
using Mascot (v2.3) and Sequest search engines through Proteome Discoverer (v1.4). 
Carbomidomethylation at Cys was set as fixed modification.  Methionine oxidation and 
asparagine and glutamine deamidation were set as variable modification.  Spectral 
counting with normalized total spectra was carried out using Scaffold software, 
(Proteome Software, Inc).  Protein probability >99% and at least one unique peptide with 
a probability score >95% were set to as minimum requirement for protein identification.   
Gene Expression 
In order to investigate transcriptional events involved in ER stress pathway, we 
isolated mRNA from tibialis anterior muscle (TA) and examined transcript levels of 
XBP-1, GRP78/BiP, and CHOP.  Briefly, total RNA was isolated using TriPure Reagent 
(Roche) and RNA content was determined by using a NanoDrop spectrophotometer and 
mRNA was diluted to 5ng/μL.  Reverse transcription from mRNA to cDNA was 
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conducted by using One-Step RT-PCR System (Life TechnologiesTM).  Semi-
quantitative PCR (sqPCR) was used to determine gene transcriptional levels and the 
primer information such as XBP-1, CHOP, and 18s was acquired from a previous study 
(2).  The band intensity of PCR products were quantified using densitometry (Image J 
Software) and expressed in arbitrary unit (AU).  For XBP-1, two variants of XBP1 
mRNA are expressed in cells.  Under normal conditions, un-spliced XBP1 mRNA 
(XBP1-u) is expressed.  However, as ER stress is induced, a spliced form of XBP1 
mRNA (XPB1-s) will be expressed.  Thus, upregulation of XBP1-s mRNA is a marker of 
ER stress activation downstream of IRE1α (147). 
Data Analysis 
To determine statistical differences in protein and mRNA expression level 
between genotype (WT vs. ALS-Tg) and Age (70d, 90d and 120-140d) data were 
analyzed using two-way ANOVAs.  Where interaction effects (genotype X age) were 
observed, the main effects are not reported.  For significant interaction effects, Tukey 
post-hoc tests were used to determine differences across time points for ALS-Tg (i.e. 70d 
vs. 90d).  T-tests were used to determine differences between WT and ALS-Tg at each 






ER stress pathway is induced in skeletal muscle of ALS mice.  PERK and IRE1α 
are two ER stress sensors known to be upregulated when ER stress is induced.  In our 
study, PERK protein level was upregulated 2.6 –fold in WG muscle of ALS-Tg vs. WT 
mice at 70d (p=0.01), 5.4-fold at 90d (p=0.025) and 5.2 fold at 120-140d (p=0.001) 
(Figure 1A and C).  There was no difference in PERK level of ALS-Tg WG between 70, 
90 and 120-140d (no main effect for age or genotype X age interaction).  To assess the 
specificity of the antibody for total PERK, the antibody was pre-incubated with a PERK-
antibody blocking peptide.  Under these conditions, the protein band at ~140kDa 
identified as PERK was not visible (Figure 1B), confirming the specificity of the PERK 
antibody.  Since activated PERK undergoes auto-phosphorylation, we also assessed the 
ratio of phospho-PERK to total PERK.  The phospho-PERK/total PERK ratio was 
increased 2-fold in WG of ALS-Tg mice at 120-140d (p=0.012) indicating greater 
activation of existing PERK protein at the symptomatic age (Figure 1A and D).  Previous 
studies have shown that PERK can activate eIF2α kinase, resulting in phosphorylation of 
eIF2α at Ser51 and suppression of protein synthesis during ER stress (147).  We therefore 
assessed the downstream effects of activation of PERK.  In WG muscle, the ratio of 
phospho-eIF2α/total eIF2α was increased 2.3-fold in ALS-Tg vs. WT at 70d (p=0.005), 
remained elevated at 90d (p=0.048) and increased further to 12-fold at 120-140d 
(p=0.011; Figure 2A and B).  For phospho-eIF2α/total eIF2α there was a genotype X age 
interaction effects with the increase in ALS-Tg only increasing between 70d and 120-
140d (70d vs. 90d; p=0.227; 70d vs. 120-140d p=0.018; 90d vs. 120-140 p=0.062).  Total 
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eIF2α was not altered, just phosphorylation at Ser51, indicating inhibition of protein 
translation at these ages.   
In addition to PERK, up-regulation of ER stress sensor IRE1α was also observed 
in WG of ALS-Tg mice by 70d.  IRE1α protein levels were increased 2.5-fold at 70d 
(p=0.043) remained elevated at 90d (p=0.0005) and showed a further increase to 4.9 -fold 
WT levels at 120-140d (p=0.0002 vs. WT by t-test; p=0.008 for 70d vs. 120-140d for 
ALS-Tg by Tukey post-hoc) (Figure 3A and B).  XBP1 mRNA splicing is commonly 
used to indicate upregulation of IRE1α since activation of IRE1α leads to mRNA splicing.  
Thus, we investigated transcript levels of the un-spliced (XBP-1u) and spliced XBP1 
(XBP-1s) forms of XBP-1.  In TA muscle, XBP-1s mRNA was increased to 1.3- and 1.4-
fold at 90d (p=0.001) and 120-140d (p<0.0001).  There was a genotype x age interaction 
effect with XBP1-s being higher at 90d vs. 70d (p=0.002) and at 120-140d vs. 70d 
(p=0.002).  XBP1-u mRNA was not altered (Figure 3C and D).   
Since cellular stress results in induction of ER chaperone proteins to handle 
misfolded and unfolded proteins, we examined changes in PDI and Grp78/BiP protein 
levels, two proteins involved in post-translational modification and known to be up-
regulated with ER stress activation (9).  Grp78/BiP was upregulated 2 -fold in WG of 
ALS-Tg vs. WT mice at 70d (p=0.006), remained elevated at 90d (p=0.025) and 
increased further to 6.7-fold at 120-140d (p=0.005) (Figure 4A and 4B).  There was a 
genotype x age interaction effect with Grp78/BiP in ALS-Tg being different at 70d vs. 
120-140d (p<0.001) and at 90d vs. 120-140d (p<0.001).  Increased expression of PDI 
was also observed (2.2 -fold but only at 120-140d (p=0.001; Figure 4A and C).  There 
was a genotype X age interaction effect for PDI with differences across all age groups for 
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ALS-Tg (70d vs. 90d, p=0.004; 70d vs. 120-140d, p=0.001; 90d vs. 120-140d, p<0.001).  
Taken together, these data show evidence of ER stress in skeletal muscle as early as 70d 
and further augmented at the symptomatic age in ALS-Tg mice. 
To confirm antibody-based findings of the Grp78/BiP increase in skeletal muscle 
of ALS-Tg mice, we carried out relative protein quantification using LCMSMS and 
spectral counting compare Grp78/BiP protein levels between genotypes (Figure 5A).  
Grp78/BiP protein was identified by 11 exclusive unique spectra which contributed to the 
identification of 10 exclusive unique Grp78/BiP peptides (Figure 5B and C).  Protein 
quantitative data analysis showed that Grp78/BiP was more abundant in skeletal muscle 
of ALS mice as spectral counting numbers were significantly higher in ALS-Tg versus 
WT mice (Figure 5D).  Collectively, our label-free spectral counting-based protein 
quantitative data is consistent with western blot data, supporting our notion that ER stress 
is activated in skeletal muscle of ALS mice. 
ER stress-specific cell death signal is induced in skeletal muscle of ALS mice.  
Several mechanisms have been suggested to link the ER stress pathway to cell death, 
including activation of the ER stress-specific cell death signal CHOP (9).  In WG of 
ALS-Tg mice, CHOP was upregulated 1.8- fold at 70d (p=0.041), remained elevated at 
90d (p=0.025) and further increased to 12-fold at 120-140d (p=0.019) (Figure 6A and B).  
There was a significant genotype X age interaction effects with ALS-Tg only being 
different at 70d vs. 120-140d (p<0.001) and at 90d vs. 120-140d (p<0.001).  There were 
no changes in CHOP mRNA (data not shown), indicating that there is post-translational 
modification and increased stability of CHOP protein (172).  In addition to evaluating 
CHOP induction in the limb muscle, we also investigated diaphragm muscle since 
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atrophy of this muscle results in respiratory failure and death in ALS mice (173).  In DIA, 
CHOP protein expression was increased 1.7 -fold in ALS-Tg vs. WT mice at 70d 
(p=0.008), remained elevated at 90d (p=0.001) and then increased further to 9-fold at 
120-140d but due to the high degree of variability in CHOP elevation, ALS-Tg vs. WT 
was not significant at 120-140d (p=0.10).  there was a genotype X age interaction effect 
with CHOP showing an increase in ALS-Tg at 120-140d vs. 70d (p=0.004) and 120-140d 
vs. 90d (p=0.005) (Figure 6C and D).   
Greater activation of ER stress pathway in glycolytic vs. oxidative muscle of ALS 
mice.  On dissection we noted that the superficial gastrocnemius muscle was more red 
than white in the ALS-Tg mice (Figure 7A).  Previous studies showed that fast type IIb 
motor units are affected first during ALS disease progression in the G93A*SOD1 mouse 
(174).  Thus, we wanted to determine whether ER stress is activated to a greater extent in 
fast glycolytic vs. fast oxidative skeletal muscle by comparing two typical ER stress 
markers Grp78/BiP and CHOP between WG (fast glycolytic) and red gastrocnemius (RG; 
fast oxidative) muscle.  At the symptomatic age (120-140d), both Grp78/BiP and CHOP 
were induced to greater extent in WG vs. RG (2.0- and 5.6-fold, respectively; p<0.05) 
(Figure 7B and C), indicating that ER stress activation is greater in fast glycolytic muscle. 
ER stress markers are not induced in cardiac muscle and liver tissues of ALS mice.  
ER stress is activated when misfolded proteins accumulate in the ER lumen.  One could 
argue that the ER stress activation we observed in our study may be a non-skeletal 
muscle specific event since the animal model we used is a whole-body SOD1 protein 
mutation and accumulation of mutant SOD1 could activate ER stress in all tissues, 
including skeletal muscle.  Thus, we investigated the ER stress pathway in non-
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pathological tissues such as cardiac muscle and liver.  Two classical ER stress markers, 
Grp78/BiP and CHOP, were not different between WT and ALS-Tg mice for heart or 
liver at any age (see Figure 8).  Therefore, ER stress activation is observed in skeletal but 






In this study we show that ER stress is activated in skeletal muscle of 
G93A*SOD1 mice and thus may play a role in muscle atrophy in ALS.  This is based on 
evidence that: i) ER stress is activated at 70d, an early pre-symptomatic age and is further 
upregulated at 120-140d, an age when mice are symptomatic; ii) skeletal muscle ER 
stress induces the cell death signal CHOP; iii) ER stress is activated to a greater extent in 
highly glycolytic muscles with primarily type IIb fibers which are affected by an early 
loss of fast fatigable motor axons; and iv) the ER stress activation is specific to skeletal 
vs. cardiac muscle.  These data support the hypothesis that ER stress plays a role in 
muscle atrophy in ALS mice. 
ER stress response in ALS  
Our lab previously reported impairments in SR Ca2+ uptake, leading to elevations 
in resting cytosolic Ca2+ concentration in muscle fibers from G93A*SOD1 mice (7).  We 
therefore hypothesized that altered intracellular Ca2+ in association with increased 
oxidative stress in muscle cells would lead to misfolded proteins and activate the UPR 
and ER stress responses.  We propose a model (Figure 9) where age-dependent activation 
of ER stress sensors PERK and IRE1α in response to misfolded proteins leads to 
increases in protein chaperones Grp78/BiP and PDI in skeletal muscle.  Prolonged 
oxidative stress (in this case due to mutant SOD1) and persistent accumulation of 
misfolded proteins further augments the ER stress response and activates the apoptotic 
signal CHOP leading to muscle atrophy.  At 70d, an age where muscle grip function is 
still 100% of WT levels (7), there is already an ~2-fold increase in the ER stress markers 
PERK, IRE1α, Grp78/BiP and CHOP.  By 84d grip function is reduced to 77% WT 
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levels and by 120-140d, when grip function is zero (i.e. mice are no longer able to grasp a 
metal grid) (7), there are further increases in IRE1α, Grp78/BiP and CHOP as well as 
increased phospho-PERK and phospho-eIF2α/total eIF2α.  Based on these data we cannot 
determine if impaired Ca2+ regulation and ER stress are causative or a consequence of 
muscle atrophy, but only that they are associated.  Using the same animal model, studies 
using MRI to asses muscle volume show significant muscle loss as early as 8 wks of age 
and continuous loss over the lifespan of these mice (175; 176).  Collectively these data 
show muscle atrophy and weakness over the timeframe that we observed increases in 
markers of ER stress, suggestive of some involvement of protein misfolding, activation of 
the ER stress response and possibly apoptosis.  The impairment in muscle protein 
translation as well as apoptosis would contribute to muscle cell atrophy and weakness 
which, in conjunction with motoneuron degeneration, would contribute to the 
pathophysiology and disease progression in ALS. 
Proteins that require folding and post-translational modification, primarily 
secretory and membrane bound proteins, are processed in the ER.  Proteins that do not 
fold properly are degraded by the ubiquitin proteasome pathway.  If misfolded/unfolded 
proteins accumulate, the unfolded protein response is triggered to promote proper folding 
and autophagy is activated to support cell survival.  However, if there is a persistent 
increase in misfolded/unfolded proteins that exceeds the capacity of the ER to regulate 
proper folding, then protein translation is inhibited to reduce protein load and there is 
activation of an ER stress-induced cell death pathway via upregulation of CHOP.  
Activation of the ER stress response is increasingly being recognized as a cellular 
mechanism in neurodegenerative as well as metabolic diseases such as diabetes (177; 
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178).  The biological role of ER stress activation in motor neurons has been shown in one 
study in which deletion of an ER stress-induced pro-apoptotic signaling protein (puma) in 
ALS mice resulted in improved motor neuron survival and delayed disease onset and 
motor dysfunction (152).  Although our study did not directly investigate the cellular 
consequences of ER stress activation in skeletal muscle of ALS mice, it is the first study 
to show the associated changes in ER stress markers in skeletal muscles across the 
lifespan of the G93A*SOD1 mouse.   
Other studies with both ALS patients and transgenic G93A*SOD1 mice support 
the role of ER stress-related cellular dysfunction in ALS pathophysiology (21; 95; 150; 
151; 153-155).  Studies examining lumbar spinal cord sections of G93A*SOD1 mice, 
demonstrated significant upregulation of three ER stress sensors, PERK, IRE1α and 
ATF-6 as early as 60d, a time point at which these mice do not show any symptoms, 
suggesting they may trigger disease pathophysiology (153).  In addition, the ER stress-
specific cell death markers, CHOP and caspase-12, were activated, indicating apoptosis 
was induced before symptom onset (153). ATF6, IRE1α, CHOP, and caspase-12 were 
also shown to be up-regulated in the lumbar spinal cord sections of G93A*SOD1 mice at 
90d, at a late pre-symptomatic stage of the disease (150).  In yet other studies, a broad ER 
stress response occurred in spinal cords only in the end stage of ALS (~140d) when the 
mice were symptomatic which does not support the role of ER stress in ALS pathology 
(151).  Levels of ER stress-related proteins including PERK, IRE1α, ATF6, XBP-1, 
Grp78/BiP, and CHOP were upregulated in motor neurons of the spinal cords of ALS 
patients (153).  However, evidence from these studies is based on the association of ER 
stress markers with disease presence.   
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Impaired protein translation in muscle atrophy and ALS 
Motor neurons and skeletal muscles are two targets of mutant SOD1-mediated 
toxicity in ALS. In skeletal muscle cells, ER stress leading to inhibition of protein 
translation and decreased protein synthesis could explain the reduction in muscle mass of 
the G93A*SOD1 mouse (4; 175; 176).  We observed increases in PERK protein-kinase 
activity and increased phosphorylation of eIF2α on serine residue 51.  Increased phospho-
eIF2α has been shown to inhibit translation of messenger RNA into protein, effectively 
decreasing the protein load (96; 179).  Inhibition of protein translation can alter both 
muscle protein synthesis during growth but also muscle plasticity in disease.  We recently 
reported alterations in intracellular Ca2+ levels in skeletal muscle of the G93A*SOD1 
mice and reductions in the Ca2+ buffering proteins SERCA1, SERCA2 and parvalbumin 
(7).  SERCA1 is the SR/ER Ca2+ ATPase isoform expressed in fast glycolytic fibers and 
SERCA2 is expressed in fast oxidative and slow fibers (180).  Due to the shift to more 
oxidative fibers in WG (181) and TA (169), we expected an increase in SERCA2 protein 
expression.  However, SERCA2 protein was also decreased in skeletal muscle of ALS-Tg 
mice (7) despite a compensatory upregulation of SERCA2 mRNA (unpublished data).  
Thus, at least for SERCA2, we have observed transcriptional upregulation with no 
concurrent increase in protein translation.  Our current data showing increased phospho-
eIF2α/total eIF2α are consistent with this inhibition of protein translation as early as 70d.  
While there is an overall decrease in protein translation, this will specifically affect the 
secretory and transmembrane proteins that are processed in the ER (178) such as the 
SERCA pump proteins.  However, the muscle is still capable of increased protein 
synthesis and can upregulate expression of the required ER stress proteins.  Future studies 
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will be required to identify other muscle-specific proteins that are misfolded and that may 
contribute to atrophy and/or disease pathophysiology in ALS. 
ER stress, muscle metabolic capacity and disease pathology 
There are limited reports about ER stress pathways in skeletal muscles of 
motoneuron disease, although there are clinical reports of ER stress and UPR being 
activated in inclusion body myositis (122; 182), autoimmune myositis (123; 183), and 
myotonic dystrophy (124).  It has also been shown that ER stress response proteins 
IRE1α, PDI, and other ER chaperones are upregulated in skeletal muscle of mice in 
response to high fat diet feeding which lead to a decrease in protein synthesis and insulin 
resistance (108).  ER stress sensors and ER chaperones have also been shown to be 
upregulated in skeletal muscle following exercise (147; 184).  Our study is consistent 
with these prior reports of ER stress response in diseases and under conditions of various 
cellular stresses such as altered metabolic substrate supply and changes in metabolic 
activity.  Interestingly, our observation that ER stress was greater in WG compared to RG 
is consistent with the notion that an energetic stress contributes to activation of the ER 
stress response as glycolytic fibers are more likely to experience periods of hypoxia or 
perturbed energy homeostasis.   
Previous studies have shown that glycolytic skeletal muscle is more susceptible to 
atrophy in response to hypoxia (185) and in disease states such as cancer cachexia (186; 
187) and heart failure (188).  The diaphragm, a muscle of mixed fiber type with high 
glycolytic capacity, had levels of ER stress comparable to the glycolytic WG.  It thus 
appears that metabolic capacity rather than muscle fiber type per se (i.e. fast vs. slow 
contracting) is a crucial determinant of susceptibility to ER stress in skeletal muscle cells.  
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Muscles with a higher oxidative capacity have an increased capacity to respond to 
oxidative stress (187) and induce heat shock proteins (i.e. hsp70) (63; 189).  This may 
render protection and provide a greater capacity to refold proteins in highly oxidative 
muscle fibers.  We speculate that skeletal muscles with high glycolytic capacity and those 
with high repetitive use (i.e. diaphragm) are most susceptible to ER stress due to the 
greater metabolic stress with contractile activity and a reduced capacity to deal with 
misfolded proteins. 
Potential limitations 
In the current study we have assessed markers of ER stress using commercially 
available antibodies.  The specificity and selectivity of antibodies for the protein ligand 
are critical to the interpretation of data from western blot analyses.  We have confirmed 
the specificity of some of these protein markers using either a blocking peptide (PERK) 
or mass spectrometry (Grp78/BiP).  Supporting our data, a recent study using proteomics 
and bioinformatics tools reported activation of stress responses in gastrocnemius muscle 
of ALS-Tg mice at 98d including Alpha-crystallin B chain (Cryab), Heat shock protein 
HSP 90-beta (Hsp90ab1) and protein disulfide-isomerase A3 (Pdia3) that suggest 
abnormalities in the ER protein folding machinery and activation of the UPR (167).  Our 
observations of increased expression of proteins involved in UPR and ER stress are 
consistent with this report and illustrate that two independent techniques have been used 





Mutant SOD1, mitochondrial disruption and ER/SR dysfunction 
Previous studies indicated that mutant SOD1 is present within the ER lumen 
which may account for activation of ER stress in SOD1-linked ALS cases (33).  Mutant 
SOD1 also accumulates in mitochondria specifically in motoneurons (vs. sensory neurons) 
(190).  Based on the ubiquitous expression of SOD1 (25) one would expect activation of 
the UPR and ER stress pathway from mutant SOD1 in all tissues.  However, our results 
of two typical ER stress markers, Grp78/BiP and CHOP, showed that ER stress is not 
present in cardiac muscles or liver tissues.  We speculate that this is due to the high 
oxidative capacity, and increased mitochondrial content in these tissues.  Motoneurons 
and glycolytic skeletal muscle, however, have low mitochondrial content and thus 
mitochondrial impairment will be detrimental to survival of these cells.  Decreased 
mitochondrial inner membrane potential and mitochondrial Ca2+ buffering have been 
observed in response to osmotic stress and plasma membrane depolarization in muscle 
fibers of G93A*SOD1 mice (48).  The same group has shown that reduced mitochondrial 
membrane potential is greatest in muscle fibers at the neuromuscular junction region 
(168).  Thus, changes in mitochondrial function leading to elevated cellular Ca2+ are 
specifically impaired at the skeletal muscle membrane nearest to its point of innervation.  
This may play an important role in the axonopathy associated with ALS (26; 191). 
Vulnerable motoneurons also have reduced cytosolic Ca2+ buffering capacity and 
disrupted mitochondrial and ER Ca2+ buffering.  Motoneurons with mutant (G93A) 
SOD1- had reduced mitochondrial membrane potential, lower ER Ca2+ release in 
response to a SERCA inhibitor and impaired mitochondrial Ca2+ buffering (192; 193).  
Thus, impairment of mitochondrial and ER Ca2+ storage is thought to be central to 
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motoneuron degenerative changes.  Others have shown that mutant SOD1 aggregates 
with voltage dependent anion channels in mitochondria, specifically of motoneurons (34).  
In the latter study, ADP transport but not Ca2+ uptake by motoneuron mitochondria was 
diminished.  There is emerging data on the importance of Ca2+ regulation, mitochondrial 
function and ER protein misfolding in various diseases (127; 194), but the tissue-specific 
mechanisms altered leading to muscle atrophy and weakness are still not clear.  Further, 
the role of myocyte health in axonal survival and the putative retrograde cellular 
pathophysiology remains unresolved.  Future studies will be required to determine the 
precise mechanisms by which proteins that regulate motoneuron and skeletal muscle 
interaction are affected by unfolded proteins and ER stress leading to muscle atrophy and 
weakness.   
Conclusion 
In summary, our findings show that ER stress is present in skeletal muscle of 
transgenic ALS mice starting at an early, pre-symptomatic age.  The ER stress sensors 
(PERK, IRE1α), ER chaperones (Grp78/BiP, PDI), and ER stress-induced apoptotic 
mediator (CHOP) are activated and associated with disease pathophysiology and 
inhibition of protein translation in skeletal muscle.  Additionally, we show that ER stress 
activation is greatest in glycolytic skeletal muscle and muscles of highest contractile 
activity demand.  These data suggest that ER stress induces an early cellular pathology in 





ALS, amyotrophic lateral sclerosis; SOD1, Cu/Zn superoxide dismutase; ER, 
endoplasmic reticulum; UPR, unfolded protein response; PERK, protein kinase RNA-
activated (PKR)-like ER kinase; IRE1α, inositol-requiring kinase 1-alpha; eIF2α, 
eukaryotic initiation factor 2 alpha; PDI, protein disulfide isomerase; Grp78/BiP, 78 kDa 
glucose-regulated protein and immunoglobulin binding protein; CHOP, C/EBP-
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Figure 3.1.  PERK and phospho-PERK are up-regulated in skeletal muscle of 
G93A*SOD1 ALS-Tg mice.  (A) White gastrocnemius muscle tissues from different 
ages of wild-type (WT) and transgenic G93A*SOD1 (ALS-Tg) mice were collected to 
determine protein expression levels using western blot technique.  Primary antibodies 
PERK, phospho-PERK, GAPDH were used and representative images are shown.  Three 
postnatal ages were examined as follows: early pre-symptomatic (70d; n=3 each for WT 
and ALS-Tg), late pre-symptomatic (90d; n=5 each for WT and ALS-Tg), and 
symptomatic (120-140d; n=3 each for WT and ALS-Tg) mice.  (B) Protein samples were 
incubated either with or without PERK peptides and then PERK protein levels were 
detected using western blots technique.  (C) Analysis of average arbitrary units (AU) 
obtained by densitometry for PERK.  (D) Analysis of average ratio of phosphor-PERK to 
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total PERK.  Data in C and D are presented as mean ± S.E; *, p< 0.05; **, p<0.01 WT vs. 




Figure 3.2.  Phosphorylation of eIF2α is up-regulated in skeletal muscle of 
G93A*SOD1 ALS-Tg mice.  (A) Total protein from white gastrocnemius muscle tissues 
was isolated from wild-type (WT) and transgenic G93A*SOD1 (ALS-Tg) mice.  Western 
blots showed phospho-eIF2α (Ser51) and total eIF2α.  Three different disease stages were 
used: early pre-symptomatic (70d; n=3 each for WT and ALS-Tg), late pre-symptomatic 
(90d; n=5 each for WT and ALS-Tg), and symptomatic (120-140d; n=3 each for WT and 
ALS-Tg) mice.  (B) Analysis of ratio of phospho-eIF2α to total eIF2α.  Data in B is 
presented as mean ± S.E; *, p< 0.05; **, p<0.01 WT vs ALS-Tg in the same age group.  






Figure 3.3.  IRE1α protein level and spliced Xbp-1 transcriptional level are up-
regulated in skeletal muscle of G93A*SOD1 ALS-Tg mice.  (A) Protein was isolated 
from white gastrocnemius muscle of different ages of wild-type (WT) and transgenic 
G93A*SOD1 (ALS-Tg) mice and western blot was performed by using antibody specific 
for IRE1α.  GAPDH was used as the total protein loading control.  Three postnatal ages 
were examined as follows: early pre-symptomatic (70d; n=3 each for WT and ALS-Tg), 
late pre-symptomatic (90d; n=5 each for WT and ALS-Tg), and symptomatic (120-140d; 
n=3 each for WT and ALS-Tg) mice.  (B) Analysis of average arbitrary units (AU) 
obtained by densitometry for IRE1α.  (C)  Total mRNA was isolated by using tibialis 
anterior muscle tissues and un-spliced (Xbp-1u) and spliced Xbp-1 (Xbp-1s) 
transcriptional levels were determined by using semi-quantitative PCR and PCR results 
are shown by running the products in 1.5% agarose gel.  18S was used as the internal 
control.  Three different ages animals as mentioned previously were used.  (D)  Analysis 
of average arbitrary units (AU) obtained by densitometry for Xbp-1s.  Data in B and D 
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Figure 3.4.  ER chaperones Grp78/BiP and PDI are up-regulated in skeletal muscle 
of G93A*SOD1 ALS-TG mice. (A) White gastrocnemius muscle tissues were used to 
determine Grp78/BiP and PDI expressions using western blot technique from different 
ages of wild-type (WT) and transgenic G93A*SOD1 (ALS-Tg) mice.  Representative 
images of Grp78/BiP and PDI are shown.  Three postnatal ages were examined as 
follows: early pre-symptomatic (70d; n=3 each for WT and ALS-Tg), late pre-
symptomatic (90d; n=5 each for WT and ALS-Tg), and symptomatic (120-140d; n=3 
each for WT and ALS-Tg) mice.  (B, C) Analysis of average arbitrary units (AU) 
obtained by densitometry of PDI.  Data in B are presented as mean ± S.E; **, p<0.01 WT 






Figure 3.5.  Grp78/BiP protein identification and quantitation using label-free 
spectral counting-based mass spectrometry.  (A) Workflow of label-free spectral 
counting-based protein quantitative analysis using LC-MS/MS.  Protein samples were 
separated using SDS-PAGE gel electrophoresis and gel pieces excised at ~80 kDa for the 
purpose of in-gel trypsin digestion and LC-MS/MS analysis.  Protein quantitative data 
analysis was conducted using spectral counting and interpreted by normalized total 
spectra numbers.  (B) Grp78/BiP protein identification and peptide coverage using LC-
MS/MS.  (C) Representative mass-to-charge ratio spectrum and b-/y ions fragmentation 
of Grp78/BiP peptide (highlighted in B).  (D) Protein quantitative data analysis using the 
ratio of normalized total spectra numbers of Grp78/BiP to a house keeping protein 
GAPDH.  Three independent muscles from 120-140d old wild type and ALS-Tg mice 





Figure 3.6.  CHOP is up-regulated in skeletal muscles of G93A*SOD1 ALS-Tg mice.  
(A) White gastrocnemius (WG) muscle tissues were obtained from wild-type (WT) and 
transgenic G93A*SOD1 (ALS-Tg) mice of different ages and used to determine CHOP 
protein levels using western blot technique.  GAPDH was used as the total protein 
loading control. Three postnatal ages were examined as follows: early pre-symptomatic 
(70d; n=3 each for WT and ALS-Tg), late pre-symptomatic (90d; n=5 each for WT and 
ALS-Tg), and symptomatic (120-140d; n=3 each for WT and ALS-Tg) mice.  (B) 
Analysis of average arbitrary units (AU) obtained by densitometry of CHOP in WG.  (C) 
Same as A, with diaphragm (DIA) muscle tissues used to assess CHOP protein level.  (D) 
Analysis of average arbitrary units (AU) obtained by densitometry of CHOP in DIA.  
Data in B and D are presented as mean ± S.E; *, p< 0.05; **, p<0.01 WT vs. ALS-Tg in 





Figure 3.7.  Comparison of Grp78/BiP and CHOP protein levels between white and 
red gastrocnemius muscle tissues of G93A*SOD1 ALS-Tg mice.  (A) Image of deep 
portion of gastrocnemius muscle showing white and red gastrocnemius (yellow dashed 
areas) muscle region.  (B) White (WG) and red (RG) gastrocnemius muscle tissues of 
symptomatic animals (120-140d; n=3 each for WT and ALS-Tg) were collected.  
Grp78/BiP and CHOP protein levels were determined using western blot technique.  (C) 
Analysis of Grp78/BiP and CHOP average ratio of ALS-Tg to WT.  Data in B is 






Figure 3.8.  Grp78/BiP and CHOP protein levels in cardiac muscle and liver tissue 
of G93A*SOD1 ALS-Tg mice.  (A) Cardiac muscle (HRT) was collected and protein 
levels determined using western blot technique.  Grp78/BiP and CHOP antibodies were 
used and three postnatal ages were examined: early pre-symptomatic (70d; n=3 each for 
WT and ALS-Tg), late pre-symptomatic (90d; n=5 each for WT and ALS-Tg), and 
symptomatic (120-140d; n=3 each for WT and ALS-Tg) mice.  (B) Liver tissues (LIV) 
was collected and protein levels were determined as described above.  Analysis of 
average arbitrary units (AU) obtained by densitometry of Grp78/BiP and CHOP in HRT 





Figure 3.9.  Schematic figure showing unfolded protein and endoplasmic reticulum 
(ER) stress pathway and its proposed role in skeletal muscle atrophy and weakness 
in ALS.  In skeletal muscle of ALS-Tg mice, the G93A*SOD1 mutation leads to 
oxidative stress and protein misfolding.  This leads to an age-dependent activation of ER 
stress sensors protein kinase RNA-activated-like ER kinase (PERK) and inositol-
requiring kinase 1-alpha (IRE1α).  Normally, these ER stress sensors physically interact 
with the ER chaperone immunoglobulin binding protein (Grp78/BiP) which suppresses 
their activation but accumulation of unfolded/misfolded proteins activates Grp78/BiP, 
including an upregulation of Grp78/BiP and protein disulfide isomerase (PDI) protein 
expression.  Prolonged and severe ER stress can trigger apoptosis by ER stress-specific 
cell death signals, including C/EBP homologous protein (CHOP) and caspase-12, leading 




Chapter 4: SERCA1 overexpression in skeletal muscle preserves motor function and 
delays disease onset in a mouse model of ALS 
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Intracellular Ca2+ homeostasis and induction of ER stress are pathophysiological 
features of skeletal muscle in amyotrophic lateral sclerosis (ALS).  The purpose of this 
study was to investigate whether muscle-restricted overexpression of SERCA1 would 
improve motor function, disease progression and markers of ER stress in ALS mice.  
B6SJL-Tg(SOD1*G93A)1Gur/J (ALS) mice were bred with skeletal muscle α-actinin 
SERCA1 overexpressing mice to generate: i) wild type (WT; n=11); ii) SERCA1 
overexpression (WT/+SERCA1; n=14); iii) SOD1*G93A ALS (ALS-Tg; n=7); iv) 
SERCA1 overexpressing SOD1*G93A ALS mice (AL-Tg/+SERCA1; n=11).  Motor 
function (grip test) and time of symptom onset was assessed weekly and then skeletal 
muscles obtained to assess atrophy and markers of ER stress.  SERCA1 expression and 
activity of the SR Ca2+ ATPase were decreased in quadriceps (QUAD) of ALS-Tg vs. 
WT mice (to 10% and 50% of WT, respectively) but rescued to WT levels in ALS-
Tg/+SERCA1 GAS.  This was associated with an attenuation of muscle atrophy in 
gastrocnemius and QUAD muscles. ALS-Tg/+SERCA1 mice had improved motor 
function at 14 weeks (111.4 ± 16.2 vs. 67.7 ± 13.1 sec; p<0.05) and 16 weeks (53.1 ± 
11.8 vs. 8.9 ± 3.4 sec; p<0.05) compared to ALS-Tg and a delay in disease onset (101.9 ± 
2.6 vs. 91.1 ± 4.7 days).  The ER stress apoptotic signaling protein CHOP was 
upregulated in 2.6-fold in ALS-Tg but not attenuated in ALS-Tg/+SERCA1 GAS.  These 
data indicate that SERCA1 overexpression in skeletal muscle improves motor function 
and slows disease progression in a mouse model of ALS but does not attenuate the ER 
stress response.  We hypothesize that the improvements are due to improved muscle 
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health secondary to improved intracellular Ca2+ regulation but are not sufficient to 





Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a 
devastating neurodegenerative disease which affects 3 out of 100,000 people a year in the 
United States (1).  The clinical features of ALS include upper and lower motor neuron 
degeneration leading to progressive muscle atrophy (1).  Consequently, respiratory failure 
due to muscle weakness leads to death 3-5 years after disease onset (1).  The underlying 
molecular defects in ALS are varied, with more than 50 genes identified (24).  However, 
90-95% of ALS cases are sporadic with unknown causes and only 5-10% of cases are 
familial ALS and linked to a genetic mutations (24).  Among the genetic causes, 
mutations in the Cu/Zn superoxide dismutase 1 (SOD1) gene contribute to ~20% of all 
familial ALS cases (24).  Transgenic mouse models representing SOD1 mutations have 
been developed (4), well characterized and greatly increased our understanding of the 
pathological mechanisms of ALS (24).  The Glycine to Alanine at codon 93 (G93A) 
SOD1 mutation results in a “gain-of-function” toxicity from increased production of 
reactive oxygen species (i.e. H2O2) with several proposed downstream pathological 
mechanisms such as glutamate excitotoxicity, mitochondrial dysfunction, and 
intracellular calcium dysregulation that help to explain to muscle weakness (24; 37).  
In skeletal muscle, there are rapid fluctuations in intracellular Ca2+ during muscle 
contraction, with levels increasing 40 to 100-fold during contractile activity (195).  
Consequently, both resting Ca2+ and Ca2+ release and reuptake events are tightly 
regulated by intracellular Ca2+ channels, pumps, and buffering proteins such as ryanodine 
receptor (RyR), sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), and parvalbumin 
(PV) (196).  Redox modifications and impaired function of Ca2+ -handling proteins is 
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detrimental to their ability to bind or sequester Ca2+ (49).  Thus, redox-modified proteins 
such as RYR and SERCA may contribute to elevations in Ca2+ and muscle pathology in 
various muscle diseases including ALS (7) and Duchenne Muscular Dystrophy (DMD) 
(13; 197).  Forced overexpression of Ca2+ handling proteins that increase Ca2+ influx into 
muscle can induce a pathology that mimics DMD (198-200) while improvements in Ca2+ 
clearance by overexpression of the fast-twitch SERCA isoform (SERCA1) has been 
shown to rescue the muscle pathology and improve function in two models of DMD (13; 
197).  Thus, improving intracellular Ca2+ homeostasis may be beneficial for 
neuromuscular diseases where Ca2+ overload is part of the downstream muscle pathology.   
Our lab has previous shown elevations in intracellular Ca2+ in single muscle fibers 
of the G93A*SOD1 mouse (12).  This was associated with decreased levels of SERCA1, 
SERCA2 and PV protein in limb gastrocnemius muscle (12).  We have also reported an 
increase in the unfolded protein response (UPR) and ER stress markers in skeletal muscle 
of the G93A*SOD1 mouse which are thought to be due to impaired ER intracellular Ca2+ 
regulation (10).  Based on these findings we hypothesized that improving intracellular 
Ca2+ clearance capacity in skeletal muscle of ALS mice would preserve motor function, 
ameliorate muscle atrophy, and rescue the ALS phenotype.  We also hypothesized that it 
would mitigate the ER stress response in skeletal muscle.  Thus, the purpose of this study 
was to evaluate the motor function and the phenotype of skeletal muscle in G93A*SOD1 
mice with muscle-specific overexpression of SERCA1.  Our results show that SERCA1 
overexpression preserved whole body motor function, delayed disease onset and 
attenuated the muscle atrophy in G93A*SOD1 mice.  Surprisingly, SERCA1 
overexpression did not attenuate markers of ER stress.  Overall, our results indicate that 
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improving intracellular Ca2+ regulation in skeletal muscle can improve muscle health and 





All procedures were conducted under a protocol approved by the Institutional 
Animal Care and Use Committee (IACUC) of the University of Maryland, College Park.   
Animals 
Control (C57BL/6 SJL hybrid) female and C57BL/6 SJL-Tg SOD1*G93A (ALS-
Tg) male mice were obtained from Jax Laboratories and bred to established a colony at 
the animal facility of University of Maryland, College Park as previously described (7).  
Male and female skeletal muscle SERCA1 overexpression mice were obtained from 
Cincinnati Children’s Hospital Medical Center.  SERCA1 overexpression is restricted to 
skeletal muscle by a modified human skeletal muscle α-actinin promoter (201).  SERCA1 
Tg breeders were then used to establish a colony of +SERCA1 mice at the University of 
Maryland Central Animal Research Facility as previously described (13).  Male 
WT/+SERCA1 mice were bred with female ALS-Tg mice to obtain 4 genotypes: i) wild-
type (WT); ii) SERCA1 overexpression (WT/+SERCA1); iii) G93A*SOD1 (ALS-Tg), 
and SERCA1 overexpressing G93A*SOD1 (ALS-Tg/+SERCA1).  This study was 
designed to obtain 8-10 mice per genotype.  All mice were weaned at 21 days and 
genotyped for expression of the G93A SOD1 mutation and for SERCA1 using primer 
sequences and methods previously described (7; 13).  All mice were kept in the same 
room condition (typical ambient conditions 20.9% O2 and 22 ± 1
oC) with equal access to 
food and water, bedding, and light cycles (12h light/12h dark).   
Assessment of motor function and disease onset  
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Motor function of the mice was evaluated weekly from 9 weeks to 16 weeks of 
age with a grip test.  Briefly, the grip test is the time the mice were able to hold their body 
weight while suspended from a wire mesh lid as previously described (7).  In this study, 
each mouse was subjected to three trials with the maximum test time being 180 s and a 
10 min rest period between trials.  The average of three trials was used for reporting grip 
test performance.  The test was conducted and analyzed in a blinded fashion.  Disease 
onset was defined as the time corresponding to the first signs of myotonic symptoms such 
as muscle tremor or hindlimb stiffness. The rapid reduction in grip test performance was 
used as another criteria to evaluate the demonstration of disease onset.  
Experimental Procedures 
At 16 wks of age mice were euthanized by CO2 inhalation followed by cervical 
dislocation.  Skeletal muscles including gastrocnemius (GAS), tibialis anterior (TA) and 
quadriceps (QUAD) were removed and weighed by investigators who were blinded to the 
genotype of the mice.  Muscle samples were then quick frozen in liquid nitrogen and 
stored at -80oC until subsequent analyses.  At the time of sacrifice, the flexor digitorum 
brevis (FDB) muscle was removed from a subset of mice (n=4 for each genotype; 3 
females, 1 male each) and single muscle fibers isolated for assessing [Ca2+]i levels.   
Single muscle fiber isolation and free [Ca2+]i measurements  
Detailed methods for single muscle fiber isolation and [Ca2+]i measurements have 
been previously described (202).  Briefly, single muscle fibers were obtained from the 
FDB muscle by collagenase digestion with type 2 collagenase (Worthington) in minimal 
essential medium (MEM) with 10% fetal bovine serum (FBS) and 1% penicillin-
streptomycin (Invitrogen). After incubation at 37°C in 95% O2-5% CO2, single muscle 
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fibers were obtained by trituration. Subsequently, fibers were maintained in MEM 
solution with 10% FBS at 37°C, 95% O2-5% CO2 until used for [Ca2+]i assessment. 
One day after dissection, fibers were loaded with Fura-2AM for 15 min. The 
Fura-2 ratio was measured in response to varying stimuli (see protocol below) as an index 
of [Ca2+]i.  Fibers loaded with Fura-2AM were placed in a stimulation chamber 
containing parallel electrodes and the chamber was positioned on a Nikon TiU 
microscope stage.  Muscle fibers were continuously perfused with a stimulating Tyrode 
solution (121.0 mM NaCl, 5.0 mM KCl, 1.8 mM CaCl2, 0.5 mM MgCl2, 0.4 mM 
NaH2PO4, 24.0 mM NaHCO3, and 5.5 mM glucose) with 0.2% FBS (203).  The solution 
was bubbled with 95% O2-5% CO2 to maintain a pH of 7.3 (203). Levels of [Ca2+]i were 
assessed by the Fura-2 fluorescence ratio using an IonOptix Hyperswitch system with 
dual excitation, single emission filter set for Fura-2 (excitation 340 nm and 380 nm; 
emission 510 nm).  Signals were captured and analyzed using the IonWizard software 
(IonOptix). Global Fura-2 ratio was measured in muscle fibers using trains of stimuli at 
10, 30, 50, 70, 100, 120, and 150 Hz for 350 ms with fibers resting 1 min between 
frequencies.  Peak Fura-2 ratios at each frequency were determined by the average ratio 
in the last 100 ms of the 350 ms tetanus, when Ca2+ Fura-2 should be at a steady state.  
All single muscle fibers were evaluated at room temperature.  Fura-2 signals were 
measured in 7-9 fibers per mouse for a total of 28-33 fibers per genotype: WT (n=33); 
WT/+SERCA1 (n=33); ALS-Tg (n=28); ALS-Tg/+SERCA1 (n=33). 
Muscle protein expression  
The QUAD was used to confirm SERCA1 overexpression and to assess UPR and 
ER stress responses in skeletal muscle as previously described (7; 10).  The ER stress 
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response was assessed by measuring protein expression of the ER stress sensors protein 
disulfide isomerase (PDI) and Grp78/BiP and the ER stress-specific cell death signaling 
protein C/EBP homologous protein (CHOP).  Briefly, QUAD was homogenized in lysis 
buffer containing 20 mM Hepes buffer, 100 mM NaCl, 1.5 mM MgCl2, 0.1% Triton X-
100, 20 % Glycerol, 1mM DTT and protease inhibitors (cOmplete mini EDTA-free 
protease inhibitor cocktail, Roche Diagnostics, Indianapolis, IN).  After tissue 
homogenization, samples were kept at 4oC for 20 min and then centrifuged at 20,000 g.  
Supernatant was collected and frozen at -80oC until used for protein expression analyses.  
Sample protein concentration was determined using a BCA assay (Thermo Fisher 
Scientific Inc., Rockford, IL).  For assessing SERCA1, PDI, Grp78/BiP and CHOP 
protein levels, 30 μg of total protein was used.  Protein samples were solubilized in 5 x 
loading buffered and denatured by incubation at 100oC for 5 min.  Denatured protein 
samples were loaded on 8% bis-acrylamide gels and separated by SDS-PAGE 
electrophoresis.  After gel electrophoresis, proteins were transferred to PVDF membrane 
(EMD Millipore, Billerica, MA) and then blocked with 5% non-fat milk at room 
temperature for 1 h.  The following antibodies and dilutions were used to determine 
protein expression levels: SERCA1 (1:2500, Thermo Fisher Scientific Inc., Rockford, IL) 
and PDI, Grp78/BiP and CHOP (1:1000, Cell Signaling Technology).  GAPDH primary 
antibody (1:2000, Thermo Fisher Scientific Inc., Rockford, IL) was used as a total protein 
loading control.  Protein levels were quantified by band densitometry (Bio-Rad 
Laboratories Inc., Hercules CA) and protein expression levels were expressed in arbitrary 
units (AU).   
Determination of maximal SERCA1 ATPase activity  
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QUAD was used to determine maximal SERCA1 ATPase activity using the 
method described in Chin et al. 1994 (204) modified to a 96 well plate format (13).  
Briefly, QUAD was homogenized in muscle homogenizing media containing 200mM 
200 mM Sucrose, 10 mM NaN3, 1mM EDTA, and 40 mM L-histidine (pH 7.8) with a 
1:20 ratio (w/v, 0.1 g tissue: 2mL buffer).  The Ca2+-ATPase reaction was measured in a 
crude homogenate in a reaction buffer which containing 20 mM Hepes buffer (pH 7.5), 
200 mM KCl, 15mM MgCl2, 10 mM NaN3, 1mM EGTA, 5 mM ATP, 10mM 
phosphoenolpyruvate, 18U/mL lactate dehydrogenase, 18U/mL pyruvate kinase, 4 μM 
calcium ionophore A23187 and 0.3 mM NADH.  Total ATPase activity was assessed by 
adding 1 mM CaCl2 and basal ATPase was measured by adding 1 mM CaCl2 and 5mM 
cyclopiazonic acid (CPA), which is a selective SERCAs ATPase inhibitor.  The reaction 
was measured in triplicates in a 96-well plate at 37oC and NADH absorbance was 
measured at 340 nm.  Maximal SERCA1 ATPase activity was defined as the difference 
between total ATPase and basal ATPase activity.   
Statistical Analysis 
Values are expressed as mean ± standard error of the mean (SEM).  To evaluate 
differences between WT, WT/+SERCA1, ALS-Tg and ALS-Tg/+SERCA1 mice, data 
were analyzed using Student’s T-tests to compare between genotypes, with p<0.05 used 




The body mass of mice used in this study are shown in Table 4.1.  At 16 weeks, 
the average body mass of male mice was not different between any of the genotypes.  
However, for female mice, body mass of WT/+SERCA1, ALS-Tg and ALS-
Tg/+SERCA1 mice were significantly lower compared to WT mice, averaging 85%, 68% 
and 72% of WT levels, respectively.  Body mass of female ALS-Tg mice was also 
reduced (to 80%) compared to WT/+SERCA1 mice.  Due to the low number of male 
ALS-Tg mice, the data for both sexes were combined.  Combined, the body mass of WT 
and WT/+SERCA1 were not different, but the ALS-Tg and ALS-Tg/+SERCA1 mice 
were significantly reduced, to 75% and 78% of WT levels, respectively.  All other data 
reported are for male and female mice combined unless otherwise specified. 
SERCA1 expression and maximal SR Ca2+ ATPase activity in skeletal muscle of 
ALS-Tg and +SERCA1 Tg mice: Western blot analysis was used to confirm SERCA1 
overexpression in QUAD muscle of the WT/+SERCA1 and ALS-Tg/+SERCA1 Tg mice 
(Fig. 4.1A and 1B).  SERCA1 protein levels were on average 1.8-fold higher in QUAD 
of WT/+SERCA1 compared to WT mice (p<0.01).  Consistent with our previous report, 
SERCA1 protein levels were decreased in QUAD of ALS-Tg mice, to 10% of WT levels 
(p<0.01).  SERCA1 overexpression resulted in 8.1 –fold higher SERCA1 protein levels 
in QUAD of ALS-Tg/+SERCA1 mice relative to ALS-Tg mice (p<0.01), to a level not 
different from WT.  To determine whether the increase in SERCA1 protein level resulted 
in increased function of the Ca2+ ATPase, we measured muscle SR Ca2+ -ATPase activity 
(Fig. 4.1C).  In QUAD muscle of ALS-Tg mice, maximum Ca2+ -ATPase activity was 
50% of WT levels (p<0.01).  SERCA1 overexpression increased maximal Ca2+ -ATPase 
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activity in QUAD of both WT/+SERCA1 (1.5-fold vs. WT; p<0.05) and ALS-
Tg/+SERCA1 (1.8-fold vs. ALS-Tg; p<0.05) mice.  These data confirm that SERCA1 
protein levels as well as maximum SR Ca2+ ATPase activity was increased in skeletal 
muscle of WT/+SERCA and ALS-Tg/+SERCA mice. 
SERCA1 overexpression alters stimulation induced Ca2+ transients in ALS-Tg 
mice: In order to assess the effects of SERCA1 overexpression on skeletal muscle Ca2+ 
cycling during contraction and relaxation, we assessed [Ca2+]i using Fura-2 ratio in single 
fibers during electrical stimulation.  There was no significant difference in resting Fura-2 
ratio, although there was a trend (p=0.08) for single fibers from ALS-Tg to be higher than 
an all other groups (Fig. 4.2A).  Peak Fura-2 at all stimulation frequencies was not 
different in single fibers from WT and WT/+SERCA1 or between WT and ALS-Tg.  
There was, however, a significant reduction in Fura-2 ratio at all stimulation frequencies 
between ALS-Tg and ALS-Tg/+SERCA1, with peak ratios being 16% (10Hz), 22% 
(30Hz), 19% (50Hz), 17% (70Hz), 15% (100Hz), 14% (120Hz) and 11% (150Hz) lower 
in fibers from SERCA1 overexpressing ALS-Tg compared to ALS-Tg mice (Fig. 4.2B 
and 2C).  These data suggest a reduction in releasable Ca2+ during contractile activity in 
ALS-Tg/+SERCA1 mice. 
SERCA1 overexpression preserves motor function and delays disease onset in 
ALS-Tg mice: Deficits in motor function have been consistently observed with disease 
progression across the lifespan in G93A*SOD1 ALS-Tg mice (205; 206).  To determine 
whether skeletal muscle-specific increases in SERCA1 would improve motor function, 
we assessed whole body motor performance using a grip test from 9 - 16 weeks of age 
(Fig. 4.3A).  WT/+SERCA1 mice showed no signs of decreased motor function, with all 
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mice able to grip for the maximum 180 s, similar to WT.  ALS-Tg and ALS-
Tg/+SERCA1 mice showed normal motor function at an early age (up to 11 weeks).  At 
12 weeks, both ALS-Tg and ALS-Tg/+SERCA1 mice had decreased grip time compared 
to WT mice and this reduction continued until study termination (16 weeks). In spite of 
the rapid deterioration of motor function, SERCA1 overexpression was able to partially 
preserve motor function in ALS mice.  Starting at 14 wks, grip time was longer for ALS-
Tg/+SERCA1 mice compared to ALS-Tg with ALS-Tg/+SERCA1 at 62% of WT vs. 
ALS-Tg at 38% of WT levels (p<0.05).  At 16 wks ALS-Tg/+SERCA1 mice were at     
29% of WT compared to ALS-Tg at 5% of WT levels (p<0.01).  These data indicate that 
SERCA1 overexpression could partially rescue the ALS phenotype by preserving motor 
function.  
The G93A*SOD1 mice have a shortened life span of ~150d (4) with mice 
surviving ~2 wks after the first signs of disease onset (i.e. muscle tremor and hindlimb 
stiffness).  To determine whether skeletal muscle-specific SERCA1 overexpression could 
delay disease onset, we recorded the age at which disease symptoms were first observed.  
In ALS-Tg mice, disease onset was observed at 91 ± 4.7 d.  In contrast, ALS-
Tg/+SERCA1 mice had a significant delay the disease onset in ALS/+SERCA1 mice 
(102 ± 2.6 d) (see Fig. 4.3B).   
SERCA1 overexpression attenuates skeletal muscle atrophy in ALS-Tg mice :A 
decrease in muscle mass has been documented by MRI in G93A*SOD1 mice, starting as 
early as 60d (205).  In this study we assessed muscle atrophy by measuring muscle mass 
at 16 wks (Figure 4).  Muscle loss was seen in ALS-Tg, with muscle mass being 43% 
(GAS), 50% (TA) and 42% (QUAD) of WT levels (p<0.01).  However, in ALS-
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Tg/+SERCA1 mice there was an increase in muscle mass relative to ALS-Tg for all 
muscles: GAS  was 141% vs. ALS-Tg (p<0.01), TA was 167% vs. ALS (p<0.05) and 
QUAD was 153% of ALS-Tg (p<0.05).  Muscle mass in ALS-Tg/+SERCA1 was, 
however, still significantly less than WT levels for all muscle.  Interestingly, the 
WT/+SERCA1 mice have a significant decrease in muscle mass compared to WT, being 
58% (GAS), 78% (TA) and 58% (QUAD) of WT levels (p<0.01).   
SERCA1 overexpression does not attenuate activation of the ER stress response in 
ALS-Tg mice: We previously reported an increase in ER stress sensors PDI and 
Grp78/BiP as well as ER apoptotic signaling protein CHOP in gastrocnemius muscle of 
ALS-Tg mice.  In the current study, we did not detect an increase in PDI in QUAD 
muscle of ALS-Tg or any other group, with expression levels being similar to WT in all 
genotypes (Fig. 4.5A).  The ER stress chaperone protein Grp78/BiP was elevated 3.5-fold 
in the ALS-Tg mice compared to WT (p<0.05; Fig. 4.5B).  Grp78/BiP was not elevated 
in this set of ALS-Tg mice, but was 3.8-fold higher in ALS-Tg/+SERCA1 vs. WT 
(p<0.01) and 2.8-fold relative to the ALS-Tg genotype control (p<0.01).  The apoptosis-
signaling protein CHOP was not different between WT and WT/+SERCA1 QUAD 
muscle.  But, CHOP was increased 2.6-fold in ALS-Tg muscle (p<0.01) and 2.5-fold in 
ALS-Tg/+SERCA1 mice (p<0.01) (Fig. 4.5C) indicating that activation of ER-stress 






Intracellular Ca2+ plays an essential role in preserving skeletal muscle function 
and whole tissue integrity (12).  Muscles use Ca2+ not only during contraction but also as 
a second messenger in regulating muscle gene expression (207).  Ca2+ overload, defined 
as an elevation in resting intracellular Ca2+ level, leads to severe skeletal muscle damage 
via activation of Ca2+- dependent proteases such as calpains, release of phospholipase A2, 
over production of reactive oxygen species, and mitochondrial Ca2+ overload (12). 
Therefore, abnormal intracellular Ca2+ levels are thought to be one of the factors 
contributing to skeletal muscle damage in various pathological conditions such as in 
over-training, trauma, tissue ischemia, muscle cachexia, and disease such as Duchenne 
muscular dystrophy and ALS (12).   Considering the importance of preserving normal 
resting intracellular Ca2+ levels, skeletal muscle fibers have various ways of removing 
and buffering Ca2+ concentration in the cytoplasm such as plasma membrane Ca2+ pumps, 
cytosolic Ca2+ buffering proteins and Ca2+ regulatory proteins in the SR (13).  The most 
significant of these is SERCA1, which is the SR/ER membrane Ca2+ ATPase responsible 
for the removal of Ca2+ into the SRduring muscle relaxation, following its release for 
muscle contraction (13).  It can also reduce intracellular Ca2+ levels after a pathological 
overload (13).  Overexpression of SERCA1 was shown to increase cytoplasmic clearance 
of Ca2+ and reduce mitochondrial swelling in response to Ca2+ exposure (197).  It is now 
known that SERCA1 also plays an important role in mitigating skeletal muscle disease 
pathology (12; 13; 15). 
The importance  of SERCA1 in regulating Ca2+ signaling and skeletal muscle 
function in muscle disease pathology was shown in two recent studies where 
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overexpression of SERCA1 in skeletal muscle significantly improved the dystrophic 
phenotype (13; 197).  In dystrophin deficient mdx mice, dystrophin and utrophin deficient 
(mdx/Utr-/-) and Sarcoglycan null (Sgcd-/-) mice, SERCA1 overexpression attenuated the 
pathological features such as central nucleation and muscle fibrosis in skeletal muscle 
and reduced creatine kinase, a serum markers of muscle damage (13; 200).  And in both 
mdx and mdx/Utr-/- mice, SERCA1 overexpression improved force production in response 
to damage-inducing eccentric contractions (13).  Thus, increased SERCA1 expression 
and improved intracellular Ca2+ clearance had profound effects on improving 
pathological and functional consequences in skeletal muscle (13; 15).  These data support 
the hypothesis that Ca2+ dysregulation is the final pathological event in skeletal muscle 
diseases and that upregulation of SERCA1 protein level or increasing SERCA1 function 
is an attractive therapeutic strategy to treating these diseases.   
Our previous study showed elevations in intracellular Ca2+ in single muscle fibers 
from G93A*SOD1 mice (12). This was associated with decreases in SERCA1 and 
SERCA2 as well as the Ca2+ buffering protein parvalbumin (7).  Based on these findings, 
we hypothesized that decreased SERCA1 function could induce skeletal muscle 
pathology in ALS and that activation of SERCA1 function, by treating the animals with a 
small molecule activator of SERCA1 (6-gingerol), would improve muscle function.  
Indeed, our preliminary report of this study showed that 6-gingerol treatment 
significantly improved grip function in G93A*SOD1 mice and attenuated the ER stress 
protein markers PERK, PDI and Grp78/BiP and as well as the ER stress apoptotic 
signaling protein CHOP  (15).  These data suggested that increasing SERCA1 function 
can improve both motor function and reduce ER stress in skeletal muscle.  To directly 
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assess the effects of increased SERCA1 activity in attenuating the ALS phenotype in 
skeletal muscle, in the present study, we crossed skeletal muscle-specific overexpressing 
SERCA1 mice with the G93A*SOD1 ALS-Tg mice.  Our results clearly show that 
SERCA1 overexpression increases SR Ca2+ ATPase activity and results in improved Ca2+ 
handling in single muscle fibers of ALS-Tg mice.  Most importantly, SERCA1 
overexpression was shown to attenuate skeletal muscle atrophy, improve skeletal muscle 
function, and delay disease progression in the ALS-Tg mice.  Our study support the 
notion that impaired SERCA1 function contributes to the skeletal muscle weakness and 
ALS pathogenesis.   
Skeletal muscle atrophy is one of the main disease manifestations in ALS (12). 
However, it is still unclear whether muscle pathology is simply a consequence of motor 
neuron degeneration or a direct cause of the ALS phenotype (176).  Notably, there is 
evidence indicating that skeletal muscle atrophy may precede changes in motor neurons 
(176).  A magnetic resonance imaging (MRI) analysis of skeletal muscle volume of the 
G93A*SOD1 ALS-Tg showed a significant decrease in muscle as early as 8 weeks, 4 
weeks before the mice become symptomatic (176; 208).  Moreover, a decrease in motor 
function was observed as early as 50 days in ALS-Tg mice, much earlier than the mice 
showed clinical symptoms (176; 208).  These results suggest that muscle weakness 
occurs in the early stages of ALS disease progression, prior to motor neuron loss.  The 
role of skeletal muscle in the ALS phenotype has also been addressed in transgenic mice 
where mutant SOD1 proteins were only expressed in skeletal muscle (6).  Mice with 
skeletal muscle-specific overexpression of mutant SOD1 also demonstrated severe 
muscle atrophy and progressive muscle paralysis, although disease progression was 
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delayed (6).   Most importantly, distal degeneration was observed, strongly suggesting 
that skeletal muscle pathology plays an important role in ALS pathogenesis, possibly via 
a dying-back phenomenon (6).  In our study, skeletal muscle-specific overexpression of 
SERCA1 recued skeletal muscle atrophy and improved motor function in ALS-Tg mice.  
Collectively these data support the importance of skeletal muscle in ALS disease 
progression and suggests that it has an important role in the ALS pathogenesis. 
Our recent study showed that ER stress activation was present in skeletal muscle 
and could contribute, along with altered intracellular Ca2+ regulation, to mytocyte death 
in ALS-Tg mice (10).  We previously showed that activation of ER stress is a skeletal 
muscle-specific event and is not induced in non-pathological tissues such as liver and 
cardiac muscle (10). Additionally, the ER stress-specific cell death signal CHOP was 
upregulated by 70d, prior to symptom onset, and to a greater extent in the later 
symptomatic stages of disease progression, suggesting that CHOP protein expression is 
important in ALS disease progression (10).  Further, ER stress is  activated to a greater 
extent in fast muscle, which shows an earlier decline in force in ALS-Tg mice (181), than 
slow type muscle fibers, suggesting that activation of ER stress is consistent with the 
severity of skeletal muscle pathology (10).   In the current study, we tested the hypothesis 
that improving the skeletal muscle phenotype with SERCA1 overexpression would 
reduce the ER stress activation.  Surprisingly, we found that the ER stress marker 
Grp78/BiP was upregulated in skeletal muscle of the SERCA1 Tg mice. we also found 
that SERCA1 overexpression failed to repress upregulation of Grp78/BiP and CHOP in 
skeletal muscle of ALS-Tg/+SERCA1 mice, indicating that ER stress per se was not 
involved in the improved of skeletal muscle phenotype.  This result was unexpected since 
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Ca2+ handling is tightly associated with SR/ER function and we expected that 
improvements in Ca2+ homeostasis would help to preserve SR/ER function and suppress 
the activation of ER stress.  However, considering that SERCA1 is the most abundant 
proteins in SR/ER, we cannot rule out the possibility that overexpression of SERCA1 
could induce a temporary protein-overload in the ER lumen and thus activate ER stress 
even in the wild-type background.  Further studies are needed to address the relationship 
between improved Ca2+ clearance capacity and ER homeostasis in skeletal muscle during 
ALS disease progression. 
In summary, this study shows that skeletal muscle-specific overexpression of 
SERCA1 in ALS-Tg mice preserved muscle Ca2+ handling, improved motor function, 
delayed disease onset and attenuated muscle atrophy.  Our results support the emerging 
notion that skeletal muscle pathology is a contributing factor in ALS pathogenesis. Our 
data also support targeting SERCA1 in skeletal muscle as a novel therapeutic strategy to 
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Table 4.1.  Effects of SERCA1 overexpression on body mass of wild-type (WT) and 
G93A*SOD1 (ALS-Tg) mice. 
 
 Male Female Male + Female 
Combined 
WT 30.0 ± 1.2  
(n = 7) 
25.9 ± 1.1 
(n = 4) 
28.0 ± 1.0 
(n = 11) 
WT/+SERCA1 30.3 ± 1.2 
(n = 7) 
22.0 ± 1.8*† 
(n = 6) 
26.5 ± 1.2 
(n=13) 
ALS-Tg 29.4 ± 11.5 
(n = 2) 
17.7 ± 0.9** 
(n = 5) 




26.4 ± 0.3 
(n = 5) 
18.5 ± 0.6** 
(n = 6) 
21.7 ± 1.5 ** 
(n=11) 
 
Body mass is shown in gram (g) with number of mice (n) per group are shown in 
parentheses.  Data represent mean ± SEM.  * p < 0.05 vs. WT; **p < 0.01 vs. WT; † p < 





Figure 4.1.  SERCA1 overexpression increases SERCA1 protein levels and 
maximum SR Ca2+ ATPase activity in quadriceps muscles in ALS-Tg mice.  A) 
Representative western blot image for SERCA1 protein level in quadriceps muscle from 
WT and ALS-Tg mice with and without SERCA1 overexpression.  B) Quantitative 
analysis of western blot images by densitometry.    Data shown are in arbitrary units (AU) 
for WT (n=4; 1 male and 3 female), WT/+SERCA1 (n=4; 1 male and 3 female), ALS-Tg 
(n=4; 1 male and 3 female) and ALS-Tg/+SERCA1 (n=4; 1 male and 3 female).  C) 
Maximal SR Ca2+ ATPase activity of quadriceps muscle of WT (n=4), WT/+SERCA1 
(n=4), ALS-Tg (n=4) and ALS-Tg/+SERCA1 (n=4).  Average data (B, C) represent mean 





Figure 4.2.  SERCA1 overexpression alters stimulation induced Ca2+ transients in 
skeletal muscle of ALS-Tg mice.  (A) Data qualification of the Fura-2 ratio, which 
represents single muscle fiber resting intramuscular [Ca2+]i. (B) The Fura-2 ratio was 
measured in muscle fibers using trains of stimuli at 10, 30, 50, 70, 100, 120, and 150 Hz 
for 350 ms with fibers resting 1 min between frequencies. (C) Data qualification of The 
Fura-2 ratio measured in muscle fibers using trains of stimuli at 30 and 150 Hz. †p < 0.05 










Figure 4.3.  SERCA1 overexpression in skeletal muscle attenuates muscle atrophy in 
ALS-Tg mice. Muscle mass is shown by absolute mass (mg) for gastrocnemius (GAS), 
tibialis anterior (TA), and quadriceps (Quad). *p < 0.05 vs. WT, **p < 0.01 vs. WT; † p 






Figure 4.4.  SERCA1 overexpression in skeletal muscle improves motor function 
and attenuates disease progression in ALS-Tg mice. (A) Data analysis of grip test. (B) 
Data analysis of disease onset. ). *p < 0.05 vs. WT, **p < 0.01 vs. WT; † p < 0.05 or ††p 






Figure 4.5.  SERCA1 overexpression in skeletal muscle did not repress ER stress 
markers in skeletal muscle of ALS-Tg mice. Representative wester blots images for ER 
stress markers PDI (A), Grp78/BiP (B), and CHOP (C). Quantitative analysis of western 
blot images by densitometry of   PDI (D), Grp78/BiP (E), and CHOP (F). WT (n=4), 
WT/+SERCA1 (n=4), ALS-Tg (n=4) and ALS-Tg/+SERCA1 (n=4).  Average data 
represent mean ± SEM. *p < 0.05 vs. WT, **p < 0.01 vs. WT; † p < 0.05 or ††p < 0.01 
vs. WT-Tg.  Values shown are mean ± SEM.  
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Amyotrophic lateral sclerosis (ALS) is a devastating disease which affects both 
motor neurons and skeletal muscle.  Skeletal muscle atrophy and dysfunction is one of 
the main features of disease progression and is suggested to contribute to ALS 
pathogenesis.  Our preliminary data showed that ER stress was induced in skeletal muscle 
of ALS mice and could contribute to skeletal muscle atrophy.  The purpose of this study 
was to investigate the molecular mechanisms of ER stress in skeletal muscle atrophy in 
ALS. For this purpose, we utilized affinity-based protein mass spectrometry and cell 
culture model approaches.  Antibody co-immunoprecipitation studies show that 
Grp78/BiP interacts with ATPase synthase subunits and pavalbumin proteins in skeletal 
muscle of ALS-Tg but not wild type mice.  Grp78/BiP also interacted with SERCA1 and 
SR Ca2+ ATPase activity function was reduced when Grp78/BiP was neutralized.   In 
C2C12 myotubes, H2O2-induced oxidative stress reduced SR Ca2+ ATPase activity from 
138.5 ± 22.1 to 9.6 ± 1.7 µ mole/mg protein/min. Inhibition of ER stress using 4-PBA 
attenuated the H2O2-induced decrease in in SR Ca2+ ATPase by 34% and catalase 
reversed it 100% .  These data indicate that Grp78/BiP has binding partners in multiple 
cellular organelles and in the SR plays a protective role by attenuating oxidative stress-
induced declines in SR Ca2+ regulation. These data further suggest that inhibition of ER 
stress could be an effective therapeutic way to rescue skeletal muscle dysfunction in ALS.   






Amyotrophic lateral sclerosis (ALS) is a devastating disease which affects both 
motor neurons and skeletal muscle (1).  Skeletal muscle atrophy/dysfunction is one of the 
main features of ALS pathology and ALS patients generally die from respiratory failure 
within a few years of diagnosis (1). Although most ALS cases are sporadic without 
family history, 5-10% of the ALS cases are linked to genetic mutations with family 
history and thus termed as familial ALS (1).  Among familial ALS cases, mutations in 
human Cu/Zn superoxide dismutase 1 (SOD1) proteins were first identified (32).  Animal 
models expressing human SOD1 mutations reproduce several key phenotypes of ALS 
patients and have been widely used to study pathological mechanisms in ALS (4).  It is 
suggested that mutant SOD1 proteins induce their cellular effects via a “gain-of-function” 
mechanism (33). However, it is still largely unknown how “gain-of-function” of mutant 
SOD1 proteins induces cellular toxicity.  Nevertheless, several hypotheses have been 
proposed to suggest potential pathways for ALS pathogenesis such as oxidative stress, 
mitochondrial dysfunction, and unfolded protein response (21).   
Unfolded protein response, or endoplasmic reticulum (ER) stress, is known to 
contribute to tissue pathology in various neurodegenerative diseases including ALS (21).  
ER is the main site for protein synthesis and newly synthesized peptides are folded 
properly in the ER lumen.  However, various pathological conditions can cause 
accumulation of misfolded or unfolded proteins in the ER lumen and induce the ER stress 
pathway (9).  Activation of ER stress involves in three ER stress sensors located on the 
ER membrane: protein kinase RNA activated-like ER kinase (PERK), inositol-requiring 
kinase 1-alpha (IRE1α), and activating transcription factor 6 (ATF6) (9).  Under normal 
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conditions, those three ER sensors are repressed by an ER chaperone called glucose-
regulated 78kDa protein/immunoglobulin binding protein (Grp78/BiP) (9). However, 
upon accumulation of misfolded or unfolded proteins, Grp78/BiP proteins preferentially 
bind to these abnormal proteins and thus activates the ER stress sensors (9).  Short-term 
or moderate activation of ER stress is critical to preserving cellular homeostasis but long-
term or prolonged activation of ER stress contributes to cell death via upregulation of ER 
stress-specific cell death signals such as C/EBP homologous protein (CHOP) and 
caspase-12 (9).   
Our previous studies suggest that a disruption of ER homeostasis could play a 
detrimental role in inducing skeletal muscle dysfunction in ALS mice (10).  Elevated 
intramuscular calcium level was observed in single muscle fibers of ALS mice (12). 
Concurrently, sarcoplasmic/endoplasmic reticulum Ca2+ ATPase isoform 1 (SERCA1), 
which is a key ER membrane calcium-handling protein, was shown to be downregulated 
in skeletal muscle of ALS mice, leading to our speculation that downregulation of 
SERCA1 proteins could results in interrupted calcium homeostasis in skeletal muscle of 
ALS mice (12).  Indeed, SR Ca2+ ATPase activity, a functional measure which is more 
physiologically relevant, was dramatically reduced in skeletal muscle of ALS mice (12). 
More importantly, SERCA1 overexpression in skeletal muscle of ALS mice resulted in 
improvements in the disease phenotypes including improved motor function, increased 
muscle mass, and a delay in disease onset, indicating that increasing SR Ca2+ ATPase 
activity and maintaining calcium homeostasis can preserve skeletal muscle function in 
ALS mice (Chapter 4).  
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Our recent studies showed that ER stress was activated in skeletal muscle of ALS 
and suggested that this cellular stress pathway could play a pathological role in inducing 
muscle atrophy and dysfunction in ALS (10). Therefore, in the current study, we focused 
on the molecular mechanisms by which ER stress induces skeletal muscle dysfunction. 
Since the “gain-of-function” of SOD1*G93A mutation results in increase H2O2 
production (17), we hypothesized that that H2O2 is the reactive oxygen species (ROS) that 
activates ER stress in skeletal muscle.  We also hypothesized that H2O2 is responsible for 
the decrease in SR Ca2+ ATPase activity in skeletal muscle of ALS.  In order to further 
investigate the molecular mechanism for Grp78/BiP function in skeletal muscle, we tried 
to identify novel binding partners through a protein-immunoprecipitation/pull down 





Ethics Statement: All animal procedures were conducted under a protocol 
approved by the Institutional Animal Care & Use Committee (IACUC) of the University 
of Maryland, College Park.   
Animals: Control C57BL/6 SJL hybrid female and transgenic ALS B6SJL-Tg 
(SOD1 G93A) Gur/J (G93A*SOD1) male mice were obtained from The Jackson 
Laboratory. Wild-type control (WT) and transgenic G93A*SOD1 heterozygote (ALS-Tg) 
mice were bred to establish a colony at our animal care facility at the University of 
Maryland. Mice were weaned at postnatal day 21 and genotyped.  At time of use, animals 
were euthanized by CO2 inhalation followed by cervical dislocation. Skeletal muscles 
tissues were harvested, quickly frozen in liquid nitrogen and stored at 80oC.   
C2C12 Cell Culture and drug treatment: C2C12 cells are removed from liquid 
nitrogen and quickly thawed at 37oC.  After defrost, cells are moved to 25 mL flask and 
suspended with 10 mL growth media (GM) containing 20% fetal bovine serum, 80% 
DMEM, and 1% 100 x Pen/strep. C2C12 mouse myoblast were cultured in an incubator 
at 37oC with 5% CO2.  After cultured in DMEM/10% FBS for 48 h, cell numbers are 
counted and 1.0 x 106 cells/well are moved to 12-well plates (1.0 x 105 cells/well for 24-
well plate) and cultured in differentiation medium containing 2% horse serum medium, 
98% DMEM, 10 ug/mL transferrin, 10 ug/mL human recombinant insulin, and 1% 100 x 
Pen/strep.  After 96 h of myotube differentiation, cells were treated with either hydrogen 
peroxide (H2O2), thapsigargin (TG), or appropriate vehicles (water for hydrogen peroxide 
and 4-PBA, DMSO for thapsigargin, glycerol for catalase). C2C12 myotubes were 
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harvested after 24 hours after treatment for the purpose of determining SR Ca2+ ATPase 
activity and 48 hours after treatment for the purpose for western blots analysis. 
Total Protein Extraction: Either skeletal muscle tissues or cell culture product 
samples were homogenized on ice using a polytron at 50% maximal power for three 10 s 
bursts, separated by 30 s in ice cold lysis buffer (20 mM Hepes, pH = 7.5, 150 mM NaCl, 
1.5 mM MgCl2, 0.1% Triton X-100, 20% Glycerol) containing 1 mM DTT and protease 
inhibitor cocktail (cOmplete mini EDTA-free Protease Inhibitor Cocktail, Roche). After 
20 min of incubation at 4oC followed by centrifugation for 5 min at 20,000 x g, the 
supernatant was collected, quick frozen in liquid nitrogen and stored at 80oC until 
required. A BCA protein assay kit (Thermo Scientific) was used to determine protein 
concentration in the samples.   
Western Blots: To determine protein expression levels in the sample, total protein 
samples were prepared with 5 x loading buffer and then heated at 100oC for 5 min.  After 
cooled down on the ice, protein samples were loaded onto bis-acrylamide gels and 
separated using polyacrylamide gel electrophoresis (PAGE).  Samples were then 
transferred to PVDF membrane (Millipore) and blocked with 5% (w/v) non-fat dry milk 
in Tris-buffered saline (pH 8.0) for 1 h.  The appropriate primary antibodies were added 
and incubated with membranes at 4oC overnight.  After primary antibody incubation, 
membranes were washed briefly with 1 x TBST buffer.  Either anti-mouse or anti-rabbit 
secondary antibodies were added and incubated with membranes for 1 hour at room 
temperature.  Secondary antibody signals were detected using either HRP-linked 
chemiluminescence with SuperSignal West Dura Chemiluminescence Substrate (Thermo 
Scientific) or ClarityTM ECL western blotting substrate.  The signal for the target protein 
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of each sample was quantified using Image Lab Software (5.0) and expressed in arbitrary 
unit (AU).   
Cross-link Magnetic Co-immunoprecipitation (Co-IP): Quadriceps muscle was 
used for the purpose of Co-IP and a protein Co-IP kit was obtained commercially and 
Grp78/BiP protein Co-IP was conducted accordingly to the manual.  Briefly, protein 
magnetic beads were prepared and incubated with Grp78/BiP antibody for 30 min at 
room temperature.  After incubation, bead-antibody products were collected.  For the 
purpose of cross linking, diluted discuccinimidyl suberate (DSS) were added and 
incubated with bead-antibody for 30 min at room temperature.  After cross linking, the 
products were washed briefly and collected.  Then, total protein samples were prepared 
and incubated with cross-linking products at 4oC overnight.  After protein sample 
incubation, Grp78/BiP protein complexes were washed off using elution buffer. After 
sample elution, the samples were neutralized by adding neutralization buffer and the 
sample pH were set as 7.0.  The final elution contains Grp78/BiP and its protein 
interacting partners. 
Mass Spectrometry-based Protein Identification & Quantity: In-solution 
enzymatic digestion and bottom-up protein mass spectrometry strategy were used to 
identify proteins in Grp78/BiP Co-IP products.  For this purpose, Grp78/BiP Co-IP 
products were reduced with 5 mM DTT and then alkylated with 55 mM iodoacetamide.  
Then, Grp78/BiP Co-IP produces were incubated with trypsin (1 ug) at 37oC overnight.  
Mass spectrometry-based protein identification and quantity method has been described 
previous.  Briefly, after trypsin digestion, peptide products were collected and analyzed 
by nano LC-MS/MS analysis using LTQ Orbitrap mass spectrometer coupled to a 
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Shimadzu 2D Nano HPLC system. Peptides were loaded with an autosampler into an 
Zorbax SBC18 trap column (0.3 x 5.0 mm) (Agilent Technologies, Palo Alto, CA, USA) 
at 10 mL/min with solvent A (97.5% water, 2.5% ACN, 0.1% formic acid) for 10 min, 
then eluted and separated at 300 nL/min with a gradient of 0–35% solvent B (2.5% water, 
97.5% ACN, 0.1% formic acid) in 30 min using a Zorbax SB-C18 nano column (0.075 x 
150 mm). The mass spectrometer was set to acquire a full scan at resolution 60,000 (m/z 
400) followed by data dependent MSMS analysis of top 10 peaks with more than one 
charge in the linear ion trap at unit mass resolution. The resulting LC-MS/MS data were 
searched against a mouse protein database generated from uniprot and a common 
contaminant database using Mascot (v2.3) and Sequest search engines through Proteome 
Discoverer (v1.4). Carbomidomethylation at Cys was set as fixed modification. 
Methionine oxidation and asparagine and glutamine deamidation were set as variable 
modification. Spectral counting with normalized total spectra was carried out using 
Scaffold software, (Proteome Software, Inc). Protein probability >99% and at least one 
unique peptide with a probability score >95% were set to as minimum requirement for 
protein identification (10). 
SR Ca2+ ATPase Activity Assay: SR Ca2+ ATPase activity was measured in 
C2C12 lysates and in isolated SR vesicles.  SR vesicles from skeletal muscle were a kind 
gift of R. Bloch.  The methods for measuring SR Ca2+ ATPase activity has been 
described previously (13; 204) and this was applied to C2C12 myotube lysates.    Briefly, 
for testing SR Ca2+ ATPase activity in the cell lysates, myotubes were collected and 
homogenized in homogenizing media containing 200mM 200 mM Sucrose, 10 mM NaN3, 
1mM EDTA, and 40 mM L-histidine (pH 7.8). The SR Ca2+ ATPase reaction was 
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measured in a myotube lysates in a reaction buffer containing 200 mM KCl, 20 mM 
HEPES, 10 mM NaH3, 1 mM EGTA, 15 mM MgCl2, 5 mM ATP, and 10 mM 
phophoenolpyruvate (PEP).  To measure the Ca2+ ATPase activity 18 U/mL each of 
lactate dyhydrogenase (LDH), pyruvate kinase (PK), and 2M calcium ionophore A23187 
were added to the assay buffer.    SR Ca2+ ATPase activity was measured at different 
calcium concentrations: 0.1, 0.5, 1.0, 2.0, and 5.0 mM CaCl2.  SR Ca2+ ATPase activity 
reaches the maximal activity at 1.0 mM CaCl2, whereas higher calcium concentration, 
such as 5.0 mM CaCl2, inhibits SR Ca2+ ATPase activity. The reaction is driven by 
adding 0.4 uM NADH and the absorbance of NADH is measured at 340 nm every 30 s 
for 40 min.  Specific SR Ca2+ ATPase activity is calculated using total ATPase activity at 
1mM CaCl2 minus basal ATPase activity, which is generated by adding 10 μM 
cyclopiazonic acid (CPA), which is a selective SERCA inhibitor. 
For testing SR Ca2+ ATPase activity using SR vesicles, vesicles were added into 
SR Ca2+ ATPase activity buffer activity measured under different calcium concentrations 
as described above.  Both cell lysates and SR vesicles determination of SR Ca2+ ATPase 
activity were performed in 96-well plates.   
Statistical Analysis: All results were expressed as means ± S.E. For protein 
validation using western blots of Grp78/BiP co-IP products and maximal SR Ca2+ 
ATPase activity determination in SR vesicles, a Student t-test was used. For cell culture 





Identification of Grp78/BiP protein-protein interactions using antibody-based 
protein precipitation and protein mass spectrometry.  A systematic series of methods 
coupling antibody-based protein co-immunoprecipitation with protein mass spectrometry 
has been developed and optimized in this study with the aim of identifying Grp78/BiP 
binding partners in skeletal muscle of wild (WT) and transgenic SOD1*G93A (ALS-Tg) 
mice (Figure 5.1 A).  To validate the Grp78/BiP antibody used in our study, Grp78/BiP 
co-IP products from 2 sets of WT and ALS-Tg mice were loaded onto an 8% 
polyacrylamide gel and prepared for the SDS-PAGE electrophoresis. After gel 
electrophoresis, total protein was stained with a Coomassie blue kit and our results 
showed that Grp78/BiP bands were visualized at ~80 kDa size (black arrow, Figure 5.1 
B).  To further confirm the specificity of the Grp78/BiP antibody, we excised the bands 
and analyzed by protein mass spectrometry. Grp78/BiP protein was successfully 
identified in Grp78/BiP co-IP samples, indicating that the Grp78/BiP antibody was 
specific and appropriate for the purpose of doing protein-protein interaction analysis 
(supplementary Figure 5.1) (17).   
In this study, we used quadriceps muscle tissue (QUAD) collected from 4 sets of 
WT and ALS-Tg mice. Skeletal muscle total protein was obtained and Grp78/BiP and its 
interacting proteins were enriched using the Grp78/BiP antibody-based co-precipitation 
method.  To acquire solid peptide information from protein mass spectrometry analysis, 
we took advantage of different sample preparation strategies such as bottom-up and 
middle-down proteomics (209).  Trypsin digestion usually generates small peptides and is 
used for the purpose of bottom-up proteomics.  In contrast, clostripain (Arg-C) and Asp-
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N endoproteinases digestion have been commonly used for the purpose of middle-down 
proteomics since they cleave either the C-terminus of arginine residues or N-terminus of 
aspartic and cysteic acid residues respectively, resulting in larger peptides and to the 
ability to acquire additional peptide information.  The workflow would enable us to 
acquire protein ID as well as protein quantification information based on label-free 
spectral counting analysis. Finally, western blots were completed to confirm protein 
quantification data from protein mass spectrometry. 
Identification of Grp78/BiP protein binding partners using protein mass 
spectrometry.  Protein mass spectrometry analysis identified 182 proteins in our 
Grp78/BiP co-IP products (WT, n=4; ALS, n=4).  As expected, Grp78/BiP was identified 
as the most abundant protein (Table 5.1 and Figure 5.2). Besides Grp78/BiP protein, 
several proteins on the top of the list (most abundant) are: Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH, Supplementary Figure 5.3), Sarcoplasmic/endoplasmic 
reticulum calcium ATPase 1 (SERCA1, Supplementary Figure 5.4), creatine kinase M-
type (MCK) and ADP/ATP translocase (ANT-1, Supplementary Figure 5.5).  In addition, 
label-free spectral counting analysis was conducted and protein quantification analyzed 
(Table 5.1).  Our results indicated that SERCA1 and ANT-1 were in higher abundance in 
the Grp78/BiP complex from ALS-Tg muscle samples when compared to WT samples 
while GAPDH was not altered (Table 5.1, red highlight).  Western blot analysis 
confirmed that there was a significant increase in ANT-1 (Figure 5.3B) and SERCA1 
(Figure 5.3C) (~ 7-fold and ~ 40-fold, respectively) in this Grp78/BiP complex of ALS-
Tg samples. In contrast, GAPDH did not show significant difference between WT and 
ALS-Tg (Figure 5.3D).         
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Protein subcellular locations were also analyzed (Table 5.2).  Grp78/BiP is an ER-
located chaperone and our western blots analysis confirmed that Grp78/BiP was 
interacting with SR -located proteins such as SERCA1.  However, in ALS-Tg samples 
where ER stress was activated, we found that Grp78/BiP also interacted with non-SR/ER-
located proteins such as ATP synthase subunits that are located in mitochondrial inner 
membrane.  These data suggest that Grp78/BiP may translocate to some other subcellular 
components under ER stress conditions.   Other studies in human cancer cell lines have 
shown that Grp78/BiP was localized in cell surface, cytoplasm, and mitochondria under 
cellular stress conditions (129). Collectively, our results are consistent with previous 
findings and suggest that Grp78/BiP undergoes an intracellular relocalization in ER 
stress-induced skeletal muscle.    
Effect of Grp78/BiP and SERCA1 interaction on SR Ca2+ ATPase activity. Our 
IP/protein mass spectrometry and western blots analysis showed that Grp78/BiP was 
interacting with SERCA1 in the Grp78/BiP co-IP products. For this study, we used SR 
vesicles from skeletal muscle where SERCA1 was the most abundant protein (~100 kDa, 
Figure 5.4 A).  In addition, Grp78/BiP was identified in the SR vesicle samples, further 
confirming the potential interaction between Grp78/BiP and SERCA1 proteins (Figure 
5.4 B).  To assess the functional effects of Grp78/BiP-SERCA interaction, we assessed 
SR Ca2+ ATPase activity with and without Grp78/BiP neutralization with the Grp78/BiP 
antibody.   
We confirmed maximal ATPase activity at 1 mM CaCl2 and inhibition at high 
levels (Figure 5.5 B).  To test the effect of Grp78/BiP and SERCA1 protein interaction on 
maximal SR Ca2+ ATPase activity, SR Ca2+ ATPase activity was measured under three 
122 
 
different conditions: no Grp78/BiP antibody pre-incubation, with Grp78/BiP antibody 
pre-incubation, and control antibody pre-incubation (rabbit IgG, Figure 5.5 A). There was 
a significant decrease (25.6%) in SR Ca2+ ATPase activity when SR vesicles were 
incubated with Grp78/BiP antibody (Figure 5.5 C).  To rule out the possibility of a non-
specific antibody effect, a rabbit IgG was used.  There was no effect of rabbit IgG on SR 
Ca2+ ATPase activity (Figure 5.5 C).  These data indicate that disruption of the 
Grp78/BiP - SERCA1 interaction with antibody pre-incubation decreased maximal SR 
Ca2+ ATPase activity.   
 Activation of ER stress markers with hydrogen peroxide treatment in C2C12 
myotubes. We hypothesized that oxidative stress is an important factor in inducing ER 
stress in skeletal muscle in ALS-Tg mice.  To test this notion, we used C2C12 cell culture 
system and induced oxidative stress using H2O2.  Both 100 μM and 200 μM H2O2 
treatment upregulated Grp78/BiP and CHOP protein expression in C2C12 myotubes (~2-
fold and ~1.7-fold, respectively) (Figure 5.6). Moreover, Grp78/BiP and CHOP protein 
expression did not show significant changes when myotubes were pre-treated with100 
U/mL catalase (Figure 5.6).  Thapsigargin (TG) treatment was used as a positive control 
to induce ER stress (9).   Both 1 nM and 5 nM TG significantly upregulated Grp78/BiP 
and CHOP protein levels (~2.2-fold for Grp78/BiP and ~8-fold and 10-fold for CHOP) in 
C2C12 myotubes (Figure 5.7).  To determine if 4-PBA pre-treatment could inhibit H2O2-
induced activation of ER stress, C2C12 myotubes were pre-treated with 10 mM 4-PBA 
prior to H2O2 exposure.  4-PBA attenuated the increase in Grp78/BiP expression but did 
not have an effect on CHOP expression, indicating that 4-PBA pre-treatment could only 
partially attenuate the activation of ER stress in C2C12 myotubes (Figure 5.8).   
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Collectively, these results are consistent with a previous study in which H2O2 was shown 
to induce both gene and protein expression of ER stress markers in C2C12 myotubes (22).  
The effects of oxidative stress and ER stress on maximal SR Ca2+ ATPase in 
C2C12 myotubes.  Based on previous observations, we hypothesized that oxidative stress 
and ER stress would decrease SR Ca2+ ATPase activity.  As expected, both H2O2 and TG 
treatment of C2C12 myotubes dramatically decreased maximal SR Ca2+ ATPase activity 
(Supplementary Figure 5.6 and Figure 5.9).  Compared to the vehicle treatment, 100 μM 
H2O2 and 1 nM TG treatment  decreased maximum SR Ca2+ ATPase activity by 86% and 
93%, respectively (Supplementary Figure 5.6 and Figure 5.9). To evaluate the effect of 
oxidative stress and ER stress on maximal SR Ca2+ ATPase activity, we pre-treated cells 
either with 100 U/mL catalase or 10 mM 4-PBA.  Pre-treatment with 100 U/mL catalase 
rescued the decrease in SR Ca2+ ATPase activity (Figure 5.9). Pre-treatment with 10 mM 
4-PBA also rescued the TG-induced decrease in SR Ca2+ ATPase activity 
(Supplementary Figure 5.6).  However, 10 mM 4-PBA failed to fully rescue maximal SR 
Ca2+ ATPase activity with H2O2 treatment (~34% of maximal ATPase activity with 
vehicle treatment) (Figure 5.9).  Collectively, these data show that both oxidative stress 
and ER stress diminished maximum SR Ca2+ ATPase activity in C2C12 myotubes. 
Suppression of oxidative stress can fully prevent inhibition of maximal SR Ca2+ ATPase 
activity but attenuation of ER stress only showed partially rescued the decrease in SR 
Ca2+ ATPase activity with H2O2 treatment.  These data suggest that factors other than ER 






Here we have demonstrated that Grp78/BiP preferentially binds to cytoplasm and 
mitochondria proteins under ER stress conditions in skeletal muscle of ALS-Tg mice.  
We also identified SERCA1 as a Grp78/BiP –interacting protein and our show that 
Grp78/BiP is critical to preserving SERCA function in skeletal muscle. Both oxidative 
stress and ER stress could induce a dramatic decrease in SERCA SR Ca2+ ATPase 
activity in C2C12 myotubes. However, inhibition of ER stress only partially rescued the 
decrease in SR Ca2+ ATPase activity induced by oxidative stress. 
Applying protein mass spectrometry technology to investigation of protein-protein 
interactions. Mass spectrometry-based proteomics has been shown to be a powerful tool 
to decode protein information such as protein site mutations, protein post-translational 
modifications, protein-protein interactions, and protein signaling networks (209).  
Proteins function, in part, by assembling protein complexes (protein-protein interactions), 
which are tightly associated with their cellular activity.  Therefore, it is critical to 
understand what proteins are interacting and the cellular localization of these interacting 
proteins.  In this case, protein mass spectrometry has a profound impact to the protein-
protein interactions analysis.   
Mass spectrometry-based proteomics analysis of protein-protein interactions 
usually contains three key components: antibody affinity-based target protein enrichment, 
protein mass spectrometry analysis, and data validation (210).  For the purpose of 
protein-of-interest enrichment, the protein co-immunoprecipitation strategy is widely 
used. Before using it for the purpose of co-IP, the specificity of the antibody should be 
tested and validated.  Theoretically, antibodies used for co-IP could bind to endogenous 
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proteins that function as the bait and enable the capture and isolation of specific proteins 
and their binding partners.  However, there are no such exclusive antibodies produced 
and many antibodies either show poor affinity or yield non-specific protein binding.  
Consequently, non-specific protein binding and lack of specificity still exist and the MS 
data should be evaluated carefully.  To overcome this, gene engineering strategies were 
used to express a “tag” on the protein interested and the antibody is produced specifically 
to the “tag” (210).  However, those strategies have only been applied in a limited 
numbers of species and still show limitations in animal models.  Moreover, many 
biological and physiological relevant protein-protein interactions are transient and their 
affinity capacity is largely dependent on the specific subcellular environment. Therefore, 
during the mass spectrometry analysis, only a part of the large group of protein-protein 
interactions was identified.   
Before being analyzed by mass spectrometry, proteins in co-IP products are 
denatured, alkylated, and digested with proteases (10).  Bottom-up mass spectrometry-
based proteomics strategy has been widely used for the purpose of protein analysis.  In 
this strategy, proteins enriched from various biological resources are digested into small 
peptides and analyzed with mass spectrometry.  Trypsin-driven bottom-up proteomics 
strategy has its advantage since tryptic peptides are relatively stable and can be easily 
analyzed by mass spectrometer.  Moreover, tryptic peptides would be readily fragmented 
and detected, providing satisfactory information for the purpose of protein sequence 
identification.  However, trypsin digestion usually yields very small peptides and some 
peptides could be the same or not considerably different. Consequently, those small 
peptides could be either under the detection or miss their correlation to protein database 
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during mass spectrometry analysis.  In this case, middle-down mass spectrometry-based 
proteomics will be a beneficial compensation (211).  The principle of middle-down 
proteomics is to product relatively large peptides and provides more protein coverage 
information.  In our strategy, we took advantage of those two strategies and applied them 
to the identification of Grp78/BiP interacting proteins.   
 After mass spectrometry analysis, protein IDs and quantification data could be 
assessed using analysis tools such as label free spectral counting protein qualification 
method.  To confirm the mass spectrometry data analysis, western blot technique can be 
used to validate protein quantification data.  Protein database information shows that 
Grp78/BiP interacts with a variety of ER-located proteins including heat shock protein 70 
kDa family members and calcium handling proteins such as calreticulin and calnexin 
(Uniprot.org). However, changes in Grp78/BiP protein complexes under activation of ER 
stress have not been investigated.  Recently, we showed ER stress was induced in skeletal 
muscle of ALS mice (10).  Moreover, using a non-denaturing gel electrophoresis strategy, 
we showed that there was a dramatic change in Grp78/BiP protein complex in ER stress-
induced skeletal muscle (Supplement figure 5.1).  A better understanding of changes in 
Grp78/BiP protein complex is critical to reveal the role of Grp78/BiP in modulating ER 
stress signals in skeletal muscle of ALS-Tg mice.  Therefore, we combined co-IP and 
protein mass spectrometry methods to characterize Grp78/BiP protein-protein 
interactions in skeletal muscle of ALS mice. To further validate our protein qualification 
data, we selected several protein targets identified on the top of our MS data list, such as 
GAPDH, SERCA1, and ANT-1.  Our western blots analysis was consistent with the 
protein mass spectrometry results.  
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Relocalization of Grp78/BiP under ER stress activation. Grp78/BiP has long been 
recognized as an ER-located protein and induced under ER stress conditions (9).  The 
first piece of evident showing the relocalization of Grp78/BiP to cell surface was reported 
in cancer cells, where Grp78/BiP was suggested to serve as a receptor to conduct cell 
surface signaling (131).  Later on, the re-localization of Grp78/BiP event has also been 
reported in other cell types such as in proliferating endothelial cells and monocytic cells 
(130; 131).  It was shown that Grp78/BiP was bound to cytoskeletal proteins such as 
major histocompatibility complex class I and GPI-anchored T-cadherin, suggesting that 
Grp78/BiP could have a role in regulating cell survival as a cell surface receptor (130).  
The mechanisms inducing cell surface re-localization of Grp78/BiP are still largely 
unknown but studies indicated Grp78/BiP protein posttranslational modifications could 
be involved (18).   
A recent study showed that an alternative splicing form of Grp78/BiP was 
surprisingly expressed in the cytoplasm and mitochondria (130).  Our mass spectrometry 
data analysis was consistent with previous studies showing the relocalization of 
Grp78/BiP to cytoplasm and mitochondria. In our study, five proteins identified in the 
Grp78/BiP co-IP products with our mass spectrometry analysis, which were only present 
in ALS-Tg muscle samples, included ATP synthase subunits and parvalbumin. Moreover, 
subcellular location analysis bioinformatics tools showed that these proteins are non-ER 
located proteins but expressed on mitochondrial inner membranes or within the 
cytoplasm.  Although we did not directly image Grp78/BiP localization by 
immunohistochemical technqiues in skeletal muscle of ALS-Tg mice, our results are 
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consistent with previous studies indicating the relocalization of Grp78/BiP proteins to 
some other cellular components under ER stress activation (212).   
 Previous studies suggested that cytoplasmic Grp78/BiP proteins interact with 
other cytoplasmic proteins to initiated activation of the ER stress response (9).  Notably, 
previous studies in cancer cells showed that Grp78/BiP was interacting with P58IPK, 
which is an inhibitor of PERK pathway (18).  The protein interaction between Grp78/BiP 
and P58IPK would attenuate the inhibitory effect of P58IPK on PERK pathway, which is 
essential for cell survival, and thus protected cancer cells from initiating cell death 
pathway (18).  Besides being expressed in the cytoplasm, Grp78/BiP proteins were also 
found in mitochondria (130).  This notion is further supported by the fact that the ER and 
the mitochondria physically interact (213) and this subcellular connection is critical to 
preserving mitochondrial function (214).  In mitochondria, Grp78/BiP was found in the 
mitochondrial inner membrane and matrix locations (130). Consistent with this finding, 
we also reported that Grp78/BiP interacts with proteins located in mitochondrial inner 
membrane such as ATP synthase subunits.  The physiological outcome of Grp78/BiP and 
mitochondrial inner membrane proteins has been reported. It suggested that Grp78/BiP 
protected stress-induced cell injury by regulating intracellular calcium flux, decreasing 
the production of radical oxygen species, and preserving mitochondrial respiratory 
activity (215). Our finding as well as previous studies supported the notion that 
Grp78/BiP interacts with mitochondrial proteins and protects mitochondrial function 
from stress-induced cellular dysfunction.      
Grp78/BiP - Isthmin-1 - ADP/ATP translocase interactions. Recent studies 
showed that upon activation of ER stress, Grp78/BiP proteins were expressed on the cell 
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surface and served as a receptor that modulated extracellular signaling (130).  The 
biological outcomes of cell surface expression of Grp78/BiP were suggested to induce 
cell death pathway such as apoptosis (130).  Grp78/BiP was found to be highly expressed 
on the cell surface and showed strong affinity to a secreted protein called Isthmin-1, 
which plays a role in inducing cell death in certain types of cells such as in endothelial 
cells (130). Under cellular stress conditions, Grp78/BiP were expressed on the cell 
surface and responsible for shuttling extracellular Isthmin-1 proteins into the cytoplasm 
in a clathrin-dependent way (130).  Upon movement into the cell, Isthimin-1 interacted 
with Grp78/BiP and ADP/ATP translocase forming a protein complex in mitochondria 
(130). The final effect is to decrease ADP/ATP translocase capacity to initiate ADP/ATP 
turnover (130).  Consequently, disruption of ADP/ATP transport induced mitochondrial 
dysfunction and resulted in apoptosis.  Bases on these observations, either adding 
Grp78/BiP antibody or isthmin-1 antibody showed rescue effect on cell survival.  
Therefore, Grp78/BiP - Isthmin-1 - ADP/ATP translocase has been presented as a novel 
pathway to induce apoptosis and isthmin-1 was served as a novel cytokine involved in the 
initiation of cell death.  Our mass spectrometry data and western blots validation data 
clearly showed that Grp78/BiP interacts with ADP/ATP translocase and we expect that 
Isthmin-1 could be a novel secreted factor that induces cell death and muscle atrophy in 
the animal model of ALS under ER stress activation.   
Grp78/BiP and SERCA1 protein-protein interaction in skeletal muscle.  
Grp78/BiP is a member of heat shock protein 70 kDa family (hsp70s). A previous study 
showed that hsp70 interacts with SERCA1 in skeletal muscle (20).  The biological 
consequence of those protein-protein interactions was investigated and it was suggested 
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that hsp70s had a protective role in SERCA1 function under heat stress challenge (20). 
SERCA1 is an ATP-dependent calcium pump located on the SR membrane and 
responsible for taking up calcium from cytoplasm to the ER lumen. SR Ca2+ ATPase 
activity is critical to preserving skeletal muscle function not only because it is the most 
abundance protein in the SR/ER but also because muscle contraction is known to induce 
a dramatic change in intramuscular calcium level (~300-fold) (195).  
To evaluate the biological consequence of Grp78/BiP and SERCA1 interaction, 
we developed an in vitro assay to determine SR Ca2+ ATPase activity with and without 
Grp78/BiP antibody.  Considering the protective role of hsp70s proteins in preserving 
SERCA1 function under heat stress, we hypothesized that disruption of this protein-
protein interaction would decrease SR Ca2+ ATPase activity.  Our results showed that 
there was a ~20% of decrease in maximal SR Ca2+ ATPase activity with Grp78/BiP 
antibody pre-incubation, supporting the notion that Grp78/BiP could interact with 
SERCA1 and thereby preserve maximal SR Ca2+ATPase activity.  Our results imply that 
Grp78/BiP and SERCA1 interaction is critical to maintaining SR Ca2+ ATPase activity 
under conditions of ER stress.  However, further studies need to be conducted to 
investigate the cellular outcomes of Grp78/BiP and SERCA1 protein-protein interaction 
under cellular stress conditions.    
The role of oxidative stress and ER stress in regulating SR Ca2+ ATPase activity 
in C2C12 myotubes.  Skeletal muscle contraction is driven by the dramatic elevation of 
intracellular calcium upon release from the SR/ER.  After muscle contraction, 
intracellular calcium levels are returned to resting levels by the SR Ca2+ ATPase 
(SERCA1 and SERCA2). A prolonged increase in intracellular calcium level is harmful 
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and previous studies suggested higher resting intracellular calcium levels could induce 
cell death and cause pathological conditions in muscle-related diseases (56).  Intracellular 
calcium level is tightly controlled by various calcium handling proteins such as SERCA1, 
which is an ATP-dependent calcium pump located on ER membrane and responsible for 
taking up calcium back into the SR/ER after muscle contraction.   The ATPase activity of 
SERCA1 is critical to preserving intracellular calcium balance and cellular homeostasis.  
Decreased SR Ca2+ ATPase activity in skeletal muscle is known to contribute to muscle 
pathology such as in muscular dystrophy and muscle atrophy (12; 216).  Our lab recently 
reported that maximal SR Ca2+ ATPase activity was decreased in skeletal muscle of the 
G93A*SOD1 ALS mouse model and could induce skeletal muscle function (12).  Indeed, 
both treatment with a small molecule activator of SERCA and transgenic overexpression 
of SERCA1 in skeletal muscle have been shown to improve skeletal muscle function and 
attenuate disease phenotypes in ALS mice (unpublished data and Chapter 4).  These data 
suggested to us that SR Ca2+ ATPase activity is critical to preserving muscle function and 
attenuating disease progression in ALS mice.   
Pathological factors inducing skeletal muscle dysfunction in ALS are still largely 
unknown.  However, mutant SOD1 protein-mediated oxidative stress is suggested to be a 
primary candidate due to its immediate connection with overproduction of hydrogen 
peroxide (17). We hypothesized that oxidative stress and ER stress would decrease SR 
Ca2+ ATPase activity in the skeletal muscle and inhibition of these two cellular stress 
pathways would attenuate the decreased in SR Ca2+ ATPase activity.  For this purpose, 
we took advantage of the C2C12 myotube culture model and oxidative stress and ER 
stress were induced using in vitro pharmacological treatments, hydrogen peroxide (H2O2) 
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and thapsigargin (TG) treatment respectively.  Our results showed that both H2O2 and TG 
treatment dramatically reduced maximal SR Ca2+ ATPase activity.  Moreover, pre-
treatment of myotubes with 4-PBA, which is a chemical chaperone and represses ER 
stress response, was shown to attenuate the decrease in SR Ca2+ ATPase activity induced 
by TG.  However, 4-PBA pre-treatment only partly prevented the decrease in maximal 
SR Ca2+ ATPase activity induced by H2O2 treatment.  These data indicate that inhibition 
of ER stress could be a therapeutic method to rescue skeletal muscle damage.  
Additionally, besides ER stress, other factors are suggested to contribute to the decrease 
in maximal SR Ca2+ ATPase activity induced by oxidative stress. 
In summary, by studying the Grp78/BiP protein-protein interactions we have 
shown that Grp78/BiP interacts with proteins expressed in the cytoplasm and 
mitochondria, suggesting the cellular relocalization of Grp78/BiP under ER stress 
activation.  Moreover, Grp78/BiP interacts with SERCA1 in skeletal muscle and appears 
to be protective in terms of maintaining SR Ca2+ ATPase function.  We also show that 
oxidative stress and ER stress dramatically reduce maximal SR Ca2+ ATPase activity and 
that inhibition of ER stress could be beneficial in preventing this decline.  Overall these 
data suggest that inhibition of ER stress could be beneficial for treating skeletal muscle in 
ALS.  However, other factors also contribute to the oxidative stress-induced decrease in 
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Figure 5.1: Identification of Grp78/BiP protein-protein interactions using co-
immunoprecipitation and protein mass spectrometry.  (A) Skeletal muscle total 
protein from four sets of wild type and ALS animals was isolated. Grp78/BiP and its 
binding proteins were enriched with Grp78/BiP protein co-immunoprecipitation (co-IP).  
Before being sent to mass spectrometry, co-IP protein products were digested with 
different proteases.  Liquid chromatography-tandem mass spectrometry was used for the 
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purpose of protein identification and western blots were used to validate protein mass 
spectrometry data.  (B) 30 ug of total muscle protein from wild type and ALS mice were 
loaded on 8% sodium dodecyl sulfate polyacrylamide gel (SDS-PAGE).  After SDS-
PAGE gel electrophoresis, the protein gel was washed briefly with water and incubated 
with coomassie blue stain buffer.  Grp78/BiP (black arrow) and other protein bands were 




Table 5.1. Top seven proteins identified in the Grp78/BiP co-precipitation products 






Heat shock 70kD protein 5 (Glucose-regulated protein) 
OS=Mus musculus GN=Hspa5 PE=3 SV=1 101 67 
Glyceraldehyde-3-phosphate dehydrogenase OS=Mus 
musculus GN=Gapdh PE=1 SV=2 10 13 
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 
OS=Mus musculus GN=Atp2a1 PE=2 SV=1 2 15 
Creatine kinase M-type OS=Mus musculus GN=Ckm PE=1 
SV=1 4 7 
ADP/ATP translocase=Mus musculus GN=Alb PE=1 SV=3 0 8 
Pterin-mimicking anti-idiotope heavy chain variable region 
(Fragment) OS=Mus musculus PE=4 SV=1 9 5 
ATP synthase subunit alpha, mitochondrial OS=Mus 






Figure 5.2: Identification of Grp78/BiP protein in Grp78/BiP co-IP products using 
LC-MS/MS.  A) Grp78/BiP was identified in one of our samples with ~50% peptide 
coverage (yellow highlight), 26 exclusive unique peptides, and 32 total spectra.  B) b- 






Figure 5.3: Validation of ANT-1, SERCA1, GAPDH proteins by western blots in 
Grp78/BiP co-IP products.  (A) Grp78/BiP co-IP products from wild type (WT, n=4) 
and SOD1*G93A (ALS-Tg, n=4) samples were prepared for the purpose of doing 
western blots.  The representative western blots results of ANT-1, SERCA1, GAPDH, 
and Grp78/BiP were shown.  Data analysis of ANT-1 (B), SERCA1 (C), GAPDH (D) 




Table 5.2. Proteins identified in Grp78/BiP co-IP products using protein mass 
spectrometry.   
 
Protein qualification was analyzed with spectral-counting numbers and its subcellular 




Figure 5.4. Identification of SERCA1 and Grp78/BiP proteins in SR vesicles.  (A) 
Four SR vesicle samples were loaded on 8% sodium dodecyl sulfate polyacrylamide gel 
(SDS-PAGE).  After SDS-PAGE gel electrophoresis, the protein gel was washed briefly 
with water and stained with coomassie blue.  SERCA1 was shown to be the most 
abundant protein in the SR vesicles (~100kDa). (B) Two SR vesicle samples were 
prepared for SDS-PAGE gel electrophoresis and analyzed with western blots.  Grp78/BiP 





Figure 5.5. Decreased SR Ca2+ ATPase activity with Grp78/BiP antibody incubation 
in SR vesicles. (A) Maximal SERCA1 ATPase activity was determined in three 
conditions: no Grp78/BiP antibody incubation (No Ab), Grp78/BiP incubation 
(Grp78/BiP Ab), and control rabbit IgG incubation (Control IgG).  (B) Maximal 
SERCA1 ATPase activity was shown at 1.0 mM free calcium concentration (red).  (C) 
Maximal SERCA1 ATPase activity was determined and data analysis was presented as m 





Figure 5.6.  Activation of ER stress in C2C12 myotubes with hydrogen peroxidate 
treatment.  C2C12 myotubes were treated with 100 mM and 200 uM hydrogen peroxide 
(H2O2).  100 U/mL catalase (Cat.) pre-treatment was used to neutralize the effect of 
hydrogen peroxide.  After treatment, cells were collected and prepared for western blots 
analysis. The protein level of Grp78/BiP and CHOP was tested and β-actin was used as 
the total protein loading control (A and C).  (B) The protein qualification of Grp78/BiP 
and CHOP was presented as arbitrary units (B and D).  Data was presented as means ± 





Figure 5.7.  Activation of ER stress in C2C12 myotubes with thapsigargin treatment.  
C2C12 myotubes were treated with 1 nM and 5 nM thapsigargin (Tg).  To test the effect 
of 4-PBA (PBA) on ER stress markers Grp78 and CHOP, cells were pre-treated with 10 
mM 4-PBA before adding thapsigargin.  After treatment, cells were collected and 
prepared for western blots analysis. The protein level of Grp78/BiP and CHOP was tested 
and β-actin was used as the total protein loading control (A and C).  (B) The protein 
qualification of Grp78/BiP and CHOP was presented as arbitrary units (B and D).  Data 






Figure 5.8. The effect of 4-PBA (PBA) pre-treatment attenuated hydrogen peroxide-
induced ER stress activation. C2C12 myotubes were treated with 200 mM and 1 mM 
hydrogen peroxide (H2O2). To test the effect of 4-PBA (PBA) on ER stress markers 
Grp78 and CHOP, cells were pre-treated with 10 mM 4-PBA before adding hydrogen 
peroxide.  After treatment, cells were collected and prepared for western blots analysis. 
The protein level of Grp78/BiP and CHOP was tested and β-actin was used as the total 
protein loading control (A and C).  (B) The protein qualification of Grp78/BiP and CHOP 
was presented as arbitrary units (B and D).  Data was presented as means ± S.E. *p<0.05 
vs. hydrogen peroxide-only vehicle treatment (Veh.). †p<0.05 vs. PBA pre-treatment 







Figure 5.9.  The effect of oxidative stress and 4-PBA treatment on maximal SR Ca2+ 
ATPase activity.  Hydrogen peroxide (100 µM H2O2) was used to induce oxidative 
stress in C2C12 myotubes.  To evaluate the effect of catalase and 4-PBA on maximal 
SERCA1 ATPase activity, C2C12 myotubes were pre-treated either with control vehicle 
(CON), 100 U/mL catalase (Cat.) or 10 mM 4-PBA (PBA).  After treatment, myotubes 
were collected and maximal SERCA1 ATPase activity was tested.  Data was presented as 






Supplementary Figure 5.1.  Identification of Grp78/BiP protein complexs using 
denaturing gel electrophoresis.  Quadriceps muscle tissues were collected from wild 
type (QT, n=2) and SOD1*G93A (ALS Tg, n=2) mice and prepared for the purpose of 
doing denaturing gel electrophoresis.  After gel electrophoresis, proteins were transferred 
to PVDF and then incubated with Grp78/BiP antibody.  After primary antibody 
incubation, the secondary antibody was used and the protein bands were visualized using 
our imaging system.  Total protein stain with coomassie blue was used for protein 






Supplement figure 5.2: Identification of G78/BiP protein in the protein bands 
excised from Grp78/BiP co-IP products.  A) Grp78/BiP was identified in one of our 
samples with ~21% peptide coverage (yellow highlight), 8 exclusive unique peptides, and 
19 total spectra.  B) b- and y- ion fragmentation of a peptide FEELNMDLFR was 





Supplement figure 5.3: Identification GAPDH protein Grp78/BiP co-IP products 
used for protein mass spectrometry analysis.  A) GAPDH was identified in one of our 
samples with ~26% peptide coverage (yellow highlight), 7 exclusive unique peptides, and 
17 total spectra.  B) b- and y- ion fragmentation of a peptide 





Supplement figure 5.4: Identification SERCA1 protein Grp78/BiP co-IP products 
used for protein mass spectrometry analysis.  A) SERCA1 was identified in one of our 
samples with ~26% peptide coverage (yellow highlight), 8 exclusive unique peptides, and 
19 total spectra.  B) b- and y- ion fragmentation of a peptide VGEATETALTTLVEK was 






Supplement figure 5.5: Identification ANT-1 protein Grp78/BiP co-IP products used 
for protein mass spectrometry analysis.  A) ANT-1 was identified in one of our 
samples with ~26% peptide coverage (yellow highlight), 9 exclusive unique peptides, and 






Supplement figure 5.6.  The effect of 4-PBA treatment on maximal SERCA1 
ATPase activity with ER stress.  Thapsigargin (1 nM Tg) was used to induce ER stress 
in C2C12 myotubes.  To evaluate the effect of 4-PBA on maximal SERCA1 ATPase 
activity, C2C12 myotubes were pre-treated with either control vehicle (CON), 10 mM or 
5 mM 4-PBA (PBA).  After treatment, myotubes were collected and maximal SERCA1 






Supplementary Figure 5.7. Activation of ER stress in C2C12 myotubes with 
hydrogen peroxide (H2O2) and thapsigargin (TG) treatment.  (A) C2C12 myotubes 
were treated with either of H2O2 or 100 U/mL catalase plus H2O2. After treatment, cells 
were collected and prepared for the western blots analysis.  (B) C2C12 myotubes were 
treated with either different concentration of Tg and then collected and prepared for the 
western blots analysis.  PERK, p-PERK, IRE1α, p-eIF2α, Grp78/BiP, and CHOP were 





Supplementary Figure 5.8. Oxidative stress and ER stress induced C2C12 myotube 
atrophy.  (A) H2O2 was used for the purpose of inducing oxidative stress in C2C12 
myotubes. C2C12 myotubes were treated with either different concentration of H2O2 or 
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100 U/mL catalase (Cat.) plus H2O2 for two days.  Images were taken before drug 
treatment (day 0), in the end of first day treatment (day 1) and second day treatment (day 
2). (B) C2C12 myotube diameter was analyzed using Image J and presented as arbitrary 
units (A.U.).  Data was presented as Mean ± s.e. *p<0.05 vs. 1mM H2O2 treatment at 





Chapter 6: Summary and Future Directions 
We conducted three independent studies to interpret the potential molecular 
causes underlying ER stress-induced skeletal muscle dysfunction and atrophy in ALS.   
In the Study #1, we investigated ER stress pathway in skeletal muscle of ALS.  
Our results for the first time showed that ER stress was activated in skeletal muscle of 
ALS mice (10). Moreover, we suggested that prolonged activation of ER stress could 
contribute to skeletal muscle atrophy in ALS mice based on several lines of evident.  First, 
ER stress-specific cell death signal CHOP was induced dramatically in the late stage of 
ALS disease progression.  Second, ER stress activation was only present in skeletal 
muscle and motor neurons. Considering motor neurons and skeletal muscle are two 
primary targets in ALS, we suggested ER stress activation is highly relevant to disease 
pathology. Further, ER stress markers were induced to a greater extent in muscles with 
predominantly fast fibers compared with muscles with predominantly slow fibers, 
indicating that ER stress activation is associated with skeletal muscle pathogenesis (10).   
Our previous study showed that there was an elevated resting intramuscular 
calcium level in muscle fibers of ALS mice and we suspected that decreased SERCA1 
protein expression level contributed to the calcium dysregulation in skeletal muscle of 
ALS (12).  Therefore, in Study #2 we took advantage of a transgenic gain of function 
strategy in which SERCA1 was specifically overexpressed in skeletal muscle of ALS-Tg 
mice.  Our results showed that overexpression of SERCA1 in skeletal muscle was 
beneficial to ALS-Tg mice and indicated that increased SERCA SR Ca2+ ATPase activity  
leads to improved  skeletal muscle function in ALS-Tg mice.  Considering the potential 
role of ER stress in inducing skeletal muscle atrophy in ALS mice, we also determined 
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ER stress markers in this study.  Surprisingly, overexpression of SERCA1 in skeletal 
muscle did not repress activation of ER stress in ALS mice.  Our results indicated that: 1) 
the SERCA1 rescue effect on the skeletal muscle phenotype in ALS is independent of 
repressing ER stress pathway; and 2) overexpression of SERCA1 could induce temporary 
activation of ER stress in skeletal muscle of both wild type and ALS mice. 
Considering the important role of oxidative stress and ER stress in inducing 
skeletal muscle dysfunction and atrophy in ALS mice, for Study #3, we developed an 
antibody affinity-based protein mass spectrometry strategy to investigate Grp78/BiP 
protein-protein interaction patterns in skeletal muscle of wild type and ALS-Tg mice. In 
this study, Grp78/BiP antibody was used for the purpose of protein precipitation. 
Consequently, Grp78/BiP and its protein complex were enriched and analyzed by mass 
spectrometry.  Several highly abundant identified proteins from mass spectrometry 
analysis were validated using western blot. Grp78/BiP is known as an ER lumen-located 
protein.  However, our MS data analysis showed that Grp78/BiP protein was 
preferentially bound to non-ER proteins such as ATP synthase subunits, which are 
located in mitochondria, and parvalbumin, a cytoplasm-located protein in muscle from 
ALS-Tg mice.  Moreover, our previous study showed that ER stress was specifically 
activated in skeletal muscle of ALS.  Collectively, our results are consistent with 
previous studies showing the subcellular translocation of Grp78/BiP protein under 
cellular stress conditions (130). SERCA1 is known as an ATPase located on the SR/ER 
membrane and responsible for calcium uptake from cytoplasm to ER lumen after a bout 
of calcium release such as during muscle contraction.  Interestingly, our MS data analysis 
showed that Grp78/BiP interacted with SERCA1 in skeletal muscle of both wild type and 
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ALS mice.  To determine the functional importance of this protein-protein interaction, we 
tested SERCA1 ATPase activity with Grp78/BiP antibody incubation. Our results 
showed that Grp78/BiP antibody pre-incubation induced a 20% decrease in SR Ca2+ 
ATPase activity, which was not seen with control rabbit IgG incubation, indicating that 
preservation of this protein-protein interaction could be critical to SERCA1 function.   
Finally, considering the important role of SERCA1 function in preserving skeletal muscle 
function, we used a muscle cell model to investigate oxidative stress/ER stress/SR Ca2+ 
ATPase activity.  Our cell culture study indicated that oxidative stress was not a single 
factor inducing ER stress and suggested that other factors contribute to activation of ER 
stress in ALS. 
Limitations 
In Study #1, although we showed that ER stress was activated in skeletal muscle 
of ALS, our study did not directly test the causal role of ER stress in inducing skeletal 
muscle atrophy in ALS mice.  In this case, specific deletion of ER stress-induced cell 
death signal CHOP would be a solution, which is addressed in the future direction.  In 
Study #2, although we studied muscle mass and disease progression, we did not 
determine if improvement of skeletal muscle phenotype could rescue the motor neuron 
atrophy based on the “dying-back” model of ALS.  In this case, tissue histology could be 
used to investigate if there are any improvements in motor neuron survival in the spinal 
cord withSERCA1 overexpression in ALS-Tg mice.  In Study #3, although Grp78/BiP 
interaction mass spectrometry data indicated that Grp78/BiP proteins interact with 
proteins from other cellular locations, a more physiology-relevant condition should be 
used to validate the mass spectrometry data. For example, a skeletal muscle histology 
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strategy can be used to visualize Grp78/BiP proteins in the cross-section of skeletal 
muscle of wild type and ALS-Tg mice.  
  
Future direction 
Isthmin-1: a novel cytokine inducing cell death in skeletal muscle under ER stress? 
Isthmis-1 (ISM-1) was identified as a 60 kDa secreted protein containing two 
functional  sequences: thrombospondin type 1 repeat domain (TSP-1) and adhesion-
associated domain in MUC4 and other proteins domain (AMOP) (217).  Both protein 
domains are typically located in secreted proteins and responsible for cell adhesion and 
cell migration, indicating its potential role as a cytokine involved in modulating cellular 
signaling (217). ISM-1 was firstly identified as a novel inhibitor of endogenous 
angiogenesis. In in vitro studies, ISM-1 was shown to inhibit angiogenesis during 
endothelial cell capillary network formation as well as induce apoptosis (218). In animal 
studies, ISM-1 overexpression was shown to inhibit tumor growth (219). Moreover, 
knockout of ISM-1 in zebrafish embryos resulted in abnormal intersegmental vessel 
formation (218). It is clear that ISM-1 induces apoptosis and represses angiogenesis (218). 
However, the potential molecular mechanism for how extracellular ISM-1 directs signals 
into the cell and initiates the anti-angiogenenic action is still unknown. Recently, a mass 
spectrometry-based protein receptor assay showed Grp78/BiP interacted with ISM-1 
(218).  Binding affinity assay showed that cell surface Grp78/BiP had a very high affinity 
to ISM-1, further confirming this protein-protein interaction (130). Consequently, the 
mechanism of how ISM-1 initiates its pro-apoptotic effect was revealed. In this model, 
Grp78/BiP translocated to cell surface under cellular stress conditions, where Grp78/BiP 
159 
 
worked as a protein receptor and modulated the cellular re-localization of ISM-1 from the 
extracellular space to the cytoplasm in a clathrin-dependent endocytosis fashion (130).  
Once translocated into the cell, ISM-1/Grp78/BiP was shown to interact with ADP/ATP 
translocase, which is a mitochondrial membrane protein and shuttles ATP from 
mitochondria to cytoplasm (130).  Once binding to ADP-ATP translocase, ISM-
1/Grp78/BiP inhibited ADP/ATP turnover, resulting in mitochondrial dysfunction, and 
thus inducing mitochondria-dependent cell death (130).  Those studies reveal several 
clues about the role of IMS-1 in integrating cell signals.  First, ISM-1 could be a novel 
cytokine initiating extracellular and intracellular signals to induce cell death and tissue 
dysfunction. Second, although the role of ISM-1 in driving apoptosis has been revealed, 
several questions still need to be answered such as in which tissue ISM-1 proteins get 
secreted and how ISM-1 protein translocates into the cell (e.g., protein posttranslational 
modifications)? Finally, ISM-1 could also induce apoptosis in some other cell types such 
as myocytes.   
Our primary data indicated that Grp78/BiP interacted with the mitochondrial 
protein ADP/ATP translocase under activation of ER stress, leading us to ask these 
questions in the future: 1) Is Grp78/BiP is expressed in the cell surface in skeletal muscle 
fibers of ALS-Tg mice? 2) Does Grp78/BiP bind to ISM-1 in skeletal muscle of ALS-Tg 
mice? 3) Is ISM-1 a novel cytokine to induce skeletal muscle atrophy under ER stress 
activation?   
In vivo determination of ER stress inducing muscle atrophy in ALS 
Activation of ER stress contributes to muscle pathology in various muscle 
diseases such as in sporadic inclusion-body myositis, cancer cachexia induced skeletal 
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muscle wasting, muscular dystrophy, stroke-induced myopathy, and neurodegenerative 
diseases (124).  The causal role of ER stress in inducing muscle pathology is further 
established in both transgenic animal models and pharmacological drug treatment studies.  
For example, a study conducted by Moorwood et al (149) showed that several ER stress 
markers including Grp78/BiP, CHOP, and caspase-12, were induced in skeletal muscle in 
a mouse model of Duchenne muscular dystrophy (DMD).  Caspase-12 is identified as an 
ER stress-specific induced cell death signal.  When caspase-12 from DMD mice was 
deleted, ER stress was inhibited (149). Moreover, an improved phenotype was observed 
in this study including improvements in skeletal muscle function and attenuation in 
muscle degeneration (149).  This study suggested that ER stress activation contributes to 
muscle dysfunction in DMD mice and that inhibition of the ER stress apoptotic pathway 
offers a novel therapeutic method to treat muscle pathology in DMD (149). 
Inhibition of ER stress pathway was suggested as an effective strategy to delay 
disease progression in ALS-Tg mice (152).  Studies conducted by Kieran et al showed 
that treating ALS mice with arimoclomol, which is a coinducer of heat shock proteins 
and represses ER stress activation, could improve muscle function, preserve motoneuron 
survival, and increase lifespan in ALS mice (152).  Although activation of ER stress in 
motoneruons is also a main feature and arimoclomol treatment could attenuate disease 
progression by improving motoneuron function in ALS-Tg mice, this study provided the 
first line of evidence that there is a link between inhibition of ER stress and improved 
muscle function in ALS-Tg mice (152). Our study further confirmed the notion that 
activation of ER stress is causally associated with ALS disease progression. In our study, 
ALS-Tg mice treated with 6-gingerol, a small molecular previously shown to activate the 
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SR Ca2+ ATPase pump, showed improvements in muscle function. Most importantly, ER 
stress markers were repressed with drug treatment (unpublished data).   
Although several therapeutic treatments have been proposed to address the role of 
ER stress in initiating disease pathology in ALS-Tg mice (152), to fully determine the 
role of ER stress activation in inducing skeletal muscle dysfunction, a better model such 
as transgenic animals should be used for this purpose.  Previous studies indicated that 
either upregulation of ER chaperones, such as hsp70s, or deletion of ER stress-specific 
cell death signals such as CHOP and caspase-12 was an attractive strategy to repress the 
activation of ER stress (149). As a transcriptional factor, CHOP is suggested to integrate 
cell death signals induced by ER stress such as pro-apoptotic regulator Bcl-2-associated x 
proteins (9). Therefore, CHOP knockout animal models have been used to investigate ER 
stress-induced organ dysfunction (220). Caspase-12 knockout strategy has been also 
presented in several studies. However, caspase-12 is not present in human, wakening its 
role as an appealing therapeutic target for treating human diseases. Therefore, to study 
the role of ER stress in inducing skeletal muscle atrophy in ALS, skeletal muscle-specific 
deletion of CHOP could be used and crossed with ALS mice.  Outcome determinations 
include skeletal muscle function, muscle mass, disease onset, and disease progression. 
This study will address several key points regarding pathological mechanism in ALS.  In 
the first place, this study will fully evaluate the role of ER stress activation in inducing 
skeletal muscle atrophy and dysfunction in ALS. In the second place, our study will 
address the primary role of muscle pathology in inducing ALS pathophysiology.  
Previous studies presented the principle of “dying-back” model in ALS disease, in which 
ALS pathophysiology is thought to stem from skeletal muscle or neuron-muscle junctions. 
162 
 
However, early pathological events in skeletal muscle of ALS are still unknown. Here we 
presented that ER stress activation in skeletal muscle not only resulted in muscle 
pathology but also could contribute to muscle-induced whole body ALS phenotype. In 
the last, our study will provide a piece of evidence that can be used in treating some other 
types of ER stress-involved muscle dysfunction/diseases. It should be noted that skeletal 
muscle function is tightly associated with muscle metabolism and several lines of 
evidence indicated that activation of ER stress contributed to metabolic defects in skeletal 
muscle and it will be interesting to ask if inhibition of ER stress, which preserves skeletal 















Figure 6.1. “All Roads Lead to Rome”- the schematic model of skeletal muscle 
atrophy in ALS. . Based on our three independent studies, proposed model is proposed 
with various potential mechanisms inducing skeletal muscle atrophy and dysfunction in 
ALS from Study #1 (blue-dots line), Study #2 (black-dots line), and Study #3 (red-dots 
line). Study #1 investigated ER stress pathway and we suggested that ER stress-specific 
cell signal CHOP could induce myocyte death and induce skeletal muscle atrophy in ALS.  
Study #2 investigated the effect skeletal muscle overexpressing SERCA1 on skeletal 
muscle function and atrophy in ALS-Tg mice. SERCA1 preserved skeletal muscle 
function and improved the ALS phenotype in ALS-Tg mice.  Study #3 investigated the 
molecular mechanisms underlying ER stress-induced skeletal muscle atrophy in ALS.  
Oxidative stress and ER stress could induce muscle dysfunction by regulating SERCA 
function.  Furthermore, we proposed the hypothesis that ISM-1 could play a role as a 
novel cytokine to induce mitochondrial dysfunction and tissue atrophy by interacting 
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